JP5118627B2 - スピロオキシインドール化合物および治療剤としてのその使用 - Google Patents
スピロオキシインドール化合物および治療剤としてのその使用 Download PDFInfo
- Publication number
- JP5118627B2 JP5118627B2 JP2008506802A JP2008506802A JP5118627B2 JP 5118627 B2 JP5118627 B2 JP 5118627B2 JP 2008506802 A JP2008506802 A JP 2008506802A JP 2008506802 A JP2008506802 A JP 2008506802A JP 5118627 B2 JP5118627 B2 JP 5118627B2
- Authority
- JP
- Japan
- Prior art keywords
- indole
- furo
- oxospiro
- benzodioxol
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000001875 compounds Chemical class 0.000 title claims description 138
- 239000003814 drug Substances 0.000 title description 15
- 229940124597 therapeutic agent Drugs 0.000 title description 2
- 125000001072 heteroaryl group Chemical group 0.000 claims description 416
- 125000000623 heterocyclic group Chemical group 0.000 claims description 393
- -1 aralkenyl Chemical group 0.000 claims description 391
- 125000003118 aryl group Chemical group 0.000 claims description 377
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 332
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 292
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 291
- 125000000217 alkyl group Chemical group 0.000 claims description 278
- 229910052739 hydrogen Inorganic materials 0.000 claims description 232
- 239000001257 hydrogen Substances 0.000 claims description 232
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 212
- 125000001188 haloalkyl group Chemical group 0.000 claims description 204
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims description 201
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims description 187
- 150000002431 hydrogen Chemical class 0.000 claims description 177
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 165
- 125000003342 alkenyl group Chemical group 0.000 claims description 143
- 125000005843 halogen group Chemical group 0.000 claims description 131
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 127
- 125000000304 alkynyl group Chemical group 0.000 claims description 122
- 229910052757 nitrogen Inorganic materials 0.000 claims description 104
- 125000004450 alkenylene group Chemical group 0.000 claims description 88
- 125000002947 alkylene group Chemical group 0.000 claims description 88
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 85
- 125000004419 alkynylene group Chemical group 0.000 claims description 84
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 79
- 125000001424 substituent group Chemical group 0.000 claims description 76
- 125000000262 haloalkenyl group Chemical group 0.000 claims description 68
- 125000003545 alkoxy group Chemical group 0.000 claims description 57
- 125000004438 haloalkoxy group Chemical group 0.000 claims description 56
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 55
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 48
- 125000005605 benzo group Chemical group 0.000 claims description 42
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 41
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 28
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 18
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 18
- 125000004043 oxo group Chemical group O=* 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 17
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 15
- 125000002346 iodo group Chemical group I* 0.000 claims description 13
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 13
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 12
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 7
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 7
- 125000003229 2-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 6
- 125000003469 3-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims description 6
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 6
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 6
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Natural products CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 229910052717 sulfur Inorganic materials 0.000 claims description 5
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 496
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 60
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 44
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 38
- 239000004202 carbamide Substances 0.000 claims 38
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 13
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 claims 9
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 9
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 6
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims 6
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 5
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 claims 5
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 5
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 5
- 125000003003 spiro group Chemical group 0.000 claims 5
- 125000000301 2-(3-chlorophenyl)ethyl group Chemical group [H]C1=C([H])C(=C([H])C(Cl)=C1[H])C([H])([H])C([H])([H])* 0.000 claims 4
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 claims 4
- 125000002927 2-methoxybenzyl group Chemical group [H]C1=C([H])C([H])=C(C(OC([H])([H])[H])=C1[H])C([H])([H])* 0.000 claims 4
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 claims 4
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims 4
- 125000006284 3-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(F)=C1[H])C([H])([H])* 0.000 claims 4
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims 4
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 claims 4
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims 4
- 125000004860 4-ethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])C([H])([H])[H] 0.000 claims 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims 4
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims 4
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 4
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 claims 4
- DNUTZBZXLPWRJG-UHFFFAOYSA-M piperidine-1-carboxylate Chemical compound [O-]C(=O)N1CCCCC1 DNUTZBZXLPWRJG-UHFFFAOYSA-M 0.000 claims 4
- KICNGTSGLUFGHH-UHFFFAOYSA-N spiro[1h-indole-3,7'-6h-furo[2,3-f][1,3]benzodioxole]-2-one Chemical compound C1OC2=CC=3OCOC=3C=C2C21C1=CC=CC=C1NC2=O KICNGTSGLUFGHH-UHFFFAOYSA-N 0.000 claims 4
- 125000000579 2,2-diphenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])* 0.000 claims 3
- 125000006282 2-chlorobenzyl group Chemical group [H]C1=C([H])C(Cl)=C(C([H])=C1[H])C([H])([H])* 0.000 claims 3
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 claims 3
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 claims 3
- YDTGEQZIOFPADD-UHFFFAOYSA-N 4'-[(6-methoxypyridin-3-yl)amino]-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2NC1=CC=C(OC)N=C1 YDTGEQZIOFPADD-UHFFFAOYSA-N 0.000 claims 3
- 125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 claims 3
- 150000001408 amides Chemical class 0.000 claims 3
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims 3
- QMEKTTCBVOOSHJ-UHFFFAOYSA-N 1'-(3-aminopropyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCN)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 QMEKTTCBVOOSHJ-UHFFFAOYSA-N 0.000 claims 2
- GGZDPBXUIMTXCX-UHFFFAOYSA-N 1'-(3-cyclopropylpropyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCC1CC1 GGZDPBXUIMTXCX-UHFFFAOYSA-N 0.000 claims 2
- MFQUWJBHQNNTCU-UHFFFAOYSA-N 1'-[(2-methylcyclopropyl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CC1CC1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O MFQUWJBHQNNTCU-UHFFFAOYSA-N 0.000 claims 2
- ASYZQJHAJLSZAD-UHFFFAOYSA-N 1'-[(6-methylpyridin-3-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C1=NC(C)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O ASYZQJHAJLSZAD-UHFFFAOYSA-N 0.000 claims 2
- CKJHZRHELGEWBS-UHFFFAOYSA-N 1'-[[4-(trifluoromethoxy)phenyl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC(OC(F)(F)F)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O CKJHZRHELGEWBS-UHFFFAOYSA-N 0.000 claims 2
- VHZAENHYWWAFBA-UHFFFAOYSA-N 1'-benzhydrylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1C(C=1C=CC=CC=1)C1=CC=CC=C1 VHZAENHYWWAFBA-UHFFFAOYSA-N 0.000 claims 2
- DQUNBDRRYSBCBV-UHFFFAOYSA-N 1'-pentyl-6-phenoxyspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C1(C1=CC=2)COC1=CC=2OC1=CC=CC=C1 DQUNBDRRYSBCBV-UHFFFAOYSA-N 0.000 claims 2
- PHMRUZIIERITEP-UHFFFAOYSA-N 1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 PHMRUZIIERITEP-UHFFFAOYSA-N 0.000 claims 2
- GETLKOJLHYPMAK-UHFFFAOYSA-N 1-[(6-chloropyridin-3-yl)methyl]spiro[2H-indole-3,7'-6H-furo[2,3-f][1,3]benzodioxole] Chemical compound ClC1=CC=C(C=N1)CN1CC2(C3=CC=CC=C13)COC=1C2=CC2=C(OCO2)C=1 GETLKOJLHYPMAK-UHFFFAOYSA-N 0.000 claims 2
- PLWSNXOCEIBKNG-UHFFFAOYSA-N 1-[(6-methoxypyridin-3-yl)methyl]spiro[2H-indole-3,7'-6H-furo[2,3-f][1,3]benzodioxole] Chemical compound COC1=CC=C(C=N1)CN1CC2(C3=CC=CC=C13)COC1=CC3=C(OCO3)C=C12 PLWSNXOCEIBKNG-UHFFFAOYSA-N 0.000 claims 2
- 125000006507 2,4-difluorobenzyl group Chemical group [H]C1=C(F)C([H])=C(F)C(=C1[H])C([H])([H])* 0.000 claims 2
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 claims 2
- 125000006508 2,6-difluorobenzyl group Chemical group [H]C1=C([H])C(F)=C(C(F)=C1[H])C([H])([H])* 0.000 claims 2
- 125000004847 2-fluorobenzyl group Chemical group [H]C1=C([H])C(F)=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- 125000006179 2-methyl benzyl group Chemical group [H]C1=C([H])C(=C(C([H])=C1[H])C([H])([H])*)C([H])([H])[H] 0.000 claims 2
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 claims 2
- 125000003852 3-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(Cl)=C1[H])C([H])([H])* 0.000 claims 2
- DYQNWBBSVZGJLO-UHFFFAOYSA-N 4'-(3,5-difluoroanilino)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2NC1=CC(F)=CC(F)=C1 DYQNWBBSVZGJLO-UHFFFAOYSA-N 0.000 claims 2
- CZACZWJTBBVSNR-UHFFFAOYSA-N 4'-[(4,6-dimethylpyridin-2-yl)amino]-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2NC1=CC(C)=CC(C)=N1 CZACZWJTBBVSNR-UHFFFAOYSA-N 0.000 claims 2
- CQMDIWLOIGECLF-UHFFFAOYSA-N 4'-[(4-methyl-1,3-thiazol-2-yl)amino]-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2NC1=NC(C)=CS1 CQMDIWLOIGECLF-UHFFFAOYSA-N 0.000 claims 2
- HVFUAXCTAFMIBJ-UHFFFAOYSA-N 4'-bromo-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC=C(Br)C2=C1N(CCCCC)C(=O)C21C2=CC(OCO3)=C3C=C2OC1 HVFUAXCTAFMIBJ-UHFFFAOYSA-N 0.000 claims 2
- AHFINSWGYAZBOZ-UHFFFAOYSA-N 4-chloro-2-(trifluoromethyl)benzaldehyde Chemical group FC(F)(F)C1=CC(Cl)=CC=C1C=O AHFINSWGYAZBOZ-UHFFFAOYSA-N 0.000 claims 2
- RNOVGJWJVRESAA-UHFFFAOYSA-N 4-fluoro-2-(trifluoromethyl)phenol Chemical group OC1=CC=C(F)C=C1C(F)(F)F RNOVGJWJVRESAA-UHFFFAOYSA-N 0.000 claims 2
- 125000004861 4-isopropyl phenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 2
- YYVUSJOJYZSQKC-UHFFFAOYSA-N 5'-methyl-1'-[[5-(trifluoromethyl)furan-2-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC(C)=CC=C2N1CC1=CC=C(C(F)(F)F)O1 YYVUSJOJYZSQKC-UHFFFAOYSA-N 0.000 claims 2
- DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 claims 2
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 claims 2
- 229960003966 nicotinamide Drugs 0.000 claims 2
- 235000005152 nicotinamide Nutrition 0.000 claims 2
- 239000011570 nicotinamide Substances 0.000 claims 2
- DENPQNAWGQXKCU-UHFFFAOYSA-N thiophene-2-carboxamide Chemical compound NC(=O)C1=CC=CS1 DENPQNAWGQXKCU-UHFFFAOYSA-N 0.000 claims 2
- BKMXPNAWGWSRIY-UHFFFAOYSA-N (3,4,5-trimethoxyphenyl)methylurea Chemical compound COC1=CC(CNC(N)=O)=CC(OC)=C1OC BKMXPNAWGWSRIY-UHFFFAOYSA-N 0.000 claims 1
- RPEULPUEYFQGPF-UHFFFAOYSA-N 1'-(1,2,4-oxadiazol-3-ylmethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC=1N=CON=1 RPEULPUEYFQGPF-UHFFFAOYSA-N 0.000 claims 1
- VTPRPQDBWWGAFL-UHFFFAOYSA-N 1'-(1,3-benzodioxol-5-ylmethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1OC2=CC=3OCOC=3C=C2C21C1=CC=CC=C1N(CC=1C=C3OCOC3=CC=1)C2=O VTPRPQDBWWGAFL-UHFFFAOYSA-N 0.000 claims 1
- JRESYUYCWHYDCY-UHFFFAOYSA-N 1'-(1,3-thiazol-4-ylmethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC1=CSC=N1 JRESYUYCWHYDCY-UHFFFAOYSA-N 0.000 claims 1
- ARATTZXFWCIHQP-UHFFFAOYSA-N 1'-(2,1,3-benzothiadiazol-4-ylmethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1OC2=CC=3OCOC=3C=C2C21C1=CC=CC=C1N(CC=1C3=NSN=C3C=CC=1)C2=O ARATTZXFWCIHQP-UHFFFAOYSA-N 0.000 claims 1
- VSYDOYJZDIOHIN-UHFFFAOYSA-N 1'-(2,1,3-benzothiadiazol-5-ylmethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1OC2=CC=3OCOC=3C=C2C21C1=CC=CC=C1N(CC1=CC3=NSN=C3C=C1)C2=O VSYDOYJZDIOHIN-UHFFFAOYSA-N 0.000 claims 1
- NKFPSNRHRZXGDX-UHFFFAOYSA-N 1'-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1OC2=CC=3OCOC=3C=C2C21C1=CC=CC=C1N(CC1OC3=CC=CC=C3OC1)C2=O NKFPSNRHRZXGDX-UHFFFAOYSA-N 0.000 claims 1
- QVYXLZNJHVDOPG-UHFFFAOYSA-N 1'-(2-aminoethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCN)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 QVYXLZNJHVDOPG-UHFFFAOYSA-N 0.000 claims 1
- QBBPVYOZLZVPEK-UHFFFAOYSA-N 1'-(2-bromoethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCBr)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 QBBPVYOZLZVPEK-UHFFFAOYSA-N 0.000 claims 1
- CAWCKOZFWXJYGT-UHFFFAOYSA-N 1'-(2-cyclopropylethyl)-4'-quinolin-3-ylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC(C=3C=C4C=CC=CC4=NC=3)=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCC1CC1 CAWCKOZFWXJYGT-UHFFFAOYSA-N 0.000 claims 1
- ZQCFXLVLNULFCD-UHFFFAOYSA-N 1'-(2-cyclopropylethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCC1CC1 ZQCFXLVLNULFCD-UHFFFAOYSA-N 0.000 claims 1
- SSAAEWBZOTUPNX-UHFFFAOYSA-N 1'-(2-ethoxyethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCOCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 SSAAEWBZOTUPNX-UHFFFAOYSA-N 0.000 claims 1
- NZEOITLIMNITRZ-UHFFFAOYSA-N 1'-(2-ethylbutyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CC(CC)CC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 NZEOITLIMNITRZ-UHFFFAOYSA-N 0.000 claims 1
- FVDMZRBAWQAOOZ-UHFFFAOYSA-N 1'-(2-morpholin-4-yl-2-oxoethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CC(=O)N1CCOCC1 FVDMZRBAWQAOOZ-UHFFFAOYSA-N 0.000 claims 1
- BPDQMSDNTVPVIC-UHFFFAOYSA-N 1'-(2-oxo-2-piperidin-1-ylethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CC(=O)N1CCCCC1 BPDQMSDNTVPVIC-UHFFFAOYSA-N 0.000 claims 1
- SNEVEBJNSPVPGQ-UHFFFAOYSA-N 1'-(2-piperidin-1-ylethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCN1CCCCC1 SNEVEBJNSPVPGQ-UHFFFAOYSA-N 0.000 claims 1
- XKYWYNOBQLFJHB-UHFFFAOYSA-N 1'-(2-piperidin-4-ylethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCC1CCNCC1 XKYWYNOBQLFJHB-UHFFFAOYSA-N 0.000 claims 1
- JGNOTIUPVSMKRP-UHFFFAOYSA-N 1'-(2-pyrrol-1-ylethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCN1C=CC=C1 JGNOTIUPVSMKRP-UHFFFAOYSA-N 0.000 claims 1
- REIUZAXANRBWIO-UHFFFAOYSA-N 1'-(2h-triazol-4-ylmethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC1=CNN=N1 REIUZAXANRBWIO-UHFFFAOYSA-N 0.000 claims 1
- NPUKYFDTBUQMSC-UHFFFAOYSA-N 1'-(3,4-dihydro-2h-1,5-benzodioxepin-7-ylmethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O1CCCOC2=CC(CN3C(C4(C5=CC=6OCOC=6C=C5OC4)C4=CC=CC=C43)=O)=CC=C21 NPUKYFDTBUQMSC-UHFFFAOYSA-N 0.000 claims 1
- QRTMSVZHEMRJFE-UHFFFAOYSA-N 1'-(3-chloropropyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCl)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 QRTMSVZHEMRJFE-UHFFFAOYSA-N 0.000 claims 1
- GQAMGYNINYASHU-UHFFFAOYSA-N 1'-(3-hydroxypropyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCO)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 GQAMGYNINYASHU-UHFFFAOYSA-N 0.000 claims 1
- WEPGWUYYPMCUDT-UHFFFAOYSA-N 1'-(3-methylbut-2-enyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CC=C(C)C)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 WEPGWUYYPMCUDT-UHFFFAOYSA-N 0.000 claims 1
- SQXXJGJKOCQFBH-UHFFFAOYSA-N 1'-(3-phenylmethoxypropyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCOCC1=CC=CC=C1 SQXXJGJKOCQFBH-UHFFFAOYSA-N 0.000 claims 1
- CJBQJCRGRVFUOT-UHFFFAOYSA-N 1'-(3-piperidin-1-ylpropyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCN1CCCCC1 CJBQJCRGRVFUOT-UHFFFAOYSA-N 0.000 claims 1
- LKOVUXHBNGSKFW-UHFFFAOYSA-N 1'-(3-pyrrol-1-ylpropyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCN1C=CC=C1 LKOVUXHBNGSKFW-UHFFFAOYSA-N 0.000 claims 1
- BOUAZUSMAPCRKM-UHFFFAOYSA-N 1'-(3-pyrrolidin-1-ylpropyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCN1CCCC1 BOUAZUSMAPCRKM-UHFFFAOYSA-N 0.000 claims 1
- SCELVKQCHNUOOH-UHFFFAOYSA-N 1'-(4,4,4-trifluorobutyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCC(F)(F)F)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 SCELVKQCHNUOOH-UHFFFAOYSA-N 0.000 claims 1
- XYEIWIUZVAEGJE-UHFFFAOYSA-N 1'-(4-methylpentyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCC(C)C)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 XYEIWIUZVAEGJE-UHFFFAOYSA-N 0.000 claims 1
- NTPSMBDHZVNDHS-UHFFFAOYSA-N 1'-(5-chloropentyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCCCl)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 NTPSMBDHZVNDHS-UHFFFAOYSA-N 0.000 claims 1
- SIOYIEGGMNRCOQ-UHFFFAOYSA-N 1'-(5-methylhexyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC(C)C)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 SIOYIEGGMNRCOQ-UHFFFAOYSA-N 0.000 claims 1
- LMYIODPHDKTUIO-UHFFFAOYSA-N 1'-(cyclobutylmethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC1CCC1 LMYIODPHDKTUIO-UHFFFAOYSA-N 0.000 claims 1
- OGKXJSLVDCYBIQ-UHFFFAOYSA-N 1'-(cyclohexylmethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC1CCCCC1 OGKXJSLVDCYBIQ-UHFFFAOYSA-N 0.000 claims 1
- YHERPHNXNWNVOO-UHFFFAOYSA-N 1'-(cyclopropylmethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC1CC1 YHERPHNXNWNVOO-UHFFFAOYSA-N 0.000 claims 1
- MCQZHODKEUGHMD-UHFFFAOYSA-N 1'-(furan-2-ylmethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC1=CC=CO1 MCQZHODKEUGHMD-UHFFFAOYSA-N 0.000 claims 1
- YISYALOZMMIVDE-UHFFFAOYSA-N 1'-(naphthalen-1-ylmethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1OC2=CC=3OCOC=3C=C2C21C1=CC=CC=C1N(CC=1C3=CC=CC=C3C=CC=1)C2=O YISYALOZMMIVDE-UHFFFAOYSA-N 0.000 claims 1
- IRTXUHFNKHSVMV-UHFFFAOYSA-N 1'-(oxan-2-ylmethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC1CCCCO1 IRTXUHFNKHSVMV-UHFFFAOYSA-N 0.000 claims 1
- BFVPTTJCADYNAJ-UHFFFAOYSA-N 1'-(oxan-4-ylmethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC1CCOCC1 BFVPTTJCADYNAJ-UHFFFAOYSA-N 0.000 claims 1
- XGZKLUXHCVAMQO-UHFFFAOYSA-N 1'-(oxolan-2-ylmethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC1CCCO1 XGZKLUXHCVAMQO-UHFFFAOYSA-N 0.000 claims 1
- LHJYTPHTRANOAL-UHFFFAOYSA-N 1'-(phenylmethoxymethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1COCC1=CC=CC=C1 LHJYTPHTRANOAL-UHFFFAOYSA-N 0.000 claims 1
- JZKHDHFPODDKMV-UHFFFAOYSA-N 1'-(piperidin-4-ylmethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC1CCNCC1 JZKHDHFPODDKMV-UHFFFAOYSA-N 0.000 claims 1
- FTOGYMPSUFBHJN-UHFFFAOYSA-N 1'-(pyridin-2-ylmethyl)-6-(trifluoromethoxy)spiro[2h-1-benzofuran-3,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C=1C(OC(F)(F)F)=CC=C2C=1OCC2(C1=CC=CC=C11)C(=O)N1CC1=CC=CC=N1 FTOGYMPSUFBHJN-UHFFFAOYSA-N 0.000 claims 1
- SQICVPOVJXBQIN-UHFFFAOYSA-N 1'-(pyridin-2-ylmethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC1=CC=CC=N1 SQICVPOVJXBQIN-UHFFFAOYSA-N 0.000 claims 1
- SWKJUHBCOLARHI-UHFFFAOYSA-N 1'-(pyridin-3-ylmethyl)-6-(trifluoromethoxy)spiro[2h-1-benzofuran-3,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C=1C(OC(F)(F)F)=CC=C2C=1OCC2(C1=CC=CC=C11)C(=O)N1CC1=CC=CN=C1 SWKJUHBCOLARHI-UHFFFAOYSA-N 0.000 claims 1
- AJTGUERLIJOXRF-UHFFFAOYSA-N 1'-(pyridin-3-ylmethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC1=CC=CN=C1 AJTGUERLIJOXRF-UHFFFAOYSA-N 0.000 claims 1
- BCCYMGKEQKJKOZ-UHFFFAOYSA-N 1'-(pyridin-4-ylmethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC1=CC=NC=C1 BCCYMGKEQKJKOZ-UHFFFAOYSA-N 0.000 claims 1
- IOUPBOXMRKTMGK-UHFFFAOYSA-N 1'-(thiophen-2-ylmethyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC1=CC=CS1 IOUPBOXMRKTMGK-UHFFFAOYSA-N 0.000 claims 1
- ZQEIEXQGFYYNMT-UHFFFAOYSA-N 1'-[(1-cyclobutylpiperidin-4-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC(CC1)CCN1C1CCC1 ZQEIEXQGFYYNMT-UHFFFAOYSA-N 0.000 claims 1
- PHSAKMNVWAMSSQ-UHFFFAOYSA-N 1'-[(1-cyclohexylpiperidin-4-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC(CC1)CCN1C1CCCCC1 PHSAKMNVWAMSSQ-UHFFFAOYSA-N 0.000 claims 1
- WMXCRRYCMGUVCZ-UHFFFAOYSA-N 1'-[(1-cyclopentylpiperidin-4-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC(CC1)CCN1C1CCCC1 WMXCRRYCMGUVCZ-UHFFFAOYSA-N 0.000 claims 1
- IIQACCGKWWUQSE-UHFFFAOYSA-N 1'-[(1-ethylpiperidin-4-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C1CN(CC)CCC1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O IIQACCGKWWUQSE-UHFFFAOYSA-N 0.000 claims 1
- SLROUEVGEJXQDO-UHFFFAOYSA-N 1'-[(1-methyl-6-oxopyridin-3-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC(=O)N(C)C=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O SLROUEVGEJXQDO-UHFFFAOYSA-N 0.000 claims 1
- BBRGYFGKJNYOSI-UHFFFAOYSA-N 1'-[(1-methylbenzimidazol-2-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC=C2N(C)C(CN3C4=CC=CC=C4C4(C5=CC=6OCOC=6C=C5OC4)C3=O)=NC2=C1 BBRGYFGKJNYOSI-UHFFFAOYSA-N 0.000 claims 1
- VMOJFBHVOGHJRQ-UHFFFAOYSA-N 1'-[(1-methylbenzotriazol-5-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CC1=CC=C2N(C)N=NC2=C1 VMOJFBHVOGHJRQ-UHFFFAOYSA-N 0.000 claims 1
- DYUITQZLECTEEV-UHFFFAOYSA-N 1'-[(1-methylpiperidin-4-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C1CN(C)CCC1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O DYUITQZLECTEEV-UHFFFAOYSA-N 0.000 claims 1
- RTLYWNQXZGLIJD-UHFFFAOYSA-N 1'-[(1-pentan-3-ylpiperidin-4-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C1CN(C(CC)CC)CCC1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O RTLYWNQXZGLIJD-UHFFFAOYSA-N 0.000 claims 1
- BSRPLSYDPSGQDG-UHFFFAOYSA-N 1'-[(1-propan-2-ylpiperidin-4-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C1CN(C(C)C)CCC1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O BSRPLSYDPSGQDG-UHFFFAOYSA-N 0.000 claims 1
- TXWQLKXQMHGURO-UHFFFAOYSA-N 1'-[(1-pyridin-2-ylpiperidin-4-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC(CC1)CCN1C1=CC=CC=N1 TXWQLKXQMHGURO-UHFFFAOYSA-N 0.000 claims 1
- PSSJGPYANIPXDQ-UHFFFAOYSA-N 1'-[(2,2,3,3-tetrafluorocyclobutyl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC1(F)C(F)(F)CC1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O PSSJGPYANIPXDQ-UHFFFAOYSA-N 0.000 claims 1
- WVOJCMQIONWQQK-UHFFFAOYSA-N 1'-[(2,3-difluorophenyl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC1=CC=CC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1F WVOJCMQIONWQQK-UHFFFAOYSA-N 0.000 claims 1
- ARQRUISTPWKFSJ-UHFFFAOYSA-N 1'-[(2,4-difluorophenyl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC1=CC(F)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O ARQRUISTPWKFSJ-UHFFFAOYSA-N 0.000 claims 1
- CNIISRVZSVZYRD-UHFFFAOYSA-N 1'-[(2,5-difluorophenyl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC1=CC=C(F)C(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 CNIISRVZSVZYRD-UHFFFAOYSA-N 0.000 claims 1
- QVNNBLFAIHQNGV-UHFFFAOYSA-N 1'-[(2,6-difluorophenyl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC1=CC=CC(F)=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O QVNNBLFAIHQNGV-UHFFFAOYSA-N 0.000 claims 1
- NZSGJTDQUFOQEI-UHFFFAOYSA-N 1'-[(2-chloro-1,3-thiazol-5-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound S1C(Cl)=NC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O NZSGJTDQUFOQEI-UHFFFAOYSA-N 0.000 claims 1
- YUJBKOVXXMEPFL-UHFFFAOYSA-N 1'-[(2-chloro-4-fluorophenyl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound ClC1=CC(F)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O YUJBKOVXXMEPFL-UHFFFAOYSA-N 0.000 claims 1
- ADXDXRGHOAKFNW-UHFFFAOYSA-N 1'-[(2-cyclopropyl-4-oxo-1h-pyrimidin-6-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound N=1C(O)=CC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=NC=1C1CC1 ADXDXRGHOAKFNW-UHFFFAOYSA-N 0.000 claims 1
- XKZZFRZGGCDJTK-UHFFFAOYSA-N 1'-[(2-methyl-1,3-thiazol-4-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound S1C(C)=NC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 XKZZFRZGGCDJTK-UHFFFAOYSA-N 0.000 claims 1
- PUEWHVPXTGDJHM-UHFFFAOYSA-N 1'-[(2-oxo-1,3-benzothiazol-3-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1OC2=CC=3OCOC=3C=C2C21C1=CC=CC=C1N(CN1C(SC3=CC=CC=C31)=O)C2=O PUEWHVPXTGDJHM-UHFFFAOYSA-N 0.000 claims 1
- YIXYHDKIFLPTNX-UHFFFAOYSA-N 1'-[(2-phenylphenyl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC1=CC=CC=C1C1=CC=CC=C1 YIXYHDKIFLPTNX-UHFFFAOYSA-N 0.000 claims 1
- KEYCNSBXRZCERC-UHFFFAOYSA-N 1'-[(2-propan-2-yl-1,3-oxazol-4-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O1C(C(C)C)=NC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 KEYCNSBXRZCERC-UHFFFAOYSA-N 0.000 claims 1
- DKLRWVFHELFKGI-UHFFFAOYSA-N 1'-[(3,5-difluorophenyl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC1=CC(F)=CC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 DKLRWVFHELFKGI-UHFFFAOYSA-N 0.000 claims 1
- MUGICCIBIFQXME-UHFFFAOYSA-N 1'-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CC1=NOC(C)=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O MUGICCIBIFQXME-UHFFFAOYSA-N 0.000 claims 1
- VDNNGROEBXRVQB-UHFFFAOYSA-N 1'-[(3-fluorophenyl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC1=CC=CC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 VDNNGROEBXRVQB-UHFFFAOYSA-N 0.000 claims 1
- CKTUKNOPGUZTPA-UHFFFAOYSA-N 1'-[(3-methoxyphenyl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound COC1=CC=CC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 CKTUKNOPGUZTPA-UHFFFAOYSA-N 0.000 claims 1
- MOMXDTHBGFNVJQ-UHFFFAOYSA-N 1'-[(3-methyl-5-phenyl-1,2-oxazol-4-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CC=1C(C)=NOC=1C1=CC=CC=C1 MOMXDTHBGFNVJQ-UHFFFAOYSA-N 0.000 claims 1
- QHIBPTVXLHQTMD-UHFFFAOYSA-N 1'-[(3-nitrophenyl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound [O-][N+](=O)C1=CC=CC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 QHIBPTVXLHQTMD-UHFFFAOYSA-N 0.000 claims 1
- RVISZLWDGRHVJI-UHFFFAOYSA-N 1'-[(3-pyrrol-1-ylphenyl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC(C=1)=CC=CC=1N1C=CC=C1 RVISZLWDGRHVJI-UHFFFAOYSA-N 0.000 claims 1
- VBHPJGRHUZKUJA-UHFFFAOYSA-N 1'-[(4-chlorophenoxy)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC(Cl)=CC=C1OCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O VBHPJGRHUZKUJA-UHFFFAOYSA-N 0.000 claims 1
- CBZDSRKPCQBACL-UHFFFAOYSA-N 1'-[(4-fluoro-3-methylphenyl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=C(F)C(C)=CC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 CBZDSRKPCQBACL-UHFFFAOYSA-N 0.000 claims 1
- DTVRNKGYGSHILK-UHFFFAOYSA-N 1'-[(4-fluorophenyl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC(F)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O DTVRNKGYGSHILK-UHFFFAOYSA-N 0.000 claims 1
- CNPOLAKRFUNSKM-UHFFFAOYSA-N 1'-[(4-hydroxy-1,2,2,6,6-pentamethylpiperidin-4-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1C(C)(C)N(C)C(C)(C)CC1(O)CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O CNPOLAKRFUNSKM-UHFFFAOYSA-N 0.000 claims 1
- ZLYVJSRDNJIKGH-UHFFFAOYSA-N 1'-[(4-methoxyphenyl)methyl]-6-(trifluoromethoxy)spiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C1=CC(OC)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=C(OC(F)(F)F)C=C3OC2)C1=O ZLYVJSRDNJIKGH-UHFFFAOYSA-N 0.000 claims 1
- RGHIDJBRMWASIV-UHFFFAOYSA-N 1'-[(4-phenylphenyl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC(C=C1)=CC=C1C1=CC=CC=C1 RGHIDJBRMWASIV-UHFFFAOYSA-N 0.000 claims 1
- XEHUHFDAEQGOCP-UHFFFAOYSA-N 1'-[(4-pyrazol-1-ylphenyl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC(C=C1)=CC=C1N1C=CC=N1 XEHUHFDAEQGOCP-UHFFFAOYSA-N 0.000 claims 1
- HCWRHFDIYSCUJH-UHFFFAOYSA-N 1'-[(4-pyrrol-1-ylphenyl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC(C=C1)=CC=C1N1C=CC=C1 HCWRHFDIYSCUJH-UHFFFAOYSA-N 0.000 claims 1
- SRIOKKJYFBEZSD-UHFFFAOYSA-N 1'-[(5-bromofuran-2-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O1C(Br)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O SRIOKKJYFBEZSD-UHFFFAOYSA-N 0.000 claims 1
- RDOOPPPVWNCVGI-UHFFFAOYSA-N 1'-[(5-chloro-1,3,4-thiadiazol-2-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound S1C(Cl)=NN=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O RDOOPPPVWNCVGI-UHFFFAOYSA-N 0.000 claims 1
- QFWRYOMLYKFIMQ-UHFFFAOYSA-N 1'-[(5-chloro-1-benzothiophen-3-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CC1=CSC2=CC=C(Cl)C=C21 QFWRYOMLYKFIMQ-UHFFFAOYSA-N 0.000 claims 1
- PXNLGQYRAQQLRL-UHFFFAOYSA-N 1'-[(5-chlorofuran-2-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O1C(Cl)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O PXNLGQYRAQQLRL-UHFFFAOYSA-N 0.000 claims 1
- OTRJFXKTNUJFGM-UHFFFAOYSA-N 1'-[(5-chlorothiophen-2-yl)methyl]-5'-fluorospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC(F)=CC=C2N1CC1=CC=C(Cl)S1 OTRJFXKTNUJFGM-UHFFFAOYSA-N 0.000 claims 1
- JNBPICRKECPDTB-UHFFFAOYSA-N 1'-[(5-chlorothiophen-2-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound S1C(Cl)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O JNBPICRKECPDTB-UHFFFAOYSA-N 0.000 claims 1
- QDZCRRSOTKOOEY-UHFFFAOYSA-N 1'-[(5-fluoro-2-methylphenyl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CC1=CC=C(F)C=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O QDZCRRSOTKOOEY-UHFFFAOYSA-N 0.000 claims 1
- VQCYDVYLHDWDNZ-UHFFFAOYSA-N 1'-[(5-methyl-1,2-oxazol-4-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O1N=CC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1C VQCYDVYLHDWDNZ-UHFFFAOYSA-N 0.000 claims 1
- IIALACDSVNRKDV-UHFFFAOYSA-N 1'-[(5-methyl-2-phenyltriazol-4-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound N1=C(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)C(C)=NN1C1=CC=CC=C1 IIALACDSVNRKDV-UHFFFAOYSA-N 0.000 claims 1
- LQAXLOXMGYGMPF-UHFFFAOYSA-N 1'-[(5-methylfuran-2-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O1C(C)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O LQAXLOXMGYGMPF-UHFFFAOYSA-N 0.000 claims 1
- NKLQZJKICGIATF-UHFFFAOYSA-N 1'-[(5-methylsulfonylfuran-2-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O1C(S(=O)(=O)C)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O NKLQZJKICGIATF-UHFFFAOYSA-N 0.000 claims 1
- WJDNFTGYDVTHDN-UHFFFAOYSA-N 1'-[(5-phenyl-1,3-oxazol-4-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC=1N=COC=1C1=CC=CC=C1 WJDNFTGYDVTHDN-UHFFFAOYSA-N 0.000 claims 1
- NHFVLUQQMNIGQA-UHFFFAOYSA-N 1'-[(6-fluoro-4h-1,3-benzodioxin-8-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O1COCC2=CC(F)=CC(CN3C4=CC=CC=C4C4(C5=CC=6OCOC=6C=C5OC4)C3=O)=C21 NHFVLUQQMNIGQA-UHFFFAOYSA-N 0.000 claims 1
- KTEJABWLSIDCJF-UHFFFAOYSA-N 1'-[(6-morpholin-4-ylpyridin-3-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC(C=N1)=CC=C1N1CCOCC1 KTEJABWLSIDCJF-UHFFFAOYSA-N 0.000 claims 1
- YJOUTZMMEUJKFB-UHFFFAOYSA-N 1'-[(6-oxo-1h-pyridin-3-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC=1C=CC(=O)NC=1 YJOUTZMMEUJKFB-UHFFFAOYSA-N 0.000 claims 1
- YJQSCPRMCHUZAL-UHFFFAOYSA-N 1'-[(6-pyrrolidin-1-ylpyridin-3-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC(C=N1)=CC=C1N1CCCC1 YJQSCPRMCHUZAL-UHFFFAOYSA-N 0.000 claims 1
- NMLFFWKYAICRGF-UHFFFAOYSA-N 1'-[(7-methoxy-2-oxo-1,4-benzoxazin-3-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CC1=NC2=CC=C(OC)C=C2OC1=O NMLFFWKYAICRGF-UHFFFAOYSA-N 0.000 claims 1
- UVLKIDCBVFNEOG-UHFFFAOYSA-N 1'-[(7-methoxy-2-oxochromen-4-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CC1=CC(=O)OC2=CC(OC)=CC=C21 UVLKIDCBVFNEOG-UHFFFAOYSA-N 0.000 claims 1
- FTCOYNFKHUACGY-ZZXKWVIFSA-N 1'-[(e)-pent-2-enyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(C/C=C/CC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 FTCOYNFKHUACGY-ZZXKWVIFSA-N 0.000 claims 1
- QVKIZNJCPQBHHA-CHHVJCJISA-N 1'-[(z)-4-methylhex-3-enyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CC\C=C(C)/CC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 QVKIZNJCPQBHHA-CHHVJCJISA-N 0.000 claims 1
- FOZKSYFLKKYSAS-UHFFFAOYSA-N 1'-[2-(1-cyclopentylpiperidin-4-yl)ethyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCC(CC1)CCN1C1CCCC1 FOZKSYFLKKYSAS-UHFFFAOYSA-N 0.000 claims 1
- QJTUHCOYYIGOQP-UHFFFAOYSA-N 1'-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C1CN(C(C)C)CCC1CCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O QJTUHCOYYIGOQP-UHFFFAOYSA-N 0.000 claims 1
- GUOJXISRQSLSJW-UHFFFAOYSA-N 1'-[2-(2,5,5-trimethyl-1,3-dioxan-2-yl)ethyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O1CC(C)(C)COC1(C)CCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O GUOJXISRQSLSJW-UHFFFAOYSA-N 0.000 claims 1
- GWFFQXNKIDYQPZ-UHFFFAOYSA-N 1'-[2-(2-methoxyethoxy)ethyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCOCCOC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 GWFFQXNKIDYQPZ-UHFFFAOYSA-N 0.000 claims 1
- DMETYASETWMKDX-UHFFFAOYSA-N 1'-[2-(diethylamino)ethyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCN(CC)CC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 DMETYASETWMKDX-UHFFFAOYSA-N 0.000 claims 1
- FTKFBEZKJKDETG-UHFFFAOYSA-N 1'-[2-(dipyridin-2-ylamino)ethyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCN(C=1N=CC=CC=1)C1=CC=CC=N1 FTKFBEZKJKDETG-UHFFFAOYSA-N 0.000 claims 1
- IYGPXKMZGBDZBB-UHFFFAOYSA-N 1'-[2-(pyridin-2-ylamino)ethyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCNC1=CC=CC=N1 IYGPXKMZGBDZBB-UHFFFAOYSA-N 0.000 claims 1
- GRJHVJVJZHRSCH-UHFFFAOYSA-N 1'-[2-[1-(oxan-4-yl)piperidin-4-yl]ethyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCC(CC1)CCN1C1CCOCC1 GRJHVJVJZHRSCH-UHFFFAOYSA-N 0.000 claims 1
- ZJCQRDCZAJGIAZ-UHFFFAOYSA-N 1'-[3-(1-phenylpropan-2-ylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCCNC(C)CC1=CC=CC=C1 ZJCQRDCZAJGIAZ-UHFFFAOYSA-N 0.000 claims 1
- XHAYGGWAINLZBA-UHFFFAOYSA-N 1'-[3-(2,2,2-trifluoroethylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCNCC(F)(F)F)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 XHAYGGWAINLZBA-UHFFFAOYSA-N 0.000 claims 1
- IHYUJNPXNWGBFA-UHFFFAOYSA-N 1'-[3-(2,2-dimethylpropylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCNCC(C)(C)C)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 IHYUJNPXNWGBFA-UHFFFAOYSA-N 0.000 claims 1
- UJAKRJUYBSQLLH-UHFFFAOYSA-N 1'-[3-(2,2-diphenylethylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNCC(C=1C=CC=CC=1)C1=CC=CC=C1 UJAKRJUYBSQLLH-UHFFFAOYSA-N 0.000 claims 1
- BGEVEDJWJVANIK-UHFFFAOYSA-N 1'-[3-(2-cyclohexylethylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNCCC1CCCCC1 BGEVEDJWJVANIK-UHFFFAOYSA-N 0.000 claims 1
- ZWVBSNRCANQYBC-UHFFFAOYSA-N 1'-[3-(2-cyclopropylethylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNCCC1CC1 ZWVBSNRCANQYBC-UHFFFAOYSA-N 0.000 claims 1
- GKPLEGSELZQOTP-UHFFFAOYSA-N 1'-[3-(2-ethoxyethylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCNCCOCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 GKPLEGSELZQOTP-UHFFFAOYSA-N 0.000 claims 1
- LJRMJCNWSHKGEP-UHFFFAOYSA-N 1'-[3-(2-methylpropylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCNCC(C)C)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 LJRMJCNWSHKGEP-UHFFFAOYSA-N 0.000 claims 1
- CMWJKTXLFOEZEZ-UHFFFAOYSA-N 1'-[3-(2-morpholin-4-ylethylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNCCN1CCOCC1 CMWJKTXLFOEZEZ-UHFFFAOYSA-N 0.000 claims 1
- YOTXLZNPGJPHMA-UHFFFAOYSA-N 1'-[3-(2-phenylethylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNCCC1=CC=CC=C1 YOTXLZNPGJPHMA-UHFFFAOYSA-N 0.000 claims 1
- IDPKQUVBWCGWLS-UHFFFAOYSA-N 1'-[3-(2-piperidin-1-ylethylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNCCN1CCCCC1 IDPKQUVBWCGWLS-UHFFFAOYSA-N 0.000 claims 1
- OFKYTAQWJRVYFL-UHFFFAOYSA-N 1'-[3-(2-propan-2-yloxyethylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCNCCOC(C)C)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 OFKYTAQWJRVYFL-UHFFFAOYSA-N 0.000 claims 1
- GIVMUMRKJJGCBV-UHFFFAOYSA-N 1'-[3-(2-pyridin-2-ylethylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNCCC1=CC=CC=N1 GIVMUMRKJJGCBV-UHFFFAOYSA-N 0.000 claims 1
- NQRKQWACFYEZHR-UHFFFAOYSA-N 1'-[3-(2-pyridin-3-ylethylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNCCC1=CC=CN=C1 NQRKQWACFYEZHR-UHFFFAOYSA-N 0.000 claims 1
- KTPWASWOTPXWSH-UHFFFAOYSA-N 1'-[3-(2-pyrrolidin-1-ylethylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNCCN1CCCC1 KTPWASWOTPXWSH-UHFFFAOYSA-N 0.000 claims 1
- ZKGULDRBOBFADQ-UHFFFAOYSA-N 1'-[3-(3,3-dimethylbutylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCNCCC(C)(C)C)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 ZKGULDRBOBFADQ-UHFFFAOYSA-N 0.000 claims 1
- IERASTOZDZPGKT-UHFFFAOYSA-N 1'-[3-(3-ethoxypropylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCNCCCOCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 IERASTOZDZPGKT-UHFFFAOYSA-N 0.000 claims 1
- WCFWUULSAZRTMZ-UHFFFAOYSA-N 1'-[3-(3-methoxypropylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCNCCCOC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 WCFWUULSAZRTMZ-UHFFFAOYSA-N 0.000 claims 1
- KAQLIWUBQOKVDS-UHFFFAOYSA-N 1'-[3-(3-methylbutan-2-ylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCNC(C)C(C)C)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 KAQLIWUBQOKVDS-UHFFFAOYSA-N 0.000 claims 1
- LZSIEVQKLPECOI-UHFFFAOYSA-N 1'-[3-(3-morpholin-4-ylpropylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNCCCN1CCOCC1 LZSIEVQKLPECOI-UHFFFAOYSA-N 0.000 claims 1
- HNCNQTHOSBIPGC-UHFFFAOYSA-N 1'-[3-(3-phenylpropylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNCCCC1=CC=CC=C1 HNCNQTHOSBIPGC-UHFFFAOYSA-N 0.000 claims 1
- ZNYVZFDSYHHZAE-UHFFFAOYSA-N 1'-[3-(3-propan-2-yloxypropylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCNCCCOC(C)C)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 ZNYVZFDSYHHZAE-UHFFFAOYSA-N 0.000 claims 1
- KHUOVTZHBOHNIQ-UHFFFAOYSA-N 1'-[3-(benzylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNCC1=CC=CC=C1 KHUOVTZHBOHNIQ-UHFFFAOYSA-N 0.000 claims 1
- ZZOXELOTQICWBO-UHFFFAOYSA-N 1'-[3-(cyclobutylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNC1CCC1 ZZOXELOTQICWBO-UHFFFAOYSA-N 0.000 claims 1
- LUYOBNDESCLUEH-UHFFFAOYSA-N 1'-[3-(cyclohexylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNC1CCCCC1 LUYOBNDESCLUEH-UHFFFAOYSA-N 0.000 claims 1
- UOUKWMJAQFNKGK-UHFFFAOYSA-N 1'-[3-(cyclohexylmethylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNCC1CCCCC1 UOUKWMJAQFNKGK-UHFFFAOYSA-N 0.000 claims 1
- UPDLYRDYEYEHOW-UHFFFAOYSA-N 1'-[3-(cyclopentylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNC1CCCC1 UPDLYRDYEYEHOW-UHFFFAOYSA-N 0.000 claims 1
- UISDRWUXULANES-UHFFFAOYSA-N 1'-[3-(cyclopropylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNC1CC1 UISDRWUXULANES-UHFFFAOYSA-N 0.000 claims 1
- PXVJDDCCIYXSPR-UHFFFAOYSA-N 1'-[3-(dibenzylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCN(CC=1C=CC=CC=1)CC1=CC=CC=C1 PXVJDDCCIYXSPR-UHFFFAOYSA-N 0.000 claims 1
- JCMJXQVYLSVERX-UHFFFAOYSA-N 1'-[3-(dibutylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCN(CCCC)CCCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 JCMJXQVYLSVERX-UHFFFAOYSA-N 0.000 claims 1
- RDWJRFRCVQZACW-UHFFFAOYSA-N 1'-[3-(dipropylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCN(CCC)CCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 RDWJRFRCVQZACW-UHFFFAOYSA-N 0.000 claims 1
- VNYQRQRGWZFLDX-UHFFFAOYSA-N 1'-[3-(ethylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCNCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 VNYQRQRGWZFLDX-UHFFFAOYSA-N 0.000 claims 1
- BPYFAQKNQFVZIZ-UHFFFAOYSA-N 1'-[3-(furan-2-ylmethylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNCC1=CC=CO1 BPYFAQKNQFVZIZ-UHFFFAOYSA-N 0.000 claims 1
- WJLAJIVERFTSGL-UHFFFAOYSA-N 1'-[3-(heptylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCNCCCCCCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 WJLAJIVERFTSGL-UHFFFAOYSA-N 0.000 claims 1
- DROIEEGOLIMRBU-UHFFFAOYSA-N 1'-[3-(hexylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCNCCCCCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 DROIEEGOLIMRBU-UHFFFAOYSA-N 0.000 claims 1
- FBNNHEWWOKNJJJ-UHFFFAOYSA-N 1'-[3-(methylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCNC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 FBNNHEWWOKNJJJ-UHFFFAOYSA-N 0.000 claims 1
- FUAKYDPHCKZGBA-UHFFFAOYSA-N 1'-[3-(octylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCNCCCCCCCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 FUAKYDPHCKZGBA-UHFFFAOYSA-N 0.000 claims 1
- OXXPBPLYKYQPSU-UHFFFAOYSA-N 1'-[3-(oxolan-2-ylmethylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNCC1CCCO1 OXXPBPLYKYQPSU-UHFFFAOYSA-N 0.000 claims 1
- ISJQJNRXVQAQLY-UHFFFAOYSA-N 1'-[3-(pentylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCNCCCCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 ISJQJNRXVQAQLY-UHFFFAOYSA-N 0.000 claims 1
- PLOCDOPROXMVQK-UHFFFAOYSA-N 1'-[3-(propan-2-ylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCNC(C)C)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 PLOCDOPROXMVQK-UHFFFAOYSA-N 0.000 claims 1
- XFELXRGXQMNWJP-UHFFFAOYSA-N 1'-[3-(propylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCNCCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 XFELXRGXQMNWJP-UHFFFAOYSA-N 0.000 claims 1
- DEAVQKWZOCWTSM-UHFFFAOYSA-N 1'-[3-(pyridin-2-ylmethylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNCC1=CC=CC=N1 DEAVQKWZOCWTSM-UHFFFAOYSA-N 0.000 claims 1
- VXIGMEVBCJZINU-UHFFFAOYSA-N 1'-[3-(pyridin-4-ylmethylamino)propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNCC1=CC=NC=C1 VXIGMEVBCJZINU-UHFFFAOYSA-N 0.000 claims 1
- JMUAEBKYOCTRHF-UHFFFAOYSA-N 1'-[3-[(2,4-difluorophenyl)methylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC1=CC(F)=CC=C1CNCCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O JMUAEBKYOCTRHF-UHFFFAOYSA-N 0.000 claims 1
- FICRZITUFLCJFS-UHFFFAOYSA-N 1'-[3-[(2,6-difluorophenyl)methylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC1=CC=CC(F)=C1CNCCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O FICRZITUFLCJFS-UHFFFAOYSA-N 0.000 claims 1
- DILASYFAVLTISK-UHFFFAOYSA-N 1'-[3-[(2-chlorophenyl)methylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound ClC1=CC=CC=C1CNCCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O DILASYFAVLTISK-UHFFFAOYSA-N 0.000 claims 1
- ZODZMHGOSAKWPY-UHFFFAOYSA-N 1'-[3-[(2-fluorophenyl)methylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC1=CC=CC=C1CNCCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O ZODZMHGOSAKWPY-UHFFFAOYSA-N 0.000 claims 1
- MEEMDZHVQBAUDY-UHFFFAOYSA-N 1'-[3-[(2-methylphenyl)methylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CC1=CC=CC=C1CNCCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O MEEMDZHVQBAUDY-UHFFFAOYSA-N 0.000 claims 1
- LQEUTMOCWBMSOO-UHFFFAOYSA-N 1'-[3-[(3,5-difluorophenyl)methylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC1=CC(F)=CC(CNCCCN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 LQEUTMOCWBMSOO-UHFFFAOYSA-N 0.000 claims 1
- KLPVJDRSPLQDDW-UHFFFAOYSA-N 1'-[3-[(3-fluorophenyl)methylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC1=CC=CC(CNCCCN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 KLPVJDRSPLQDDW-UHFFFAOYSA-N 0.000 claims 1
- BYZBJKQJIRMDJL-UHFFFAOYSA-N 1'-[3-[(3-methylphenyl)methylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CC1=CC=CC(CNCCCN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 BYZBJKQJIRMDJL-UHFFFAOYSA-N 0.000 claims 1
- AOGOECHLLUJSEE-UHFFFAOYSA-N 1'-[3-[(4-chlorophenyl)methylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC(Cl)=CC=C1CNCCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O AOGOECHLLUJSEE-UHFFFAOYSA-N 0.000 claims 1
- NFAVDEHOSBHAGE-UHFFFAOYSA-N 1'-[3-[(4-fluorophenyl)methylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC(F)=CC=C1CNCCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O NFAVDEHOSBHAGE-UHFFFAOYSA-N 0.000 claims 1
- IXJAPWUOUCVUBD-UHFFFAOYSA-N 1'-[3-[(4-methoxyphenyl)methylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC(OC)=CC=C1CNCCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O IXJAPWUOUCVUBD-UHFFFAOYSA-N 0.000 claims 1
- UDCGWFCIYMWQPU-UHFFFAOYSA-N 1'-[3-[(5-methylfuran-2-yl)methylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O1C(C)=CC=C1CNCCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O UDCGWFCIYMWQPU-UHFFFAOYSA-N 0.000 claims 1
- BHGKHGRGPYLBFJ-UHFFFAOYSA-N 1'-[3-[2-(1-methylpyrrolidin-2-yl)ethylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CN1CCCC1CCNCCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O BHGKHGRGPYLBFJ-UHFFFAOYSA-N 0.000 claims 1
- CNLNTOSWWGLRBL-UHFFFAOYSA-N 1'-[3-[2-(2-chlorophenyl)ethylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound ClC1=CC=CC=C1CCNCCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O CNLNTOSWWGLRBL-UHFFFAOYSA-N 0.000 claims 1
- UZVFBTOFGNRWJE-UHFFFAOYSA-N 1'-[3-[2-(2-fluorophenyl)ethylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC1=CC=CC=C1CCNCCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O UZVFBTOFGNRWJE-UHFFFAOYSA-N 0.000 claims 1
- CEYASFAHFWOXGT-UHFFFAOYSA-N 1'-[3-[2-(3-chlorophenyl)ethylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound ClC1=CC=CC(CCNCCCN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 CEYASFAHFWOXGT-UHFFFAOYSA-N 0.000 claims 1
- WLMWLYMCMQDYFT-UHFFFAOYSA-N 1'-[3-[2-(3-fluorophenyl)ethylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC1=CC=CC(CCNCCCN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 WLMWLYMCMQDYFT-UHFFFAOYSA-N 0.000 claims 1
- KYVMDVPKCQYOHG-UHFFFAOYSA-N 1'-[3-[2-(4-fluorophenyl)ethylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC(F)=CC=C1CCNCCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O KYVMDVPKCQYOHG-UHFFFAOYSA-N 0.000 claims 1
- ZMNCNZXODMGMKV-UHFFFAOYSA-N 1'-[3-[2-(4-methylphenyl)ethylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC(C)=CC=C1CCNCCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O ZMNCNZXODMGMKV-UHFFFAOYSA-N 0.000 claims 1
- LSKIODHJZLRCHT-UHFFFAOYSA-N 1'-[3-[2-(4-phenylphenyl)ethylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CCCNCCC(C=C1)=CC=C1C1=CC=CC=C1 LSKIODHJZLRCHT-UHFFFAOYSA-N 0.000 claims 1
- WSRQVRHAOPWHNZ-UHFFFAOYSA-N 1'-[3-[2-(diethylamino)ethyl-methylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCN(C)CCN(CC)CC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 WSRQVRHAOPWHNZ-UHFFFAOYSA-N 0.000 claims 1
- DZTRFTAZBLJISJ-UHFFFAOYSA-N 1'-[3-[2-(dimethylamino)ethylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCNCCN(C)C)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 DZTRFTAZBLJISJ-UHFFFAOYSA-N 0.000 claims 1
- KXULAJWWUJTZPU-UHFFFAOYSA-N 1'-[3-[2-[di(propan-2-yl)amino]ethylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCNCCN(C(C)C)C(C)C)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 KXULAJWWUJTZPU-UHFFFAOYSA-N 0.000 claims 1
- IUASKJBQAMDKMU-UHFFFAOYSA-N 1'-[3-[3-(dimethylamino)propylamino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCNCCCN(C)C)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 IUASKJBQAMDKMU-UHFFFAOYSA-N 0.000 claims 1
- MQYFFEWXYLIVQO-XZATXCMXSA-N 1'-[3-[[(1r)-1-cyclohexylethyl]amino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1([C@H](NCCCN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)C)CCCCC1 MQYFFEWXYLIVQO-XZATXCMXSA-N 0.000 claims 1
- MQYFFEWXYLIVQO-HSYKDVHTSA-N 1'-[3-[[(1s)-1-cyclohexylethyl]amino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1([C@@H](NCCCN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)C)CCCCC1 MQYFFEWXYLIVQO-HSYKDVHTSA-N 0.000 claims 1
- DMRGBBZJIXZGBU-UHFFFAOYSA-N 1'-[3-[bis(2-methoxyethyl)amino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCN(CCOC)CCOC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 DMRGBBZJIXZGBU-UHFFFAOYSA-N 0.000 claims 1
- IQYCAXRMNVCNOF-UHFFFAOYSA-N 1'-[3-[butyl(methyl)amino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCN(C)CCCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 IQYCAXRMNVCNOF-UHFFFAOYSA-N 0.000 claims 1
- ALVULQJOJUSPIX-UHFFFAOYSA-N 1'-[3-[di(propan-2-yl)amino]propyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCN(C(C)C)C(C)C)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 ALVULQJOJUSPIX-UHFFFAOYSA-N 0.000 claims 1
- VYWBCISEJJHPLO-UHFFFAOYSA-N 1'-[4,4-bis(4-fluorophenyl)butyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)CCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O VYWBCISEJJHPLO-UHFFFAOYSA-N 0.000 claims 1
- XWIPCPSWCFODHH-UHFFFAOYSA-N 1'-[[1-(3,3-dimethylbutyl)piperidin-4-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C1CN(CCC(C)(C)C)CCC1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O XWIPCPSWCFODHH-UHFFFAOYSA-N 0.000 claims 1
- GIDNRYZABBHQMA-UHFFFAOYSA-N 1'-[[1-(3-methylbutyl)piperidin-4-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C1CN(CCC(C)C)CCC1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O GIDNRYZABBHQMA-UHFFFAOYSA-N 0.000 claims 1
- LYKUAZYGPFZFKK-UHFFFAOYSA-N 1'-[[1-(3-methylsulfanylpropyl)piperidin-4-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C1CN(CCCSC)CCC1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O LYKUAZYGPFZFKK-UHFFFAOYSA-N 0.000 claims 1
- FJRYXOZWRWZSEY-UHFFFAOYSA-N 1'-[[1-(oxan-4-yl)piperidin-4-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC(CC1)CCN1C1CCOCC1 FJRYXOZWRWZSEY-UHFFFAOYSA-N 0.000 claims 1
- RVRNPEPDGYUWQV-UHFFFAOYSA-N 1'-[[1-(pyridin-2-ylmethyl)piperidin-4-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC(CC1)CCN1CC1=CC=CC=N1 RVRNPEPDGYUWQV-UHFFFAOYSA-N 0.000 claims 1
- FWLCYWBAWQWLBM-UHFFFAOYSA-N 1'-[[1-(pyridin-3-ylmethyl)piperidin-4-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC(CC1)CCN1CC1=CC=CN=C1 FWLCYWBAWQWLBM-UHFFFAOYSA-N 0.000 claims 1
- LCMYJUQZARTJDT-UHFFFAOYSA-N 1'-[[1-(thiophen-2-ylmethyl)piperidin-4-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC(CC1)CCN1CC1=CC=CS1 LCMYJUQZARTJDT-UHFFFAOYSA-N 0.000 claims 1
- QERDOWSUOLIWGH-UHFFFAOYSA-N 1'-[[2-(4-pyrimidin-2-ylpiperazine-1-carbonyl)phenyl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C=1C=CC=C(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)C=1C(=O)N(CC1)CCN1C1=NC=CC=N1 QERDOWSUOLIWGH-UHFFFAOYSA-N 0.000 claims 1
- VPVFWHQUYJDNOS-UHFFFAOYSA-N 1'-[[2-(trifluoromethoxy)phenyl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC(F)(F)OC1=CC=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O VPVFWHQUYJDNOS-UHFFFAOYSA-N 0.000 claims 1
- AVFVDDSXMJXONJ-UHFFFAOYSA-N 1'-[[2-[4-(1,3-benzodioxol-5-ylmethyl)piperazine-1-carbonyl]phenyl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CC1=CC=CC=C1C(=O)N1CCN(CC=2C=C3OCOC3=CC=2)CC1 AVFVDDSXMJXONJ-UHFFFAOYSA-N 0.000 claims 1
- RKKXQUMZFNJUPV-UHFFFAOYSA-N 1'-[[2-fluoro-3-(trifluoromethyl)phenyl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC=C(C(F)(F)F)C(F)=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O RKKXQUMZFNJUPV-UHFFFAOYSA-N 0.000 claims 1
- KICHXJFSHZIQSA-UHFFFAOYSA-N 1'-[[2-fluoro-4-(trifluoromethyl)phenyl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC1=CC(C(F)(F)F)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O KICHXJFSHZIQSA-UHFFFAOYSA-N 0.000 claims 1
- NUXBCNBOWPVIIA-UHFFFAOYSA-N 1'-[[2-fluoro-5-(trifluoromethyl)phenyl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC1=CC=C(C(F)(F)F)C=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O NUXBCNBOWPVIIA-UHFFFAOYSA-N 0.000 claims 1
- HDRYXQCJOGBONA-UHFFFAOYSA-N 1'-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC1=CC=CC(C(F)(F)F)=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O HDRYXQCJOGBONA-UHFFFAOYSA-N 0.000 claims 1
- SEAKXUNSPYBGCJ-UHFFFAOYSA-N 1'-[[3-(4-methylpiperazine-1-carbonyl)phenyl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1CN(C)CCN1C(=O)C1=CC=CC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 SEAKXUNSPYBGCJ-UHFFFAOYSA-N 0.000 claims 1
- RTCCXWATAANXDR-UHFFFAOYSA-N 1'-[[3-(4-pyrimidin-2-ylpiperazine-1-carbonyl)phenyl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C=1C=CC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=CC=1C(=O)N(CC1)CCN1C1=NC=CC=N1 RTCCXWATAANXDR-UHFFFAOYSA-N 0.000 claims 1
- WWYHBAYMQOVCPI-UHFFFAOYSA-N 1'-[[3-(trifluoromethoxy)phenyl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC(F)(F)OC1=CC=CC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 WWYHBAYMQOVCPI-UHFFFAOYSA-N 0.000 claims 1
- TVQUIPUFUDUAHL-UHFFFAOYSA-N 1'-[[3-fluoro-4-(trifluoromethyl)phenyl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=C(C(F)(F)F)C(F)=CC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 TVQUIPUFUDUAHL-UHFFFAOYSA-N 0.000 claims 1
- VPSLUNFHHRCRBG-UHFFFAOYSA-N 1'-[[3-fluoro-5-(trifluoromethyl)phenyl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC(F)(F)C1=CC(F)=CC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 VPSLUNFHHRCRBG-UHFFFAOYSA-N 0.000 claims 1
- HZCJPQPBMYEGLM-UHFFFAOYSA-N 1'-[[3-hydroxy-5-(trifluoromethyl)thiophen-2-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=C(C(F)(F)F)SC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1O HZCJPQPBMYEGLM-UHFFFAOYSA-N 0.000 claims 1
- ANMKGVMPNMUIEO-UHFFFAOYSA-N 1'-[[3-methoxy-5-(trifluoromethyl)thiophen-2-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=C(C(F)(F)F)SC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1OC ANMKGVMPNMUIEO-UHFFFAOYSA-N 0.000 claims 1
- AWUJFVQKIGWIAV-UHFFFAOYSA-N 1'-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC(C=C1)=CC=C1N1C=NC=N1 AWUJFVQKIGWIAV-UHFFFAOYSA-N 0.000 claims 1
- YGCQMVZDPGIAJX-UHFFFAOYSA-N 1'-[[4-(4-methylpiperazine-1-carbonyl)phenyl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1CN(C)CCN1C(=O)C(C=C1)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O YGCQMVZDPGIAJX-UHFFFAOYSA-N 0.000 claims 1
- WOAIECMTJKOJAI-UHFFFAOYSA-N 1'-[[4-(4-pyrimidin-2-ylpiperazine-1-carbonyl)phenyl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C=1C=C(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)C=CC=1C(=O)N(CC1)CCN1C1=NC=CC=N1 WOAIECMTJKOJAI-UHFFFAOYSA-N 0.000 claims 1
- LLDBZKSLZMAMTM-UHFFFAOYSA-N 1'-[[4-(morpholine-4-carbonyl)phenyl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C=1C=C(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)C=CC=1C(=O)N1CCOCC1 LLDBZKSLZMAMTM-UHFFFAOYSA-N 0.000 claims 1
- QCNPSUOAZCQXQS-UHFFFAOYSA-N 1'-[[4-[4-(1,3-benzodioxol-5-ylmethyl)piperazine-1-carbonyl]phenyl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CC(C=C1)=CC=C1C(=O)N1CCN(CC=2C=C3OCOC3=CC=2)CC1 QCNPSUOAZCQXQS-UHFFFAOYSA-N 0.000 claims 1
- LIBIIKAPKCSHPM-UHFFFAOYSA-N 1'-[[4-chloro-2-(trifluoromethyl)quinolin-6-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CC1=CC2=C(Cl)C=C(C(F)(F)F)N=C2C=C1 LIBIIKAPKCSHPM-UHFFFAOYSA-N 0.000 claims 1
- VSCWZDNSXJIDGV-UHFFFAOYSA-N 1'-[[4-fluoro-2-(trifluoromethyl)phenyl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC(F)(F)C1=CC(F)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O VSCWZDNSXJIDGV-UHFFFAOYSA-N 0.000 claims 1
- FGVDFTPPQSSQBH-UHFFFAOYSA-N 1'-[[4-fluoro-3-(trifluoromethyl)phenyl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=C(C(F)(F)F)C(F)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O FGVDFTPPQSSQBH-UHFFFAOYSA-N 0.000 claims 1
- KYNSEJGURMILEZ-UHFFFAOYSA-N 1'-[[5-(2-chlorophenyl)furan-2-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound ClC1=CC=CC=C1C(O1)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O KYNSEJGURMILEZ-UHFFFAOYSA-N 0.000 claims 1
- FGQPEIVOXDMRHE-UHFFFAOYSA-N 1'-[[5-(3-chlorophenyl)furan-2-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound ClC1=CC=CC(C=2OC(CN3C4=CC=CC=C4C4(C5=CC=6OCOC=6C=C5OC4)C3=O)=CC=2)=C1 FGQPEIVOXDMRHE-UHFFFAOYSA-N 0.000 claims 1
- NEBUOXBYNAHKFV-UHFFFAOYSA-N 1'-[[5-(trifluoromethyl)furan-2-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O1C(C(F)(F)F)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O NEBUOXBYNAHKFV-UHFFFAOYSA-N 0.000 claims 1
- NKPNBAVPEGIBQR-UHFFFAOYSA-N 1'-[[5-[2-(trifluoromethyl)phenyl]furan-2-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC(F)(F)C1=CC=CC=C1C(O1)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O NKPNBAVPEGIBQR-UHFFFAOYSA-N 0.000 claims 1
- KEVWQCIPSZIPNY-UHFFFAOYSA-N 1'-[[5-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=NC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=NO1 KEVWQCIPSZIPNY-UHFFFAOYSA-N 0.000 claims 1
- ZEDAATHDOBXZEF-UHFFFAOYSA-N 1'-[[5-fluoro-2-(trifluoromethyl)phenyl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC1=CC=C(C(F)(F)F)C(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 ZEDAATHDOBXZEF-UHFFFAOYSA-N 0.000 claims 1
- OSOPODHEDLQRPG-UHFFFAOYSA-N 1'-[[6-(dimethylamino)pyridin-3-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C1=NC(N(C)C)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O OSOPODHEDLQRPG-UHFFFAOYSA-N 0.000 claims 1
- JPBUNTYPRHZZCS-UHFFFAOYSA-N 1'-[[6-(trifluoromethyl)pyridin-3-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=NC(C(F)(F)F)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O JPBUNTYPRHZZCS-UHFFFAOYSA-N 0.000 claims 1
- HDHXDUNPHNLDOC-UHFFFAOYSA-N 1'-benzhydryl-5'-methylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC(C)=CC=C2N1C(C=1C=CC=CC=1)C1=CC=CC=C1 HDHXDUNPHNLDOC-UHFFFAOYSA-N 0.000 claims 1
- LRNWOJDFRXDNHS-UHFFFAOYSA-N 1'-benzhydryl-5-bromospiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC(Br)=CC=C2OCC1(C1=CC=CC=C11)C(=O)N1C(C=1C=CC=CC=1)C1=CC=CC=C1 LRNWOJDFRXDNHS-UHFFFAOYSA-N 0.000 claims 1
- PTDDUYJLOQGZPK-UHFFFAOYSA-N 1'-benzhydryl-5-hydroxyspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC(O)=CC=C2OCC1(C1=CC=CC=C11)C(=O)N1C(C=1C=CC=CC=1)C1=CC=CC=C1 PTDDUYJLOQGZPK-UHFFFAOYSA-N 0.000 claims 1
- SFOTULKPJMTGPR-UHFFFAOYSA-N 1'-benzhydryl-5-pyridin-3-ylspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC(=CC=C3OC2)C=2C=NC=CC=2)C(=O)N1C(C=1C=CC=CC=1)C1=CC=CC=C1 SFOTULKPJMTGPR-UHFFFAOYSA-N 0.000 claims 1
- FEHMEKPMEKIRNG-UHFFFAOYSA-N 1'-benzhydryl-6-(trifluoromethoxy)spiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C=1C(OC(F)(F)F)=CC=C2C=1OCC2(C1=CC=CC=C11)C(=O)N1C(C=1C=CC=CC=1)C1=CC=CC=C1 FEHMEKPMEKIRNG-UHFFFAOYSA-N 0.000 claims 1
- PUNHNDNPPHVDTC-UHFFFAOYSA-N 1'-benzylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC1=CC=CC=C1 PUNHNDNPPHVDTC-UHFFFAOYSA-N 0.000 claims 1
- UUGJZINLZDDYEU-UHFFFAOYSA-N 1'-butylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 UUGJZINLZDDYEU-UHFFFAOYSA-N 0.000 claims 1
- RTCUMTHXKKBDRN-UHFFFAOYSA-N 1'-hex-5-enylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC=C)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 RTCUMTHXKKBDRN-UHFFFAOYSA-N 0.000 claims 1
- QQGPXTPTXKAHHT-UHFFFAOYSA-N 1'-hexylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 QQGPXTPTXKAHHT-UHFFFAOYSA-N 0.000 claims 1
- QJIYSHJUWGIZHU-UHFFFAOYSA-N 1'-hexylspiro[7h-[1,3]dioxolo[4,5-g]chromene-8,3'-indole]-2',6-dione Chemical compound C12=CC=CC=C2N(CCCCCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC(=O)C1 QJIYSHJUWGIZHU-UHFFFAOYSA-N 0.000 claims 1
- AHLOWWNBTATPDG-UHFFFAOYSA-N 1'-methyl-4'-pyrimidin-5-ylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CN=CN=C1 AHLOWWNBTATPDG-UHFFFAOYSA-N 0.000 claims 1
- VZPBXHHDMVMWQY-UHFFFAOYSA-N 1'-methylsulfonylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(S(=O)(=O)C)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 VZPBXHHDMVMWQY-UHFFFAOYSA-N 0.000 claims 1
- CRSVENVZHKQEKA-UHFFFAOYSA-N 1'-pent-2-ynylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CC#CCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 CRSVENVZHKQEKA-UHFFFAOYSA-N 0.000 claims 1
- QCSJADXRVNKALO-UHFFFAOYSA-N 1'-pent-4-enylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCC=C)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 QCSJADXRVNKALO-UHFFFAOYSA-N 0.000 claims 1
- YHNAOVOHARDENS-UHFFFAOYSA-N 1'-pentyl-4'-(2-phenoxyphenyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=CC=C1OC1=CC=CC=C1 YHNAOVOHARDENS-UHFFFAOYSA-N 0.000 claims 1
- KDYIFXZGHPSOGR-UHFFFAOYSA-N 1'-pentyl-4'-(3,4,5-trimethoxyphenyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC(OC)=C(OC)C(OC)=C1 KDYIFXZGHPSOGR-UHFFFAOYSA-N 0.000 claims 1
- YTFIOOPOULFLLX-UHFFFAOYSA-N 1'-pentyl-4'-(4-phenoxyphenyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C(C=C1)=CC=C1OC1=CC=CC=C1 YTFIOOPOULFLLX-UHFFFAOYSA-N 0.000 claims 1
- AGKSAGXYEIVRRV-UHFFFAOYSA-N 1'-pentyl-4'-(4-propan-2-yloxyphenyl)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(OC(C)C)C=C1 AGKSAGXYEIVRRV-UHFFFAOYSA-N 0.000 claims 1
- KBGBXHKBNVMIOL-UHFFFAOYSA-N 1'-pentyl-4'-(pyridin-3-ylamino)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2NC1=CC=CN=C1 KBGBXHKBNVMIOL-UHFFFAOYSA-N 0.000 claims 1
- AYVCZCFPMLPQMM-UHFFFAOYSA-N 1'-pentyl-4'-(pyrimidin-2-ylamino)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2NC1=NC=CC=N1 AYVCZCFPMLPQMM-UHFFFAOYSA-N 0.000 claims 1
- VXDMCAUPRGKVLQ-UHFFFAOYSA-N 1'-pentyl-4'-(pyrimidin-4-ylamino)spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2NC1=CC=NC=N1 VXDMCAUPRGKVLQ-UHFFFAOYSA-N 0.000 claims 1
- DMVQPXUEMWQVQB-BUHFOSPRSA-N 1'-pentyl-4'-[(e)-2-phenylethenyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2\C=C\C1=CC=CC=C1 DMVQPXUEMWQVQB-BUHFOSPRSA-N 0.000 claims 1
- IMPGGPQZOYKVGV-UHFFFAOYSA-N 1'-pentyl-4'-[2-(trifluoromethoxy)phenyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=CC=C1OC(F)(F)F IMPGGPQZOYKVGV-UHFFFAOYSA-N 0.000 claims 1
- BYHBVEQRAMDHAJ-UHFFFAOYSA-N 1'-pentyl-4'-[3-(trifluoromethoxy)phenyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=CC(OC(F)(F)F)=C1 BYHBVEQRAMDHAJ-UHFFFAOYSA-N 0.000 claims 1
- YLISUWSIFGUMKZ-UHFFFAOYSA-N 1'-pentyl-4'-[4-(trifluoromethoxy)phenyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(OC(F)(F)F)C=C1 YLISUWSIFGUMKZ-UHFFFAOYSA-N 0.000 claims 1
- QWHRENGUGIZBON-UHFFFAOYSA-N 1'-pentyl-4'-[4-(trifluoromethyl)pyridin-3-yl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CN=CC=C1C(F)(F)F QWHRENGUGIZBON-UHFFFAOYSA-N 0.000 claims 1
- FYCMAEKPYZZNHL-UHFFFAOYSA-N 1'-pentyl-4'-phenoxathiin-4-ylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound S1C2=CC=CC=C2OC2=C1C=CC=C2C1=CC=CC2=C1C1(C3=CC=4OCOC=4C=C3OC1)C(=O)N2CCCCC FYCMAEKPYZZNHL-UHFFFAOYSA-N 0.000 claims 1
- KHCAPMSWLGDOMC-UHFFFAOYSA-N 1'-pentyl-4'-phenylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=CC=C1 KHCAPMSWLGDOMC-UHFFFAOYSA-N 0.000 claims 1
- PPWDAPUARFZSKG-UHFFFAOYSA-N 1'-pentyl-4'-pyridin-3-ylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=CN=C1 PPWDAPUARFZSKG-UHFFFAOYSA-N 0.000 claims 1
- BWSQWILGIFMAOO-UHFFFAOYSA-N 1'-pentyl-4'-pyridin-4-ylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=NC=C1 BWSQWILGIFMAOO-UHFFFAOYSA-N 0.000 claims 1
- BDCQYOKWNQBRIJ-UHFFFAOYSA-N 1'-pentyl-4'-pyrimidin-5-ylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CN=CN=C1 BDCQYOKWNQBRIJ-UHFFFAOYSA-N 0.000 claims 1
- KITOPRFYIWXYAD-UHFFFAOYSA-N 1'-pentyl-4'-quinolin-3-ylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC=CC2=CC(C3=CC=CC4=C3C3(C5=CC=6OCOC=6C=C5OC3)C(=O)N4CCCCC)=CN=C21 KITOPRFYIWXYAD-UHFFFAOYSA-N 0.000 claims 1
- QERQKYYWLMCENX-UHFFFAOYSA-N 1'-pentyl-4'-quinolin-6-ylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound N1=CC=CC2=CC(C3=CC=CC4=C3C3(C5=CC=6OCOC=6C=C5OC3)C(=O)N4CCCCC)=CC=C21 QERQKYYWLMCENX-UHFFFAOYSA-N 0.000 claims 1
- PYGNPLWZOWESAI-UHFFFAOYSA-N 1'-pentyl-4'-thiophen-3-ylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C=1C=CSC=1 PYGNPLWZOWESAI-UHFFFAOYSA-N 0.000 claims 1
- CBDIRGCFMYQOBK-UHFFFAOYSA-N 1'-pentyl-5-(trifluoromethyl)spiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC(C(F)(F)F)=CC=C2OC1 CBDIRGCFMYQOBK-UHFFFAOYSA-N 0.000 claims 1
- JWUDCQZKFHWVOM-UHFFFAOYSA-N 1'-pentyl-5-phenoxyspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C1(C1=C2)COC1=CC=C2OC1=CC=CC=C1 JWUDCQZKFHWVOM-UHFFFAOYSA-N 0.000 claims 1
- DDMDACHLNFOZLQ-UHFFFAOYSA-N 1'-pentyl-5-pyridin-3-ylspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C1(C1=C2)COC1=CC=C2C1=CC=CN=C1 DDMDACHLNFOZLQ-UHFFFAOYSA-N 0.000 claims 1
- BYHCUPIXPFLNOT-UHFFFAOYSA-N 1'-pentyl-5-pyridin-4-ylspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C1(C1=C2)COC1=CC=C2C1=CC=NC=C1 BYHCUPIXPFLNOT-UHFFFAOYSA-N 0.000 claims 1
- KXVTXVSJOVCSDW-UHFFFAOYSA-N 1'-pentyl-5-pyrimidin-5-ylspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C1(C1=C2)COC1=CC=C2C1=CN=CN=C1 KXVTXVSJOVCSDW-UHFFFAOYSA-N 0.000 claims 1
- MRTQCNYAQVKOGL-UHFFFAOYSA-N 1'-pentyl-6-pyridin-4-ylspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C1(C1=CC=2)COC1=CC=2C1=CC=NC=C1 MRTQCNYAQVKOGL-UHFFFAOYSA-N 0.000 claims 1
- IQNHROGZDGEPQM-UHFFFAOYSA-N 1'-pentylspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC=CC=C2OC1 IQNHROGZDGEPQM-UHFFFAOYSA-N 0.000 claims 1
- SKMITBUYSAXHIH-UHFFFAOYSA-N 1'-pentylspiro[5,6-dihydrocyclopenta[f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC(OCO3)=C3C=C2CC1 SKMITBUYSAXHIH-UHFFFAOYSA-N 0.000 claims 1
- KTFHKMBXOMMQGS-UHFFFAOYSA-N 1'-pentylspiro[5h-furo[3,4-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC(OCO3)=C3C=C2CO1 KTFHKMBXOMMQGS-UHFFFAOYSA-N 0.000 claims 1
- NAECDUFDXJDYAG-UHFFFAOYSA-N 1'-pentylspiro[6,7-dihydro-[1,3]dioxolo[4,5-g]isoquinoline-8,3'-indole]-2',5-dione Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC(OCO3)=C3C=C2C(=O)NC1 NAECDUFDXJDYAG-UHFFFAOYSA-N 0.000 claims 1
- LJJMIJUUHNZIGS-UHFFFAOYSA-N 1'-pentylspiro[6,7-dihydrobenzo[f][1,3]benzodioxole-5,3'-indole]-2',8-dione Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC(OCO3)=C3C=C2C(=O)CC1 LJJMIJUUHNZIGS-UHFFFAOYSA-N 0.000 claims 1
- UGTQLKHEIQMVBY-UHFFFAOYSA-N 1'-pentylspiro[6h-cyclopenta[f][1,3]benzodioxole-7,3'-indole]-2',5-dione Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC(OCO3)=C3C=C2C(=O)C1 UGTQLKHEIQMVBY-UHFFFAOYSA-N 0.000 claims 1
- PZKABQGUVWNWLA-UHFFFAOYSA-N 1'-pentylspiro[7,8-dihydro-6h-benzo[f][1,3]benzodioxole-5,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC(OCO3)=C3C=C2CCC1 PZKABQGUVWNWLA-UHFFFAOYSA-N 0.000 claims 1
- ZRIBKTWBEDKUQR-UHFFFAOYSA-N 1'-prop-2-ynylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1OC2=CC=3OCOC=3C=C2C21C1=CC=CC=C1N(CC#C)C2=O ZRIBKTWBEDKUQR-UHFFFAOYSA-N 0.000 claims 1
- VCIWUDKYGYHPRR-UHFFFAOYSA-N 1'-propylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 VCIWUDKYGYHPRR-UHFFFAOYSA-N 0.000 claims 1
- LKYNGTHMKCTTQC-UHFFFAOYSA-N 1,2-oxazole-3-carboxamide Chemical compound NC(=O)C=1C=CON=1 LKYNGTHMKCTTQC-UHFFFAOYSA-N 0.000 claims 1
- FTNJQNQLEGKTGD-UHFFFAOYSA-N 1,3-benzodioxole Chemical compound C1=CC=C2OCOC2=C1 FTNJQNQLEGKTGD-UHFFFAOYSA-N 0.000 claims 1
- AHWCADIFIFAXIT-UHFFFAOYSA-N 1-(2,3-dichlorophenyl)-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound ClC1=CC=CC(NC(=O)NCCN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1Cl AHWCADIFIFAXIT-UHFFFAOYSA-N 0.000 claims 1
- CGOFMALNLDXUQU-UHFFFAOYSA-N 1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound O1CCOC2=CC(NC(NCCN3C4=CC=CC=C4C4(C5=CC=6OCOC=6C=C5OC4)C3=O)=O)=CC=C21 CGOFMALNLDXUQU-UHFFFAOYSA-N 0.000 claims 1
- MWSHKTVSFLYEOT-UHFFFAOYSA-N 1-(2-fluoro-5-methylphenyl)-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound CC1=CC=C(F)C(NC(=O)NCCN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 MWSHKTVSFLYEOT-UHFFFAOYSA-N 0.000 claims 1
- WVVMKELOHOXHDF-UHFFFAOYSA-N 1-(2-methoxy-4-nitrophenyl)-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound COC1=CC([N+]([O-])=O)=CC=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O WVVMKELOHOXHDF-UHFFFAOYSA-N 0.000 claims 1
- VYDROLIPSUAPKK-UHFFFAOYSA-N 1-(2-nitrophenyl)-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound [O-][N+](=O)C1=CC=CC=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O VYDROLIPSUAPKK-UHFFFAOYSA-N 0.000 claims 1
- HBDLRQUHSIVJRO-UHFFFAOYSA-N 1-(3,4-dichlorophenyl)-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O HBDLRQUHSIVJRO-UHFFFAOYSA-N 0.000 claims 1
- HFTSRXFCSZICDP-UHFFFAOYSA-N 1-(3-chloro-2-fluorophenyl)-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound FC1=C(Cl)C=CC=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O HFTSRXFCSZICDP-UHFFFAOYSA-N 0.000 claims 1
- BIBNQKDGRAGULI-UHFFFAOYSA-N 1-(3-chloro-2-methylphenyl)-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound CC1=C(Cl)C=CC=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O BIBNQKDGRAGULI-UHFFFAOYSA-N 0.000 claims 1
- JVSRDMBKSXDDNP-UHFFFAOYSA-N 1-(3-chloro-4-methylphenyl)-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound C1=C(Cl)C(C)=CC=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O JVSRDMBKSXDDNP-UHFFFAOYSA-N 0.000 claims 1
- LFQXFEXKCKAPOK-UHFFFAOYSA-N 1-(3-fluoro-4-methylphenyl)-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound C1=C(F)C(C)=CC=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O LFQXFEXKCKAPOK-UHFFFAOYSA-N 0.000 claims 1
- MOMMCVGQIMQWQL-UHFFFAOYSA-N 1-(4-butoxyphenyl)-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound C1=CC(OCCCC)=CC=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O MOMMCVGQIMQWQL-UHFFFAOYSA-N 0.000 claims 1
- YGMZDRMBZIKMSQ-UHFFFAOYSA-N 1-(4-butylphenyl)-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound C1=CC(CCCC)=CC=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O YGMZDRMBZIKMSQ-UHFFFAOYSA-N 0.000 claims 1
- UVRHWJBDPPIUCZ-UHFFFAOYSA-N 1-(4-chloro-2-methylphenyl)-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound CC1=CC(Cl)=CC=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O UVRHWJBDPPIUCZ-UHFFFAOYSA-N 0.000 claims 1
- QRRKJGWWCNJWCN-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O QRRKJGWWCNJWCN-UHFFFAOYSA-N 0.000 claims 1
- UWPDCHOFZVSPDL-UHFFFAOYSA-N 1-(4-ethylphenyl)-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound C1=CC(CC)=CC=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O UWPDCHOFZVSPDL-UHFFFAOYSA-N 0.000 claims 1
- HAAQIGMKFBDFRY-UHFFFAOYSA-N 1-(4-fluoro-3-methylphenyl)-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound C1=C(F)C(C)=CC(NC(=O)NCCN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 HAAQIGMKFBDFRY-UHFFFAOYSA-N 0.000 claims 1
- FZRZHUNCWVKYFJ-UHFFFAOYSA-N 1-(4-fluorophenyl)-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound C1=CC(F)=CC=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O FZRZHUNCWVKYFJ-UHFFFAOYSA-N 0.000 claims 1
- AGCQQVIZHAFAOZ-UHFFFAOYSA-N 1-(4-fluorophenyl)-5-methyl-n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]pyrazole-4-carboxamide Chemical compound CC1=C(C(=O)NCCCN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)C=NN1C1=CC=C(F)C=C1 AGCQQVIZHAFAOZ-UHFFFAOYSA-N 0.000 claims 1
- UZAGYMSEIKUSBW-UHFFFAOYSA-N 1-(4-tert-butylphenyl)-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound C1=CC(C(C)(C)C)=CC=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O UZAGYMSEIKUSBW-UHFFFAOYSA-N 0.000 claims 1
- WJJBEFPGVBRBKI-UHFFFAOYSA-N 1-(5-tert-butyl-2-methoxyphenyl)-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound COC1=CC=C(C(C)(C)C)C=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O WJJBEFPGVBRBKI-UHFFFAOYSA-N 0.000 claims 1
- CPYIFLKUVCOPNS-UHFFFAOYSA-N 1-(9h-fluoren-9-yl)-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound C12=CC=CC=C2C2=CC=CC=C2C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O CPYIFLKUVCOPNS-UHFFFAOYSA-N 0.000 claims 1
- UWQKZQGZQQPEIN-UHFFFAOYSA-N 1-(furan-2-ylmethyl)-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCNC(=O)NCC1=CC=CO1 UWQKZQGZQQPEIN-UHFFFAOYSA-N 0.000 claims 1
- DIYVBUSMVVITGP-UHFFFAOYSA-N 1-[(3-fluorophenyl)methyl]-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound FC1=CC=CC(CNC(=O)NCCN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 DIYVBUSMVVITGP-UHFFFAOYSA-N 0.000 claims 1
- CBQGSVSLGCLLOS-UHFFFAOYSA-N 1-[(6-fluoro-1H-benzimidazol-2-yl)methyl]spiro[2H-indole-3,7'-6H-furo[2,3-f][1,3]benzodioxole] Chemical compound FC1=CC2=C(NC(=N2)CN2CC3(C4=CC=CC=C24)COC2=CC4=C(OCO4)C=C23)C=C1 CBQGSVSLGCLLOS-UHFFFAOYSA-N 0.000 claims 1
- ARKZBHXUPOIEDE-UHFFFAOYSA-N 1-[2-(1,3-benzodioxol-5-yl)ethyl]-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound C1=C2OCOC2=CC(CCNC(NCCN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=O)=C1 ARKZBHXUPOIEDE-UHFFFAOYSA-N 0.000 claims 1
- KDPQUYLIKFAPGL-UHFFFAOYSA-N 1-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]-3-(2-phenoxyphenyl)urea Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCNC(=O)NC1=CC=CC=C1OC1=CC=CC=C1 KDPQUYLIKFAPGL-UHFFFAOYSA-N 0.000 claims 1
- WCWRNPHWIAGWKG-UHFFFAOYSA-N 1-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]-3-(2-phenylethyl)urea Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCNC(=O)NCCC1=CC=CC=C1 WCWRNPHWIAGWKG-UHFFFAOYSA-N 0.000 claims 1
- BTUCCWZCWHMMBS-UHFFFAOYSA-N 1-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]-3-(3,4,5-trimethoxyphenyl)urea Chemical compound COC1=C(OC)C(OC)=CC(NC(=O)NCCN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 BTUCCWZCWHMMBS-UHFFFAOYSA-N 0.000 claims 1
- OWVULQJJEOCPFQ-UHFFFAOYSA-N 1-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]-3-(4-phenoxyphenyl)urea Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCNC(=O)NC(C=C1)=CC=C1OC1=CC=CC=C1 OWVULQJJEOCPFQ-UHFFFAOYSA-N 0.000 claims 1
- IKPOLXKQAMPABJ-UHFFFAOYSA-N 1-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]-3-(5,6,7,8-tetrahydronaphthalen-1-yl)urea Chemical compound C1CCCC2=C1C=CC=C2NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O IKPOLXKQAMPABJ-UHFFFAOYSA-N 0.000 claims 1
- UUVOVJXRYDMRGW-UHFFFAOYSA-N 1-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]-3-[2-(trifluoromethoxy)phenyl]urea Chemical compound FC(F)(F)OC1=CC=CC=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O UUVOVJXRYDMRGW-UHFFFAOYSA-N 0.000 claims 1
- IMAOTYDCBOMBBY-UHFFFAOYSA-N 1-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]-3-[2-(trifluoromethyl)phenyl]urea Chemical compound FC(F)(F)C1=CC=CC=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O IMAOTYDCBOMBBY-UHFFFAOYSA-N 0.000 claims 1
- PIVHACYCVDWCTC-UHFFFAOYSA-N 1-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]urea Chemical compound FC(F)(F)C1=CC=CC(NC(=O)NCCN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 PIVHACYCVDWCTC-UHFFFAOYSA-N 0.000 claims 1
- LYTMPZNZYMJLMS-UHFFFAOYSA-N 1-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]-3-[4-(trifluoromethyl)phenyl]urea Chemical compound C1=CC(C(F)(F)F)=CC=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O LYTMPZNZYMJLMS-UHFFFAOYSA-N 0.000 claims 1
- HXBQQNNQQNJKRG-UHFFFAOYSA-N 1-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]-3-pentylurea Chemical compound C12=CC=CC=C2N(CCNC(=O)NCCCCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 HXBQQNNQQNJKRG-UHFFFAOYSA-N 0.000 claims 1
- IBLSBGDGXRTTSY-UHFFFAOYSA-N 1-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]-3-phenylurea Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCNC(=O)NC1=CC=CC=C1 IBLSBGDGXRTTSY-UHFFFAOYSA-N 0.000 claims 1
- XIUOFELAUBTXFJ-UHFFFAOYSA-N 1-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]-3-propylurea Chemical compound C12=CC=CC=C2N(CCNC(=O)NCCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 XIUOFELAUBTXFJ-UHFFFAOYSA-N 0.000 claims 1
- DOWBKXJZKCWXEQ-UHFFFAOYSA-N 1-[2-(3,5-dimethoxyphenyl)ethyl]-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound COC1=CC(OC)=CC(CCNC(=O)NCCN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 DOWBKXJZKCWXEQ-UHFFFAOYSA-N 0.000 claims 1
- WBYFIDYNBSVRFQ-UHFFFAOYSA-N 1-[2-(4-ethylphenyl)ethyl]-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound C1=CC(CC)=CC=C1CCNC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O WBYFIDYNBSVRFQ-UHFFFAOYSA-N 0.000 claims 1
- FPLDYJFBXFGIAP-UHFFFAOYSA-N 1-[2-(difluoromethoxy)phenyl]-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound FC(F)OC1=CC=CC=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O FPLDYJFBXFGIAP-UHFFFAOYSA-N 0.000 claims 1
- GPJFBJKZEXXNCX-UHFFFAOYSA-N 1-[4-(cyanomethyl)phenyl]-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCNC(=O)NC1=CC=C(CC#N)C=C1 GPJFBJKZEXXNCX-UHFFFAOYSA-N 0.000 claims 1
- LSEBGPTVHNVHNG-UHFFFAOYSA-N 1-[4-(dimethylamino)phenyl]-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound C1=CC(N(C)C)=CC=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O LSEBGPTVHNVHNG-UHFFFAOYSA-N 0.000 claims 1
- HRFRMIVYYUONHN-UHFFFAOYSA-N 1-[4-fluoro-2-(trifluoromethyl)phenyl]-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound FC(F)(F)C1=CC(F)=CC=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O HRFRMIVYYUONHN-UHFFFAOYSA-N 0.000 claims 1
- DLEMDIHBIGJHLG-UHFFFAOYSA-N 1-[4-methyl-3-(trifluoromethyl)phenyl]-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound C1=C(C(F)(F)F)C(C)=CC=C1NC(=O)NCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O DLEMDIHBIGJHLG-UHFFFAOYSA-N 0.000 claims 1
- HFKUYFCDKWHLAU-UHFFFAOYSA-N 1-benzyl-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCNC(=O)NCC1=CC=CC=C1 HFKUYFCDKWHLAU-UHFFFAOYSA-N 0.000 claims 1
- HTCBXRZEXZCKPH-UHFFFAOYSA-N 1-methyl-n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]benzotriazole-5-carboxamide Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCCNC(=O)C1=CC=C2N(C)N=NC2=C1 HTCBXRZEXZCKPH-UHFFFAOYSA-N 0.000 claims 1
- BZQNPRKLINDORP-UHFFFAOYSA-N 1-naphthalen-2-yl-3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]urea Chemical compound C1=CC=CC2=CC(NC(NCCN3C4=CC=CC=C4C4(C5=CC=6OCOC=6C=C5OC4)C3=O)=O)=CC=C21 BZQNPRKLINDORP-UHFFFAOYSA-N 0.000 claims 1
- WHUPSLJSMYXMCC-UHFFFAOYSA-N 2'-oxo-1'-pentyl-n-pyridin-2-ylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-4'-carboxamide Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C(=O)NC1=CC=CC=N1 WHUPSLJSMYXMCC-UHFFFAOYSA-N 0.000 claims 1
- SAEPYURJYIBTBY-UHFFFAOYSA-N 2'-oxo-1'-pentylspiro[2h-1-benzofuran-3,3'-indole]-5-carbonitrile Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC(C#N)=CC=C2OC1 SAEPYURJYIBTBY-UHFFFAOYSA-N 0.000 claims 1
- HUHCBRWRRQHFGK-UHFFFAOYSA-N 2,4,4-trimethylpentan-2-ylurea Chemical compound CC(C)(C)CC(C)(C)NC(N)=O HUHCBRWRRQHFGK-UHFFFAOYSA-N 0.000 claims 1
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 claims 1
- UXGQGJAZEPZESS-UHFFFAOYSA-N 2-(2'-oxospiro[2,5,6,7-tetrahydrocyclopenta[f][1]benzofuran-3,3'-indole]-1'-yl)acetic acid Chemical compound C12=CC=CC=C2N(CC(=O)O)C(=O)C11C2=CC(CCC3)=C3C=C2OC1 UXGQGJAZEPZESS-UHFFFAOYSA-N 0.000 claims 1
- VEJGQIDHMBGGTG-UHFFFAOYSA-N 2-(2'-oxospiro[5,6,7,8-tetrahydro-2h-benzo[f][1]benzofuran-3,3'-indole]-1'-yl)acetic acid Chemical compound C12=CC=CC=C2N(CC(=O)O)C(=O)C11C2=CC(CCCC3)=C3C=C2OC1 VEJGQIDHMBGGTG-UHFFFAOYSA-N 0.000 claims 1
- JTNKHWOBZYYRMG-UHFFFAOYSA-N 2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)-n,n-dipropylacetamide Chemical compound C12=CC=CC=C2N(CC(=O)N(CCC)CCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 JTNKHWOBZYYRMG-UHFFFAOYSA-N 0.000 claims 1
- MUQLSXKZOUKGRD-UHFFFAOYSA-N 2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)-n-pentylacetamide Chemical compound C12=CC=CC=C2N(CC(=O)NCCCCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 MUQLSXKZOUKGRD-UHFFFAOYSA-N 0.000 claims 1
- XEXCCHMAJJQTIB-UHFFFAOYSA-N 2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)-n-phenylacetamide Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CC(=O)NC1=CC=CC=C1 XEXCCHMAJJQTIB-UHFFFAOYSA-N 0.000 claims 1
- ZVYFSAYBLGVYAF-UHFFFAOYSA-N 2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)-n-propylacetamide Chemical compound C12=CC=CC=C2N(CC(=O)NCCC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 ZVYFSAYBLGVYAF-UHFFFAOYSA-N 0.000 claims 1
- APIBPJKXEFNJPQ-UHFFFAOYSA-N 2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)acetic acid Chemical compound C12=CC=CC=C2N(CC(=O)O)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 APIBPJKXEFNJPQ-UHFFFAOYSA-N 0.000 claims 1
- SCPDOXDFOSSRMG-UHFFFAOYSA-N 2-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]-n-(1,3,4-thiadiazol-2-yl)benzamide Chemical compound C=1C=CC=C(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)C=1C(=O)NC1=NN=CS1 SCPDOXDFOSSRMG-UHFFFAOYSA-N 0.000 claims 1
- XBRYZJKWZYKDBR-UHFFFAOYSA-N 2-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]-n-(1,3-thiazol-2-yl)benzamide Chemical compound C=1C=CC=C(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)C=1C(=O)NC1=NC=CS1 XBRYZJKWZYKDBR-UHFFFAOYSA-N 0.000 claims 1
- ONISECBBIZDUPE-UHFFFAOYSA-N 2-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]-n-pentylbenzamide Chemical compound CCCCCNC(=O)C1=CC=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O ONISECBBIZDUPE-UHFFFAOYSA-N 0.000 claims 1
- ACJRXZDHPRTKEX-UHFFFAOYSA-N 2-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]-n-phenylbenzamide Chemical compound C=1C=CC=C(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)C=1C(=O)NC1=CC=CC=C1 ACJRXZDHPRTKEX-UHFFFAOYSA-N 0.000 claims 1
- KKUIMXYOUNISSH-UHFFFAOYSA-N 2-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]-n-propylbenzamide Chemical compound CCCNC(=O)C1=CC=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O KKUIMXYOUNISSH-UHFFFAOYSA-N 0.000 claims 1
- GGHGAYXIUCASOW-UHFFFAOYSA-N 2-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]benzoic acid Chemical compound OC(=O)C1=CC=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O GGHGAYXIUCASOW-UHFFFAOYSA-N 0.000 claims 1
- HNGRJGOUWTVXBW-UHFFFAOYSA-N 2-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1CCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O HNGRJGOUWTVXBW-UHFFFAOYSA-N 0.000 claims 1
- DCPBXIUOOFELAF-UHFFFAOYSA-N 2-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1CCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O DCPBXIUOOFELAF-UHFFFAOYSA-N 0.000 claims 1
- BDDUUXPXEZQABZ-UHFFFAOYSA-N 2-[4-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]phenyl]benzonitrile Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC(C=C1)=CC=C1C1=CC=CC=C1C#N BDDUUXPXEZQABZ-UHFFFAOYSA-N 0.000 claims 1
- UWQIRXGEFUXOPB-UHFFFAOYSA-N 2-methyl-1'-pentylspiro[6h-furo[2,3-f][1,3]benzothiazole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC(SC(C)=N3)=C3C=C2OC1 UWQIRXGEFUXOPB-UHFFFAOYSA-N 0.000 claims 1
- 125000006512 3,4-dichlorobenzyl group Chemical group [H]C1=C(Cl)C(Cl)=C([H])C(=C1[H])C([H])([H])* 0.000 claims 1
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims 1
- 125000006509 3,4-difluorobenzyl group Chemical group [H]C1=C(F)C(F)=C([H])C(=C1[H])C([H])([H])* 0.000 claims 1
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 claims 1
- 125000006288 3,5-difluorobenzyl group Chemical group [H]C1=C(F)C([H])=C(C([H])=C1F)C([H])([H])* 0.000 claims 1
- BSFSIHVHYNAIBD-UHFFFAOYSA-N 3-(2'-oxo-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-4'-yl)benzonitrile Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=CC(C#N)=C1 BSFSIHVHYNAIBD-UHFFFAOYSA-N 0.000 claims 1
- KGFNXIHZTRJPIB-UHFFFAOYSA-N 3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propanal Chemical compound C12=CC=CC=C2N(CCC=O)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 KGFNXIHZTRJPIB-UHFFFAOYSA-N 0.000 claims 1
- MQAKKPHZWATALG-UHFFFAOYSA-N 3-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]-n-(1,3,4-thiadiazol-2-yl)benzamide Chemical compound C=1C=CC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=CC=1C(=O)NC1=NN=CS1 MQAKKPHZWATALG-UHFFFAOYSA-N 0.000 claims 1
- LOSVOQINPMOZIK-UHFFFAOYSA-N 3-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]-n-(1,3-thiazol-2-yl)benzamide Chemical compound C=1C=CC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=CC=1C(=O)NC1=NC=CS1 LOSVOQINPMOZIK-UHFFFAOYSA-N 0.000 claims 1
- IRRXHWASFLTKDA-UHFFFAOYSA-N 3-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]-n-pentylbenzamide Chemical compound CCCCCNC(=O)C1=CC=CC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 IRRXHWASFLTKDA-UHFFFAOYSA-N 0.000 claims 1
- ZJXWNEBARYTEIU-UHFFFAOYSA-N 3-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]-n-phenylbenzamide Chemical compound C=1C=CC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=CC=1C(=O)NC1=CC=CC=C1 ZJXWNEBARYTEIU-UHFFFAOYSA-N 0.000 claims 1
- OOLGIJQNXCUPLI-UHFFFAOYSA-N 3-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]-n-propylbenzamide Chemical compound CCCNC(=O)C1=CC=CC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 OOLGIJQNXCUPLI-UHFFFAOYSA-N 0.000 claims 1
- DMCIFYGGCHCQLP-UHFFFAOYSA-N 3-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]-n-pyridin-3-ylbenzamide Chemical compound C=1C=CC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=CC=1C(=O)NC1=CC=CN=C1 DMCIFYGGCHCQLP-UHFFFAOYSA-N 0.000 claims 1
- LNSPZHWSUHMVCR-UHFFFAOYSA-N 3-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]-n-pyrimidin-4-ylbenzamide Chemical compound C=1C=CC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=CC=1C(=O)NC1=CC=NC=N1 LNSPZHWSUHMVCR-UHFFFAOYSA-N 0.000 claims 1
- HESSMNOAYKBOPS-UHFFFAOYSA-N 3-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]benzoic acid Chemical compound OC(=O)C1=CC=CC(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=C1 HESSMNOAYKBOPS-UHFFFAOYSA-N 0.000 claims 1
- LXHXXOKQIQNJOD-UHFFFAOYSA-N 3-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]benzonitrile Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC1=CC=CC(C#N)=C1 LXHXXOKQIQNJOD-UHFFFAOYSA-N 0.000 claims 1
- XVURKFKMGMJWPZ-UHFFFAOYSA-N 3-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propylamino]propanenitrile Chemical compound C1OC2=CC=3OCOC=3C=C2C21C1=CC=CC=C1N(CCCNCCC#N)C2=O XVURKFKMGMJWPZ-UHFFFAOYSA-N 0.000 claims 1
- 125000006497 3-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000006180 3-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1[H])C([H])([H])[H])C([H])([H])* 0.000 claims 1
- LOLQHJFNDFKXPZ-UHFFFAOYSA-N 3-methyl-N-(3-spiro[2H-indole-3,7'-6H-furo[2,3-f][1,3]benzodioxole]-1-ylpropyl)butan-1-amine Chemical compound CC(CCNCCCN1CC2(C3=CC=CC=C13)COC1=CC3=C(OCO3)C=C12)C LOLQHJFNDFKXPZ-UHFFFAOYSA-N 0.000 claims 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- CGJXFOYBUDTZHG-UHFFFAOYSA-N 4',7'-dichloro-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound ClC1=CC=C(Cl)C2=C1N(CCCCC)C(=O)C21C2=CC(OCO3)=C3C=C2OC1 CGJXFOYBUDTZHG-UHFFFAOYSA-N 0.000 claims 1
- GRVVBOXQBYZKQC-UHFFFAOYSA-N 4'-(1,3-benzodioxol-5-yl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=C2OCOC2=CC(C2=CC=CC3=C2C2(C4=CC=5OCOC=5C=C4OC2)C(=O)N3CCCCC)=C1 GRVVBOXQBYZKQC-UHFFFAOYSA-N 0.000 claims 1
- XPEIBDAUENTOAK-UHFFFAOYSA-N 4'-(1,3-benzodioxol-5-ylamino)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=C2OCOC2=CC(NC2=CC=CC3=C2C2(C4=CC=5OCOC=5C=C4OC2)C(=O)N3CCCCC)=C1 XPEIBDAUENTOAK-UHFFFAOYSA-N 0.000 claims 1
- BHIWAAJCNQJGNQ-UHFFFAOYSA-N 4'-(1-benzofuran-2-yl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC=C2OC(C3=CC=CC4=C3C3(C5=CC=6OCOC=6C=C5OC3)C(=O)N4CCCCC)=CC2=C1 BHIWAAJCNQJGNQ-UHFFFAOYSA-N 0.000 claims 1
- ULOLPFQQKNPWFD-UHFFFAOYSA-N 4'-(1-benzothiophen-2-yl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC=C2SC(C3=CC=CC4=C3C3(C5=CC=6OCOC=6C=C5OC3)C(=O)N4CCCCC)=CC2=C1 ULOLPFQQKNPWFD-UHFFFAOYSA-N 0.000 claims 1
- RBTUBQFDDHLMOA-UHFFFAOYSA-N 4'-(1-benzothiophen-3-yl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC=C2C(C3=CC=CC4=C3C3(C5=CC=6OCOC=6C=C5OC3)C(=O)N4CCCCC)=CSC2=C1 RBTUBQFDDHLMOA-UHFFFAOYSA-N 0.000 claims 1
- HFHQPNMNQFRCNV-UHFFFAOYSA-N 4'-(1-benzylpyrazol-4-yl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C(=C1)C=NN1CC1=CC=CC=C1 HFHQPNMNQFRCNV-UHFFFAOYSA-N 0.000 claims 1
- BAIAZFGTEQBMNO-UHFFFAOYSA-N 4'-(1-methylindol-5-yl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=C2N(C)C=CC2=CC(C2=CC=CC3=C2C2(C4=CC=5OCOC=5C=C4OC2)C(=O)N3CCCCC)=C1 BAIAZFGTEQBMNO-UHFFFAOYSA-N 0.000 claims 1
- GBOQZLIWXGXTER-UHFFFAOYSA-N 4'-(1-methylpyrrol-3-yl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C=1C=CN(C)C=1 GBOQZLIWXGXTER-UHFFFAOYSA-N 0.000 claims 1
- IVRDFQNOEBNSET-UHFFFAOYSA-N 4'-(1h-indol-5-yl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=C2NC=CC2=CC(C2=CC=CC3=C2C2(C4=CC=5OCOC=5C=C4OC2)C(=O)N3CCCCC)=C1 IVRDFQNOEBNSET-UHFFFAOYSA-N 0.000 claims 1
- ZFJPROLFQIHQMI-UHFFFAOYSA-N 4'-(2,3-dihydro-1,4-benzodioxin-6-yl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O1CCOC2=CC(C3=CC=CC4=C3C3(C5=CC=6OCOC=6C=C5OC3)C(=O)N4CCCCC)=CC=C21 ZFJPROLFQIHQMI-UHFFFAOYSA-N 0.000 claims 1
- RDSMKJXPGYEJRS-UHFFFAOYSA-N 4'-(2,4-dimethoxypyrimidin-5-yl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CN=C(OC)N=C1OC RDSMKJXPGYEJRS-UHFFFAOYSA-N 0.000 claims 1
- QZXRWLMNQSAJKE-UHFFFAOYSA-N 4'-(2-butoxy-5-fluorophenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC(F)=CC=C1OCCCC QZXRWLMNQSAJKE-UHFFFAOYSA-N 0.000 claims 1
- QMJDVIDCLNZITD-UHFFFAOYSA-N 4'-(2-chlorophenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=CC=C1Cl QMJDVIDCLNZITD-UHFFFAOYSA-N 0.000 claims 1
- OFGPRLLJJSTWBU-UHFFFAOYSA-N 4'-(2-fluoro-5-methoxyphenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC(OC)=CC=C1F OFGPRLLJJSTWBU-UHFFFAOYSA-N 0.000 claims 1
- JYARFVCXCARTSH-UHFFFAOYSA-N 4'-(2-fluorophenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=CC=C1F JYARFVCXCARTSH-UHFFFAOYSA-N 0.000 claims 1
- MARKBRFERYDZRU-UHFFFAOYSA-N 4'-(2-methoxyanilino)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2NC1=CC=CC=C1OC MARKBRFERYDZRU-UHFFFAOYSA-N 0.000 claims 1
- RWCVTDPSEZAGNA-UHFFFAOYSA-N 4'-(2-methoxypyridin-3-yl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=CN=C1OC RWCVTDPSEZAGNA-UHFFFAOYSA-N 0.000 claims 1
- YQMOFARFEDELQX-UHFFFAOYSA-N 4'-(2-methoxypyrimidin-5-yl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CN=C(OC)N=C1 YQMOFARFEDELQX-UHFFFAOYSA-N 0.000 claims 1
- BESYKYQEQKFGFT-UHFFFAOYSA-N 4'-(2-methylpropyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC=C(CC(C)C)C2=C1N(CCCCC)C(=O)C21C2=CC(OCO3)=C3C=C2OC1 BESYKYQEQKFGFT-UHFFFAOYSA-N 0.000 claims 1
- HVFHFGUXINIMSO-UHFFFAOYSA-N 4'-(3,5-dichlorophenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC(Cl)=CC(Cl)=C1 HVFHFGUXINIMSO-UHFFFAOYSA-N 0.000 claims 1
- UFSIMUVREICXHS-UHFFFAOYSA-N 4'-(3-acetylphenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=CC(C(C)=O)=C1 UFSIMUVREICXHS-UHFFFAOYSA-N 0.000 claims 1
- DAUNIGODKMYARG-UHFFFAOYSA-N 4'-(3-butoxyphenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=CC(OCCCC)=C1 DAUNIGODKMYARG-UHFFFAOYSA-N 0.000 claims 1
- IOXFZDXPWCIOER-UHFFFAOYSA-N 4'-(3-chloro-4-fluorophenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(F)C(Cl)=C1 IOXFZDXPWCIOER-UHFFFAOYSA-N 0.000 claims 1
- WSOZFDGIIPQVMW-UHFFFAOYSA-N 4'-(3-chloro-4-phenylmethoxyphenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C(C=C1Cl)=CC=C1OCC1=CC=CC=C1 WSOZFDGIIPQVMW-UHFFFAOYSA-N 0.000 claims 1
- BOOKUIPTCVRTTH-UHFFFAOYSA-N 4'-(3-chlorophenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=CC(Cl)=C1 BOOKUIPTCVRTTH-UHFFFAOYSA-N 0.000 claims 1
- GNPIODRDXGINHB-UHFFFAOYSA-N 4'-(3-fluoro-4-methoxyphenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(OC)C(F)=C1 GNPIODRDXGINHB-UHFFFAOYSA-N 0.000 claims 1
- WYHWCFUJOAFGOW-UHFFFAOYSA-N 4'-(3-fluoro-4-pentoxyphenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=C(F)C(OCCCCC)=CC=C1C1=CC=CC2=C1C1(C3=CC=4OCOC=4C=C3OC1)C(=O)N2CCCCC WYHWCFUJOAFGOW-UHFFFAOYSA-N 0.000 claims 1
- ORAPBEYNBARRKP-UHFFFAOYSA-N 4'-(3-fluoro-5-methoxyphenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC(F)=CC(OC)=C1 ORAPBEYNBARRKP-UHFFFAOYSA-N 0.000 claims 1
- FYVLTICDXLWIDI-UHFFFAOYSA-N 4'-(3-fluoroanilino)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2NC1=CC=CC(F)=C1 FYVLTICDXLWIDI-UHFFFAOYSA-N 0.000 claims 1
- AUHMTFSWZHZAFL-UHFFFAOYSA-N 4'-(3-fluorophenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=CC(F)=C1 AUHMTFSWZHZAFL-UHFFFAOYSA-N 0.000 claims 1
- IJLJDQKHPHNDOD-UHFFFAOYSA-N 4'-(4-butoxy-3-fluorophenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(OCCCC)C(F)=C1 IJLJDQKHPHNDOD-UHFFFAOYSA-N 0.000 claims 1
- VJIYETPRCUISFB-UHFFFAOYSA-N 4'-(4-butoxyphenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(OCCCC)C=C1 VJIYETPRCUISFB-UHFFFAOYSA-N 0.000 claims 1
- GSUJPUJDDJTHPS-UHFFFAOYSA-N 4'-(4-butylphenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(CCCC)C=C1 GSUJPUJDDJTHPS-UHFFFAOYSA-N 0.000 claims 1
- DDCZMIPHISFRGA-UHFFFAOYSA-N 4'-(4-chlorophenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(Cl)C=C1 DDCZMIPHISFRGA-UHFFFAOYSA-N 0.000 claims 1
- BXRWNLABHQDVGT-UHFFFAOYSA-N 4'-(4-ethoxy-3-fluorophenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(OCC)C(F)=C1 BXRWNLABHQDVGT-UHFFFAOYSA-N 0.000 claims 1
- FEEJYOCSELUHEL-UHFFFAOYSA-N 4'-(4-fluoro-2-methylphenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(F)C=C1C FEEJYOCSELUHEL-UHFFFAOYSA-N 0.000 claims 1
- WASWOQMWUQOJTH-UHFFFAOYSA-N 4'-(4-fluorophenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(F)C=C1 WASWOQMWUQOJTH-UHFFFAOYSA-N 0.000 claims 1
- DHQDPSBZKNZNEU-UHFFFAOYSA-N 4'-(4-methoxyphenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(OC)C=C1 DHQDPSBZKNZNEU-UHFFFAOYSA-N 0.000 claims 1
- QWZLWXIASJJIPZ-UHFFFAOYSA-N 4'-(4-methoxypyridin-3-yl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CN=CC=C1OC QWZLWXIASJJIPZ-UHFFFAOYSA-N 0.000 claims 1
- WUOGZFBSMZBTIT-UHFFFAOYSA-N 4'-(4-methylphenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(C)C=C1 WUOGZFBSMZBTIT-UHFFFAOYSA-N 0.000 claims 1
- ACTSJBMXNQGVBW-UHFFFAOYSA-N 4'-(4-methylpiperazin-1-yl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2N1CCN(C)CC1 ACTSJBMXNQGVBW-UHFFFAOYSA-N 0.000 claims 1
- WOXGHQZVJPELCV-UHFFFAOYSA-N 4'-(4-morpholin-4-ylphenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C(C=C1)=CC=C1N1CCOCC1 WOXGHQZVJPELCV-UHFFFAOYSA-N 0.000 claims 1
- FPIGVUQJSXLNNK-UHFFFAOYSA-N 4'-(5-chloro-2-methoxyphenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC(Cl)=CC=C1OC FPIGVUQJSXLNNK-UHFFFAOYSA-N 0.000 claims 1
- YQQUHSBVEAUINQ-UHFFFAOYSA-N 4'-(5-fluoro-2-methoxyphenyl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC(F)=CC=C1OC YQQUHSBVEAUINQ-UHFFFAOYSA-N 0.000 claims 1
- XPRDNLJUDMYHMP-UHFFFAOYSA-N 4'-(5-methoxypyridin-3-yl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CN=CC(OC)=C1 XPRDNLJUDMYHMP-UHFFFAOYSA-N 0.000 claims 1
- XLZGSZXUBNMYLG-UHFFFAOYSA-N 4'-(6-fluoropyridin-2-yl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=CC(F)=N1 XLZGSZXUBNMYLG-UHFFFAOYSA-N 0.000 claims 1
- YPPPOVHTMHPNDF-UHFFFAOYSA-N 4'-(6-fluoropyridin-3-yl)-1'-methylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(F)N=C1 YPPPOVHTMHPNDF-UHFFFAOYSA-N 0.000 claims 1
- YDBINQWWEREMMT-UHFFFAOYSA-N 4'-(6-fluoropyridin-3-yl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(F)N=C1 YDBINQWWEREMMT-UHFFFAOYSA-N 0.000 claims 1
- SORQKETUXLKGLM-UHFFFAOYSA-N 4'-(6-methoxypyridin-2-yl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=CC(OC)=N1 SORQKETUXLKGLM-UHFFFAOYSA-N 0.000 claims 1
- QXTBUNZUJNFXDK-UHFFFAOYSA-N 4'-(6-methoxypyridin-3-yl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(OC)N=C1 QXTBUNZUJNFXDK-UHFFFAOYSA-N 0.000 claims 1
- ASXPQVXBXBBQEB-UHFFFAOYSA-N 4'-(furan-3-yl)-1'-methylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C=1C=COC=1 ASXPQVXBXBBQEB-UHFFFAOYSA-N 0.000 claims 1
- IMAMQKYHXYPHBZ-UHFFFAOYSA-N 4'-(furan-3-yl)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C=1C=COC=1 IMAMQKYHXYPHBZ-UHFFFAOYSA-N 0.000 claims 1
- XJDFRDSMQIPLBP-UHFFFAOYSA-N 4'-(naphthalen-2-ylamino)-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC=CC2=CC(NC3=CC=CC4=C3C3(C5=CC=6OCOC=6C=C5OC3)C(=O)N4CCCCC)=CC=C21 XJDFRDSMQIPLBP-UHFFFAOYSA-N 0.000 claims 1
- HYJSXMVKPXUMEX-DHZHZOJOSA-N 4'-[(e)-2-(4-fluorophenyl)ethenyl]-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2\C=C\C1=CC=C(F)C=C1 HYJSXMVKPXUMEX-DHZHZOJOSA-N 0.000 claims 1
- HEMNUZOUELHOQY-VURMDHGXSA-N 4'-[(z)-3-chloroprop-1-enyl]-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC=C(\C=C/CCl)C2=C1N(CCCCC)C(=O)C21C2=CC(OCO3)=C3C=C2OC1 HEMNUZOUELHOQY-VURMDHGXSA-N 0.000 claims 1
- GWEMUKFLKOVMPM-UHFFFAOYSA-N 4'-[1-(benzenesulfonyl)indol-3-yl]-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C(C1=CC=CC=C11)=CN1S(=O)(=O)C1=CC=CC=C1 GWEMUKFLKOVMPM-UHFFFAOYSA-N 0.000 claims 1
- LXZUYELEDLMUON-UHFFFAOYSA-N 4'-[2-chloro-4-[(3,5-dimethoxyphenyl)methoxy]phenyl]-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C(C(=C1)Cl)=CC=C1OCC1=CC(OC)=CC(OC)=C1 LXZUYELEDLMUON-UHFFFAOYSA-N 0.000 claims 1
- QJXSPFKYAYUCTH-UHFFFAOYSA-N 4'-[3,5-bis(trifluoromethyl)phenyl]-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 QJXSPFKYAYUCTH-UHFFFAOYSA-N 0.000 claims 1
- ZPJYLQPMKLHZCA-UHFFFAOYSA-N 4'-[4-(2-methylpropoxy)phenyl]-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(OCC(C)C)C=C1 ZPJYLQPMKLHZCA-UHFFFAOYSA-N 0.000 claims 1
- ZNFRCVNTHCOYIE-UHFFFAOYSA-N 4'-[4-(dimethylamino)phenyl]-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(N(C)C)C=C1 ZNFRCVNTHCOYIE-UHFFFAOYSA-N 0.000 claims 1
- IKWDFZABMCCIBN-UHFFFAOYSA-N 4'-[4-[(dimethylamino)methyl]phenyl]-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(CN(C)C)C=C1 IKWDFZABMCCIBN-UHFFFAOYSA-N 0.000 claims 1
- RUCBIOIGMVIWPA-UHFFFAOYSA-N 4'-[4-chloro-2-(trifluoromethyl)anilino]-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2NC1=CC=C(Cl)C=C1C(F)(F)F RUCBIOIGMVIWPA-UHFFFAOYSA-N 0.000 claims 1
- OVJJOSKIKHLSBC-UHFFFAOYSA-N 4'-[6-(dimethylamino)pyridin-3-yl]-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(N(C)C)N=C1 OVJJOSKIKHLSBC-UHFFFAOYSA-N 0.000 claims 1
- MKYJMAOGIRCWID-UHFFFAOYSA-N 4'-bromo-1'-[[5-(trifluoromethyl)furan-2-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O1C(C(F)(F)F)=CC=C1CN1C(C=CC=C2Br)=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O MKYJMAOGIRCWID-UHFFFAOYSA-N 0.000 claims 1
- KLHLFKUVNLZXBN-UHFFFAOYSA-N 4'-bromo-1'-methylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC=C(Br)C2=C1N(C)C(=O)C21C2=CC(OCO3)=C3C=C2OC1 KLHLFKUVNLZXBN-UHFFFAOYSA-N 0.000 claims 1
- KGLLFHTUYDZIHB-UHFFFAOYSA-N 4'-dibenzofuran-4-yl-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C12=CC=CC=C2OC2=C1C=CC=C2C1=CC=CC2=C1C1(C3=CC=4OCOC=4C=C3OC1)C(=O)N2CCCCC KGLLFHTUYDZIHB-UHFFFAOYSA-N 0.000 claims 1
- SQTJOXDCPGUIBT-UHFFFAOYSA-N 4'-isoquinolin-4-yl-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound C1=CC=C2C(C3=CC=CC4=C3C3(C5=CC=6OCOC=6C=C5OC3)C(=O)N4CCCCC)=CN=CC2=C1 SQTJOXDCPGUIBT-UHFFFAOYSA-N 0.000 claims 1
- QJJLYNOLBHHGGY-UHFFFAOYSA-N 4'-methoxy-1'-[[5-(trifluoromethyl)furan-2-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C=2C(OC)=CC=CC=2N1CC1=CC=C(C(F)(F)F)O1 QJJLYNOLBHHGGY-UHFFFAOYSA-N 0.000 claims 1
- LJUVRLVOYKOIEO-UHFFFAOYSA-N 4'-methyl-1'-[[5-(trifluoromethyl)furan-2-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C=2C(C)=CC=CC=2N1CC1=CC=C(C(F)(F)F)O1 LJUVRLVOYKOIEO-UHFFFAOYSA-N 0.000 claims 1
- NPTMSMOKDRFNJW-UHFFFAOYSA-N 4'-morpholin-4-yl-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2N1CCOCC1 NPTMSMOKDRFNJW-UHFFFAOYSA-N 0.000 claims 1
- VMXCZTIPLYHBSN-UHFFFAOYSA-N 4'-quinolin-3-yl-1'-[[5-(trifluoromethyl)furan-2-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O1C(C(F)(F)F)=CC=C1CN1C(C=CC=C2C=3C=C4C=CC=CC4=NC=3)=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O VMXCZTIPLYHBSN-UHFFFAOYSA-N 0.000 claims 1
- LOMZFLOALBNXHI-UHFFFAOYSA-N 4-(2'-oxo-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-4'-yl)benzonitrile Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(C#N)C=C1 LOMZFLOALBNXHI-UHFFFAOYSA-N 0.000 claims 1
- KHKFHZFSMGPMIR-UHFFFAOYSA-N 4-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)butanenitrile Chemical compound C1OC2=CC=3OCOC=3C=C2C21C1=CC=CC=C1N(CCCC#N)C2=O KHKFHZFSMGPMIR-UHFFFAOYSA-N 0.000 claims 1
- WMRRCVGZZXWDGO-UHFFFAOYSA-N 4-(3,5-dimethoxyphenyl)-1-pentylspiro[2H-indole-3,7'-6H-furo[2,3-f][1,3]benzodioxole] Chemical compound COC=1C=C(C=C(C=1)OC)C1=C2C3(CN(C2=CC=C1)CCCCC)COC1=CC2=C(OCO2)C=C13 WMRRCVGZZXWDGO-UHFFFAOYSA-N 0.000 claims 1
- MCLDQIWDLILQOP-UHFFFAOYSA-N 4-(furan-3-yl)spiro[1h-indole-3,7'-6h-furo[2,3-f][1,3]benzodioxole]-2-one Chemical compound C=12C3(C4=CC=5OCOC=5C=C4OC3)C(=O)NC2=CC=CC=1C=1C=COC=1 MCLDQIWDLILQOP-UHFFFAOYSA-N 0.000 claims 1
- KWRWHBSNLGDQMK-UHFFFAOYSA-N 4-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]-n-(1,3-thiazol-2-yl)benzamide Chemical compound C=1C=C(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)C=CC=1C(=O)NC1=NC=CS1 KWRWHBSNLGDQMK-UHFFFAOYSA-N 0.000 claims 1
- UIAAQLGIZMUFDE-UHFFFAOYSA-N 4-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]-n-pentylbenzamide Chemical compound C1=CC(C(=O)NCCCCC)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O UIAAQLGIZMUFDE-UHFFFAOYSA-N 0.000 claims 1
- SLKLPUHAYWJPIK-UHFFFAOYSA-N 4-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]-n-phenylbenzamide Chemical compound C=1C=C(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)C=CC=1C(=O)NC1=CC=CC=C1 SLKLPUHAYWJPIK-UHFFFAOYSA-N 0.000 claims 1
- ARBYMAKVZADERA-UHFFFAOYSA-N 4-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]-n-propylbenzamide Chemical compound C1=CC(C(=O)NCCC)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O ARBYMAKVZADERA-UHFFFAOYSA-N 0.000 claims 1
- NPTLPAYAUCDUEH-UHFFFAOYSA-N 4-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]-n-pyridin-3-ylbenzamide Chemical compound C=1C=C(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)C=CC=1C(=O)NC1=CC=CN=C1 NPTLPAYAUCDUEH-UHFFFAOYSA-N 0.000 claims 1
- QWJVVSLYLHDKOF-UHFFFAOYSA-N 4-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]-n-pyrimidin-4-ylbenzamide Chemical compound C=1C=C(CN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)C=CC=1C(=O)NC1=CC=NC=N1 QWJVVSLYLHDKOF-UHFFFAOYSA-N 0.000 claims 1
- PAWJGBXAVRHHFN-UHFFFAOYSA-N 4-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O PAWJGBXAVRHHFN-UHFFFAOYSA-N 0.000 claims 1
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims 1
- IOEXTRDGHITHFQ-UHFFFAOYSA-N 4-bromospiro[1h-indole-3,7'-6h-furo[2,3-f][1,3]benzodioxole]-2-one Chemical compound C1OC2=CC=3OCOC=3C=C2C21C(=O)NC1=C2C(Br)=CC=C1 IOEXTRDGHITHFQ-UHFFFAOYSA-N 0.000 claims 1
- HOZYYQIBZKAWSR-UHFFFAOYSA-N 4-chloro-N-(3-spiro[2H-indole-3,7'-6H-furo[2,3-f][1,3]benzodioxole]-1-ylpropyl)aniline Chemical compound ClC1=CC=C(C=C1)NCCCN1CC2(C3=CC=CC=C13)COC1=CC3=C(OCO3)C=C12 HOZYYQIBZKAWSR-UHFFFAOYSA-N 0.000 claims 1
- NESFKAOKCRZWEH-UHFFFAOYSA-N 4-dibenzofuran-4-ylspiro[1h-indole-3,7'-6h-furo[2,3-f][1,3]benzodioxole]-2-one Chemical compound O1C2=CC=CC=C2C2=C1C(C=1C=CC=C3NC(C4(C5=CC=6OCOC=6C=C5OC4)C3=1)=O)=CC=C2 NESFKAOKCRZWEH-UHFFFAOYSA-N 0.000 claims 1
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 claims 1
- SXIFAEWFOJETOA-UHFFFAOYSA-N 4-hydroxy-butyl Chemical group [CH2]CCCO SXIFAEWFOJETOA-UHFFFAOYSA-N 0.000 claims 1
- YQIBRGLMUJSNNQ-UHFFFAOYSA-N 4-pyrimidin-5-ylspiro[1h-indole-3,7'-6h-furo[2,3-f][1,3]benzodioxole]-2-one Chemical compound C=12C3(C4=CC=5OCOC=5C=C4OC3)C(=O)NC2=CC=CC=1C1=CN=CN=C1 YQIBRGLMUJSNNQ-UHFFFAOYSA-N 0.000 claims 1
- VINLQPRNBDKOGP-UHFFFAOYSA-N 5'-bromospiro[1h-indole-3,3'-2h-1-benzofuran]-2-one Chemical compound O=C1NC2=CC=CC=C2C21COC1=CC=C(Br)C=C12 VINLQPRNBDKOGP-UHFFFAOYSA-N 0.000 claims 1
- OXDAYNHNUDTNEO-UHFFFAOYSA-N 5'-fluoro-1'-[[5-(trifluoromethyl)furan-2-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC(F)=CC=C2N1CC1=CC=C(C(F)(F)F)O1 OXDAYNHNUDTNEO-UHFFFAOYSA-N 0.000 claims 1
- DQGIFTRPPKIWBA-UHFFFAOYSA-N 5'-hydroxyspiro[1h-indole-3,3'-2h-1-benzofuran]-2-one Chemical compound O=C1NC2=CC=CC=C2C21COC1=CC=C(O)C=C12 DQGIFTRPPKIWBA-UHFFFAOYSA-N 0.000 claims 1
- ROUITWBSEXFBNO-UHFFFAOYSA-N 5,5-difluoro-1'-pentylspiro[6,7-dihydrobenzo[f][1,3]benzodioxole-8,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC(OCO3)=C3C=C2C(F)(F)CC1 ROUITWBSEXFBNO-UHFFFAOYSA-N 0.000 claims 1
- SWEBWSPGRMLLFC-UHFFFAOYSA-N 5,6-dichloro-1'-pentylspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC(Cl)=C(Cl)C=C2OC1 SWEBWSPGRMLLFC-UHFFFAOYSA-N 0.000 claims 1
- JJFQLYUVJGTGIW-UHFFFAOYSA-N 5,6-difluoro-1'-pentylspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC(F)=C(F)C=C2OC1 JJFQLYUVJGTGIW-UHFFFAOYSA-N 0.000 claims 1
- XYDCLAZJIKWSLE-UHFFFAOYSA-N 5-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)pentanenitrile Chemical compound C1OC2=CC=3OCOC=3C=C2C21C1=CC=CC=C1N(CCCCC#N)C2=O XYDCLAZJIKWSLE-UHFFFAOYSA-N 0.000 claims 1
- AEYSZOILUKCASB-UHFFFAOYSA-N 5-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]furan-2-carbonitrile Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC1=CC=C(C#N)O1 AEYSZOILUKCASB-UHFFFAOYSA-N 0.000 claims 1
- PPQXBZNPAPTITE-UHFFFAOYSA-N 5-[(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)methyl]thiophene-2-carbonitrile Chemical compound C12=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C(=O)N1CC1=CC=C(C#N)S1 PPQXBZNPAPTITE-UHFFFAOYSA-N 0.000 claims 1
- NBRHCZIHEJCBKZ-UHFFFAOYSA-N 5-bromo-1'-[(5-chlorothiophen-2-yl)methyl]spiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound S1C(Cl)=CC=C1CN1C2=CC=CC=C2C2(C3=CC(Br)=CC=C3OC2)C1=O NBRHCZIHEJCBKZ-UHFFFAOYSA-N 0.000 claims 1
- SQRCAJCXDFNPTF-UHFFFAOYSA-N 5-bromo-1'-[[5-(trifluoromethyl)furan-2-yl]methyl]spiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound O1C(C(F)(F)F)=CC=C1CN1C2=CC=CC=C2C2(C3=CC(Br)=CC=C3OC2)C1=O SQRCAJCXDFNPTF-UHFFFAOYSA-N 0.000 claims 1
- ZZKVOPMTRYYKPY-UHFFFAOYSA-N 5-bromo-1'-pentylspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC(Br)=CC=C2OC1 ZZKVOPMTRYYKPY-UHFFFAOYSA-N 0.000 claims 1
- PPWFSERJUPTWNR-UHFFFAOYSA-N 5-chloro-6-fluoro-1'-pentylspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC(Cl)=C(F)C=C2OC1 PPWFSERJUPTWNR-UHFFFAOYSA-N 0.000 claims 1
- PFQRXMCBQXRVIS-UHFFFAOYSA-N 5-fluoro-1'-pentylspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC(F)=CC=C2OC1 PFQRXMCBQXRVIS-UHFFFAOYSA-N 0.000 claims 1
- SBYOCLSPHLNULB-UHFFFAOYSA-N 5-methoxy-1'-methylspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound O=C1N(C)C2=CC=CC=C2C21COC1=CC=C(OC)C=C12 SBYOCLSPHLNULB-UHFFFAOYSA-N 0.000 claims 1
- IJNVDDNCCYOTSD-UHFFFAOYSA-N 5-methylspiro[1h-indole-3,7'-6h-furo[2,3-f][1,3]benzodioxole]-2-one Chemical compound C1OC2=CC=3OCOC=3C=C2C21C(=O)NC1=CC=C(C)C=C12 IJNVDDNCCYOTSD-UHFFFAOYSA-N 0.000 claims 1
- VPUBCXDXSSVQDE-UHFFFAOYSA-N 5-pyridin-3-yl-1'-[[5-(trifluoromethyl)furan-2-yl]methyl]spiro[2h-1-benzofuran-3,3'-indole]-2'-one;hydrochloride Chemical compound Cl.O1C(C(F)(F)F)=CC=C1CN1C2=CC=CC=C2C2(C3=CC(=CC=C3OC2)C=2C=NC=CC=2)C1=O VPUBCXDXSSVQDE-UHFFFAOYSA-N 0.000 claims 1
- CKRGXEMTPKIAEL-UHFFFAOYSA-N 6'-(trifluoromethoxy)spiro[1h-indole-3,3'-2h-1-benzofuran]-2-one Chemical compound O=C1NC2=CC=CC=C2C21COC1=CC(OC(F)(F)F)=CC=C21 CKRGXEMTPKIAEL-UHFFFAOYSA-N 0.000 claims 1
- OEPKGOWWBDEIIQ-UHFFFAOYSA-N 6-(benzenesulfonyl)-1'-pentylspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C1(C1=CC=2)COC1=CC=2S(=O)(=O)C1=CC=CC=C1 OEPKGOWWBDEIIQ-UHFFFAOYSA-N 0.000 claims 1
- XWJYMBRWLCQRRY-UHFFFAOYSA-N 6-(trifluoromethoxy)-1'-[[5-(trifluoromethyl)furan-2-yl]methyl]spiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C=1C(OC(F)(F)F)=CC=C2C=1OCC2(C1=CC=CC=C11)C(=O)N1CC1=CC=C(C(F)(F)F)O1 XWJYMBRWLCQRRY-UHFFFAOYSA-N 0.000 claims 1
- FGGQEIMBICIDLA-UHFFFAOYSA-N 6-amino-1'-pentylspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC=C(N)C=C2OC1 FGGQEIMBICIDLA-UHFFFAOYSA-N 0.000 claims 1
- ZAVBZQNMLWZJMX-UHFFFAOYSA-N 6-anilino-1'-pentylspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C1(C1=CC=2)COC1=CC=2NC1=CC=CC=C1 ZAVBZQNMLWZJMX-UHFFFAOYSA-N 0.000 claims 1
- YAKYDBPQWYLGPZ-UHFFFAOYSA-N 6-bromo-1'-pentylspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC=C(Br)C=C2OC1 YAKYDBPQWYLGPZ-UHFFFAOYSA-N 0.000 claims 1
- SOQYTKIOWNBWOA-UHFFFAOYSA-N 6-chloro-5-fluoro-1'-pentylspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC(F)=C(Cl)C=C2OC1 SOQYTKIOWNBWOA-UHFFFAOYSA-N 0.000 claims 1
- JEILWWWNOFYNRQ-UHFFFAOYSA-N 6-methoxy-1'-pentylspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC=C(OC)C=C2OC1 JEILWWWNOFYNRQ-UHFFFAOYSA-N 0.000 claims 1
- NRDWJIYWPFNLSQ-UHFFFAOYSA-N 6-methylsulfonyl-1'-pentylspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C11C2=CC=C(S(C)(=O)=O)C=C2OC1 NRDWJIYWPFNLSQ-UHFFFAOYSA-N 0.000 claims 1
- AEIWYFKETHNEGK-UHFFFAOYSA-N 6-morpholin-4-yl-1'-pentylspiro[2h-1-benzofuran-3,3'-indole]-2'-one Chemical compound C12=CC=CC=C2N(CCCCC)C(=O)C1(C1=CC=2)COC1=CC=2N1CCOCC1 AEIWYFKETHNEGK-UHFFFAOYSA-N 0.000 claims 1
- DSHIVAYEWOFVIH-UHFFFAOYSA-N 7'-fluoro-1'-[(1-propan-2-ylpiperidin-4-yl)methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one;hydrochloride Chemical compound Cl.C1CN(C(C)C)CCC1CN1C2=C(F)C=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O DSHIVAYEWOFVIH-UHFFFAOYSA-N 0.000 claims 1
- CEPYYQHSAKUBQI-UHFFFAOYSA-N 7'-fluoro-1'-[[5-(trifluoromethyl)furan-2-yl]methyl]spiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one Chemical compound FC1=CC=CC(C2(C3=CC=4OCOC=4C=C3OC2)C2=O)=C1N2CC1=CC=C(C(F)(F)F)O1 CEPYYQHSAKUBQI-UHFFFAOYSA-N 0.000 claims 1
- LZKDWTVHELAPBO-UHFFFAOYSA-N 7-fluorospiro[1h-indole-3,7'-6h-furo[2,3-f][1,3]benzodioxole]-2-one Chemical compound C1OC2=CC=3OCOC=3C=C2C21C(=O)NC1=C2C=CC=C1F LZKDWTVHELAPBO-UHFFFAOYSA-N 0.000 claims 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 claims 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims 1
- STTPCYUJMNXSBN-UHFFFAOYSA-N C(C)(=O)NN1C(C2(C3=CC=CC=C13)COC1=CC3=C(OCO3)C=C12)=O Chemical compound C(C)(=O)NN1C(C2(C3=CC=CC=C13)COC1=CC3=C(OCO3)C=C12)=O STTPCYUJMNXSBN-UHFFFAOYSA-N 0.000 claims 1
- OEDIQKSUQWJFPN-UHFFFAOYSA-N COC1=C(C=CC(=C1)OC)C1=C2C3(CN(C2=CC=C1)CCCCC)COC1=CC2=C(OCO2)C=C13 Chemical compound COC1=C(C=CC(=C1)OC)C1=C2C3(CN(C2=CC=C1)CCCCC)COC1=CC2=C(OCO2)C=C13 OEDIQKSUQWJFPN-UHFFFAOYSA-N 0.000 claims 1
- IDWUUFLFKAOALY-UHFFFAOYSA-N COC1=C(C=CC=C1OC)C1=C2C3(CN(C2=CC=C1)CCCCC)COC1=CC2=C(OCO2)C=C13 Chemical compound COC1=C(C=CC=C1OC)C1=C2C3(CN(C2=CC=C1)CCCCC)COC1=CC2=C(OCO2)C=C13 IDWUUFLFKAOALY-UHFFFAOYSA-N 0.000 claims 1
- BGXJZEBOMPRROK-UHFFFAOYSA-N COC=1C=C(C=CC1OC)C1=C2C3(CN(C2=CC=C1)CCCCC)COC1=CC2=C(OCO2)C=C13 Chemical compound COC=1C=C(C=CC1OC)C1=C2C3(CN(C2=CC=C1)CCCCC)COC1=CC2=C(OCO2)C=C13 BGXJZEBOMPRROK-UHFFFAOYSA-N 0.000 claims 1
- WVOXROWWXZWFDC-UHFFFAOYSA-N FC(C1=CC=C(O1)CN1C(C2(C3=CC=CC=C13)COC1=C2C=CC=C1)=O)(F)F Chemical compound FC(C1=CC=C(O1)CN1C(C2(C3=CC=CC=C13)COC1=C2C=CC=C1)=O)(F)F WVOXROWWXZWFDC-UHFFFAOYSA-N 0.000 claims 1
- RVLQQUOZHIBBJG-UHFFFAOYSA-N FC1=C(C=C(C=C1)F)C1=C2C3(CN(C2=CC=C1)CCCCC)COC1=CC2=C(OCO2)C=C13 Chemical compound FC1=C(C=C(C=C1)F)C1=C2C3(CN(C2=CC=C1)CCCCC)COC1=CC2=C(OCO2)C=C13 RVLQQUOZHIBBJG-UHFFFAOYSA-N 0.000 claims 1
- BOKIQFIMANCFNX-UHFFFAOYSA-N FC1=C(C=CC(=C1)F)C1=C2C3(CN(C2=CC=C1)CCCCC)COC1=CC2=C(OCO2)C=C13 Chemical compound FC1=C(C=CC(=C1)F)C1=C2C3(CN(C2=CC=C1)CCCCC)COC1=CC2=C(OCO2)C=C13 BOKIQFIMANCFNX-UHFFFAOYSA-N 0.000 claims 1
- ITQZSEIQROAGQG-UHFFFAOYSA-N FC=1C=C(C=C(C1)F)C1=C2C3(CN(C2=CC=C1)CCCCC)COC1=CC2=C(OCO2)C=C13 Chemical compound FC=1C=C(C=C(C1)F)C1=C2C3(CN(C2=CC=C1)CCCCC)COC1=CC2=C(OCO2)C=C13 ITQZSEIQROAGQG-UHFFFAOYSA-N 0.000 claims 1
- VYFFMOCQJZGCFT-UHFFFAOYSA-N N-(3-spiro[2H-indole-3,7'-6H-furo[2,3-f][1,3]benzodioxole]-1-ylpropyl)pentan-2-amine Chemical compound CC(CCC)NCCCN1CC2(C3=CC=CC=C13)COC1=CC3=C(OCO3)C=C12 VYFFMOCQJZGCFT-UHFFFAOYSA-N 0.000 claims 1
- KVFUJPMZXDDBMM-UHFFFAOYSA-N N-(cyclopropylmethyl)-3-spiro[2H-indole-3,7'-6H-furo[2,3-f][1,3]benzodioxole]-1-ylpropan-1-amine Chemical compound C1(CC1)CNCCCN1CC2(C3=CC=CC=C13)COC1=CC3=C(OCO3)C=C12 KVFUJPMZXDDBMM-UHFFFAOYSA-N 0.000 claims 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 claims 1
- 229960003497 diloxanide furoate Drugs 0.000 claims 1
- FATQAGNUVRSMIB-UHFFFAOYSA-N ethyl 1-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]triazole-4-carboxylate Chemical compound N1=NC(C(=O)OCC)=CN1CCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O FATQAGNUVRSMIB-UHFFFAOYSA-N 0.000 claims 1
- NTRWHMBZNOCPMX-UHFFFAOYSA-N ethyl 2-(2'-oxospiro[5,6,7,8-tetrahydro-2h-benzo[f][1]benzofuran-3,3'-indole]-1'-yl)acetate Chemical compound C12=CC=CC=C2N(CC(=O)OCC)C(=O)C11C2=CC(CCCC3)=C3C=C2OC1 NTRWHMBZNOCPMX-UHFFFAOYSA-N 0.000 claims 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 claims 1
- JWBUAECUYADEEN-UHFFFAOYSA-N ethyl 3-[2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)ethyl]triazole-4-carboxylate Chemical compound CCOC(=O)C1=CN=NN1CCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O JWBUAECUYADEEN-UHFFFAOYSA-N 0.000 claims 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 claims 1
- VFQXVTODMYMSMJ-UHFFFAOYSA-N isonicotinamide Chemical compound NC(=O)C1=CC=NC=C1 VFQXVTODMYMSMJ-UHFFFAOYSA-N 0.000 claims 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims 1
- HSIZASIWHAMQOI-UHFFFAOYSA-N morpholin-4-yl-[2-(spiro[2H-indole-3,7'-6H-furo[2,3-f][1,3]benzodioxole]-1-ylmethyl)phenyl]methanone Chemical compound N1(CCOCC1)C(=O)C1=C(CN2CC3(C4=CC=CC=C24)COC2=CC4=C(OCO4)C=C23)C=CC=C1 HSIZASIWHAMQOI-UHFFFAOYSA-N 0.000 claims 1
- SNRFNJSAKHUALQ-UHFFFAOYSA-N morpholin-4-yl-[3-(spiro[2H-indole-3,7'-6H-furo[2,3-f][1,3]benzodioxole]-1-ylmethyl)phenyl]methanone Chemical compound N1(CCOCC1)C(=O)C=1C=C(CN2CC3(C4=CC=CC=C24)COC2=CC4=C(OCO4)C=C23)C=CC=1 SNRFNJSAKHUALQ-UHFFFAOYSA-N 0.000 claims 1
- IYBWKOXBYJNXQL-UHFFFAOYSA-N n-(3-methoxyphenyl)-2'-oxo-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-4'-carboxamide Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C(=O)NC1=CC=CC(OC)=C1 IYBWKOXBYJNXQL-UHFFFAOYSA-N 0.000 claims 1
- HDPZTEKBHYBHGQ-UHFFFAOYSA-N n-[2-(2'-oxo-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-4'-yl)phenyl]acetamide Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=CC=C1NC(C)=O HDPZTEKBHYBHGQ-UHFFFAOYSA-N 0.000 claims 1
- DMFPIJUSNLWHPL-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]-1,3-benzodioxole-5-carboxamide Chemical compound C1=C2OCOC2=CC(C(NCCCN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=O)=C1 DMFPIJUSNLWHPL-UHFFFAOYSA-N 0.000 claims 1
- XEDWABXZBSQAAE-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]-1-benzofuran-2-carboxamide Chemical compound C1=CC=C2OC(C(NCCCN3C4=CC=CC=C4C4(C5=CC=6OCOC=6C=C5OC4)C3=O)=O)=CC2=C1 XEDWABXZBSQAAE-UHFFFAOYSA-N 0.000 claims 1
- LZFWYCKMKVHTQO-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]-1-benzofuran-5-carboxamide Chemical compound C1=C2OC=CC2=CC(C(NCCCN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=O)=C1 LZFWYCKMKVHTQO-UHFFFAOYSA-N 0.000 claims 1
- ZUCDACJDPOHXBA-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]-1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(NCCCN3C4=CC=CC=C4C4(C5=CC=6OCOC=6C=C5OC4)C3=O)=O)=CC2=C1 ZUCDACJDPOHXBA-UHFFFAOYSA-N 0.000 claims 1
- BYSBEDUKKWJWAT-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]-2,1,3-benzoxadiazole-5-carboxamide Chemical compound C1=CC2=NON=C2C=C1C(=O)NCCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O BYSBEDUKKWJWAT-UHFFFAOYSA-N 0.000 claims 1
- ZNNUMGQFGZISLM-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]-2,3-dihydro-1,4-benzodioxine-3-carboxamide Chemical compound C1OC2=CC=CC=C2OC1C(=O)NCCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O ZNNUMGQFGZISLM-UHFFFAOYSA-N 0.000 claims 1
- YUDQVLGHBWLFSJ-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]-2,3-dihydro-1,4-benzodioxine-6-carboxamide Chemical compound O1CCOC2=CC(C(NCCCN3C4=CC=CC=C4C4(C5=CC=6OCOC=6C=C5OC4)C3=O)=O)=CC=C21 YUDQVLGHBWLFSJ-UHFFFAOYSA-N 0.000 claims 1
- UFJIPMJAAFVHRY-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]-2,3-dihydro-1-benzofuran-2-carboxamide Chemical compound C1C2=CC=CC=C2OC1C(=O)NCCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O UFJIPMJAAFVHRY-UHFFFAOYSA-N 0.000 claims 1
- PDMPOSNNMOEGCX-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]-2,3-dihydro-1-benzothiophene-5-carboxamide Chemical compound C1=C2SCCC2=CC(C(NCCCN2C3=CC=CC=C3C3(C4=CC=5OCOC=5C=C4OC3)C2=O)=O)=C1 PDMPOSNNMOEGCX-UHFFFAOYSA-N 0.000 claims 1
- SFSQPKBQHDHDEH-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]-2-phenoxyacetamide Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCCNC(=O)COC1=CC=CC=C1 SFSQPKBQHDHDEH-UHFFFAOYSA-N 0.000 claims 1
- CVTMTOPJCJVFCK-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]-2-phenylacetamide Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCCNC(=O)CC1=CC=CC=C1 CVTMTOPJCJVFCK-UHFFFAOYSA-N 0.000 claims 1
- JCNFDRHCLWRIDA-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]-2-phenylcyclopropane-1-carboxamide Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCCNC(=O)C1CC1C1=CC=CC=C1 JCNFDRHCLWRIDA-UHFFFAOYSA-N 0.000 claims 1
- OTDNDLNCPZJDAX-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]-4-pentylbenzamide Chemical compound C1=CC(CCCCC)=CC=C1C(=O)NCCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O OTDNDLNCPZJDAX-UHFFFAOYSA-N 0.000 claims 1
- OUNBINIGIMXKRO-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]-4-phenoxybutanamide Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCCNC(=O)CCCOC1=CC=CC=C1 OUNBINIGIMXKRO-UHFFFAOYSA-N 0.000 claims 1
- LBEVWBQZCISJMT-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]-4-phenylbenzamide Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCCNC(=O)C(C=C1)=CC=C1C1=CC=CC=C1 LBEVWBQZCISJMT-UHFFFAOYSA-N 0.000 claims 1
- OHLNPHCZQVOWSK-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]-n-propanoylpropanamide Chemical compound C12=CC=CC=C2N(CCCN(C(=O)CC)C(=O)CC)C(=O)C11C2=CC(OCO3)=C3C=C2OC1 OHLNPHCZQVOWSK-UHFFFAOYSA-N 0.000 claims 1
- CVYVKTTVODLTIJ-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]adamantane-1-carboxamide Chemical compound C1C(C2)CC(C3)CC2CC13C(=O)NCCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O CVYVKTTVODLTIJ-UHFFFAOYSA-N 0.000 claims 1
- JGJSYBAEMYXNEE-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]benzo[b][1]benzazepine-11-carboxamide Chemical compound C12=CC=CC=C2C=CC2=CC=CC=C2N1C(=O)NCCCN1C2=CC=CC=C2C2(C3=CC=4OCOC=4C=C3OC2)C1=O JGJSYBAEMYXNEE-UHFFFAOYSA-N 0.000 claims 1
- HAVHDERMMUCLOC-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]cyclobutanecarboxamide Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCCNC(=O)C1CCC1 HAVHDERMMUCLOC-UHFFFAOYSA-N 0.000 claims 1
- DBPBYNMLMFZIAD-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]cyclohexanecarboxamide Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCCNC(=O)C1CCCCC1 DBPBYNMLMFZIAD-UHFFFAOYSA-N 0.000 claims 1
- TXRHSKQPBPLKIR-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]cyclopentanecarboxamide Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCCNC(=O)C1CCCC1 TXRHSKQPBPLKIR-UHFFFAOYSA-N 0.000 claims 1
- LWGJYWNGLNWLMT-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]cyclopropanecarboxamide Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCCNC(=O)C1CC1 LWGJYWNGLNWLMT-UHFFFAOYSA-N 0.000 claims 1
- WKDLRNCXURJAHP-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]furan-2-carboxamide Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCCNC(=O)C1=CC=CO1 WKDLRNCXURJAHP-UHFFFAOYSA-N 0.000 claims 1
- YBKDBLMTBJRPOD-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]morpholine-4-carboxamide Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCCNC(=O)N1CCOCC1 YBKDBLMTBJRPOD-UHFFFAOYSA-N 0.000 claims 1
- YVMBIZHYYBRUGY-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]naphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(C(NCCCN3C4=CC=CC=C4C4(C5=CC=6OCOC=6C=C5OC4)C3=O)=O)=CC=C21 YVMBIZHYYBRUGY-UHFFFAOYSA-N 0.000 claims 1
- VISQZFGDHOWXAN-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]piperidine-1-carboxamide Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCCNC(=O)N1CCCCC1 VISQZFGDHOWXAN-UHFFFAOYSA-N 0.000 claims 1
- MPEIGBVRBVPKKO-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]pyrrolidine-1-carboxamide Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CCCNC(=O)N1CCCC1 MPEIGBVRBVPKKO-UHFFFAOYSA-N 0.000 claims 1
- MSTSMEUSTNKDNJ-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]quinoline-2-carboxamide Chemical compound C1=CC=CC2=NC(C(NCCCN3C4=CC=CC=C4C4(C5=CC=6OCOC=6C=C5OC4)C3=O)=O)=CC=C21 MSTSMEUSTNKDNJ-UHFFFAOYSA-N 0.000 claims 1
- JOTULMXUKXFNOK-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]quinoxaline-2-carboxamide Chemical compound C1=CC=CC2=NC(C(NCCCN3C4=CC=CC=C4C4(C5=CC=6OCOC=6C=C5OC4)C3=O)=O)=CN=C21 JOTULMXUKXFNOK-UHFFFAOYSA-N 0.000 claims 1
- FZRFYUQKCGIQLB-UHFFFAOYSA-N n-[3-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)propyl]quinoxaline-6-carboxamide Chemical compound N1=CC=NC2=CC(C(NCCCN3C4=CC=CC=C4C4(C5=CC=6OCOC=6C=C5OC4)C3=O)=O)=CC=C21 FZRFYUQKCGIQLB-UHFFFAOYSA-N 0.000 claims 1
- MSPHMZMVPMFNLU-UHFFFAOYSA-N n-[4-(2'-oxo-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-4'-yl)phenyl]acetamide Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(NC(C)=O)C=C1 MSPHMZMVPMFNLU-UHFFFAOYSA-N 0.000 claims 1
- XMOYZIPJZUJADM-UHFFFAOYSA-N n-[4-(2'-oxo-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-4'-yl)phenyl]methanesulfonamide Chemical compound CCCCCN1C(=O)C2(C3=CC=4OCOC=4C=C3OC2)C2=C1C=CC=C2C1=CC=C(NS(C)(=O)=O)C=C1 XMOYZIPJZUJADM-UHFFFAOYSA-N 0.000 claims 1
- STOKLCVDTRXYDG-UHFFFAOYSA-N n-methyl-2-(2'-oxospiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-1'-yl)-n-phenylacetamide Chemical compound O=C1C2(C3=CC=4OCOC=4C=C3OC2)C2=CC=CC=C2N1CC(=O)N(C)C1=CC=CC=C1 STOKLCVDTRXYDG-UHFFFAOYSA-N 0.000 claims 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 claims 1
- LTHCSWBWNVGEFE-UHFFFAOYSA-N octanamide Chemical compound CCCCCCCC(N)=O LTHCSWBWNVGEFE-UHFFFAOYSA-N 0.000 claims 1
- YHCVARRIYRVSDU-UHFFFAOYSA-N piperidin-1-yl-[2-(spiro[2H-indole-3,7'-6H-furo[2,3-f][1,3]benzodioxole]-1-ylmethyl)phenyl]methanone Chemical compound N1(CCCCC1)C(=O)C1=C(CN2CC3(C4=CC=CC=C24)COC2=CC4=C(OCO4)C=C23)C=CC=C1 YHCVARRIYRVSDU-UHFFFAOYSA-N 0.000 claims 1
- QMLQNZKZOZHQLN-UHFFFAOYSA-N piperidin-1-yl-[3-(spiro[2H-indole-3,7'-6H-furo[2,3-f][1,3]benzodioxole]-1-ylmethyl)phenyl]methanone Chemical compound N1(CCCCC1)C(=O)C=1C=C(CN2CC3(C4=CC=CC=C24)COC2=CC4=C(OCO4)C=C23)C=CC=1 QMLQNZKZOZHQLN-UHFFFAOYSA-N 0.000 claims 1
- UBNKDWNSKPOKPE-UHFFFAOYSA-N piperidin-1-yl-[4-(spiro[2H-indole-3,7'-6H-furo[2,3-f][1,3]benzodioxole]-1-ylmethyl)phenyl]methanone Chemical compound N1(CCCCC1)C(=O)C1=CC=C(CN2CC3(C4=CC=CC=C24)COC2=CC4=C(OCO4)C=C23)C=C1 UBNKDWNSKPOKPE-UHFFFAOYSA-N 0.000 claims 1
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 claims 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 claims 1
- IEUPFYSGJKSMNE-UHFFFAOYSA-N spiro[1h-indole-3,3'-2h-1-benzofuran]-2-one Chemical compound C1OC2=CC=CC=C2C21C1=CC=CC=C1NC2=O IEUPFYSGJKSMNE-UHFFFAOYSA-N 0.000 claims 1
- BAXXKWCEAUTVQU-UHFFFAOYSA-N tert-butyl 5-methoxy-3-(2'-oxo-1'-pentylspiro[6h-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-4'-yl)indole-1-carboxylate Chemical compound C1=C(OC)C=C2C(C3=CC=CC4=C3C3(C5=CC=6OCOC=6C=C5OC3)C(=O)N4CCCCC)=CN(C(=O)OC(C)(C)C)C2=C1 BAXXKWCEAUTVQU-UHFFFAOYSA-N 0.000 claims 1
- 208000002193 Pain Diseases 0.000 description 40
- 102000018674 Sodium Channels Human genes 0.000 description 30
- 108010052164 Sodium Channels Proteins 0.000 description 30
- 230000036407 pain Effects 0.000 description 30
- 125000004432 carbon atom Chemical group C* 0.000 description 29
- 150000003254 radicals Chemical group 0.000 description 27
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 26
- 201000010099 disease Diseases 0.000 description 25
- 238000011282 treatment Methods 0.000 description 25
- 150000005840 aryl radicals Chemical class 0.000 description 18
- 108091006146 Channels Proteins 0.000 description 15
- 229940002612 prodrug Drugs 0.000 description 15
- 239000000651 prodrug Substances 0.000 description 15
- 241000124008 Mammalia Species 0.000 description 14
- 229910052799 carbon Inorganic materials 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 239000011734 sodium Substances 0.000 description 13
- 241000282414 Homo sapiens Species 0.000 description 12
- 229940079593 drug Drugs 0.000 description 12
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 208000004296 neuralgia Diseases 0.000 description 9
- 239000003195 sodium channel blocking agent Substances 0.000 description 9
- 208000021722 neuropathic pain Diseases 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 230000001404 mediated effect Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 208000000094 Chronic Pain Diseases 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 239000000730 antalgic agent Substances 0.000 description 6
- 239000001961 anticonvulsive agent Substances 0.000 description 6
- 206010003119 arrhythmia Diseases 0.000 description 6
- 125000004429 atom Chemical group 0.000 description 6
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 108020003175 receptors Proteins 0.000 description 6
- 102000005962 receptors Human genes 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 230000002159 abnormal effect Effects 0.000 description 5
- 208000005298 acute pain Diseases 0.000 description 5
- 229940035676 analgesics Drugs 0.000 description 5
- 230000006399 behavior Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 229940005483 opioid analgesics Drugs 0.000 description 5
- 239000012453 solvate Substances 0.000 description 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 4
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 102000016913 Voltage-Gated Sodium Channels Human genes 0.000 description 4
- 108010053752 Voltage-Gated Sodium Channels Proteins 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 210000003169 central nervous system Anatomy 0.000 description 4
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 206010015037 epilepsy Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 150000002430 hydrocarbons Chemical group 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 239000003589 local anesthetic agent Substances 0.000 description 4
- 229960005015 local anesthetics Drugs 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 230000001537 neural effect Effects 0.000 description 4
- 210000002569 neuron Anatomy 0.000 description 4
- 239000000014 opioid analgesic Substances 0.000 description 4
- 229940124636 opioid drug Drugs 0.000 description 4
- 210000001428 peripheral nervous system Anatomy 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- CFMYXEVWODSLAX-UHFFFAOYSA-N tetrodotoxin Natural products C12C(O)NC(=N)NC2(C2O)C(O)C3C(CO)(O)C1OC2(O)O3 CFMYXEVWODSLAX-UHFFFAOYSA-N 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 125000004385 trihaloalkyl group Chemical group 0.000 description 4
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 206010012335 Dependence Diseases 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 208000004454 Hyperalgesia Diseases 0.000 description 3
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 3
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 206010033799 Paralysis Diseases 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 3
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000003556 anti-epileptic effect Effects 0.000 description 3
- 239000003416 antiarrhythmic agent Substances 0.000 description 3
- 230000006793 arrhythmia Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 229960001948 caffeine Drugs 0.000 description 3
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 125000005842 heteroatom Chemical group 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 201000006417 multiple sclerosis Diseases 0.000 description 3
- 150000007530 organic bases Chemical class 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Chemical group 0.000 description 3
- 229960005489 paracetamol Drugs 0.000 description 3
- 208000019865 paroxysmal extreme pain disease Diseases 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 229940125794 sodium channel blocker Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- CFMYXEVWODSLAX-QOZOJKKESA-N tetrodotoxin Chemical compound O([C@@]([C@H]1O)(O)O[C@H]2[C@@]3(O)CO)[C@H]3[C@@H](O)[C@]11[C@H]2[C@@H](O)N=C(N)N1 CFMYXEVWODSLAX-QOZOJKKESA-N 0.000 description 3
- 229950010357 tetrodotoxin Drugs 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- 239000002023 wood Substances 0.000 description 3
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- QCXJEYYXVJIFCE-UHFFFAOYSA-N 4-acetamidobenzoic acid Chemical compound CC(=O)NC1=CC=C(C(O)=O)C=C1 QCXJEYYXVJIFCE-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010003591 Ataxia Diseases 0.000 description 2
- 208000020925 Bipolar disease Diseases 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 206010059027 Brugada syndrome Diseases 0.000 description 2
- 201000003883 Cystic fibrosis Diseases 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 2
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 208000010412 Glaucoma Diseases 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 206010065390 Inflammatory pain Diseases 0.000 description 2
- 108090000862 Ion Channels Proteins 0.000 description 2
- 102000004310 Ion Channels Human genes 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- QIAFMBKCNZACKA-UHFFFAOYSA-N N-benzoylglycine Chemical compound OC(=O)CNC(=O)C1=CC=CC=C1 QIAFMBKCNZACKA-UHFFFAOYSA-N 0.000 description 2
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 208000004983 Phantom Limb Diseases 0.000 description 2
- 206010056238 Phantom pain Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 206010036376 Postherpetic Neuralgia Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 102100038277 Prostaglandin G/H synthase 1 Human genes 0.000 description 2
- 108050003243 Prostaglandin G/H synthase 1 Proteins 0.000 description 2
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 2
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 208000034972 Sudden Infant Death Diseases 0.000 description 2
- 206010042440 Sudden infant death syndrome Diseases 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 230000036982 action potential Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 206010053552 allodynia Diseases 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 229940125681 anticonvulsant agent Drugs 0.000 description 2
- 229960003965 antiepileptics Drugs 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 125000002047 benzodioxolyl group Chemical group O1OC(C2=C1C=CC=C2)* 0.000 description 2
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 2
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 2
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 2
- 125000002619 bicyclic group Chemical group 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 2
- 229960000623 carbamazepine Drugs 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 125000003636 chemical group Chemical group 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229960003920 cocaine Drugs 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 206010013663 drug dependence Diseases 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229960002870 gabapentin Drugs 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229960001848 lamotrigine Drugs 0.000 description 2
- PYZRQGJRPPTADH-UHFFFAOYSA-N lamotrigine Chemical compound NC1=NC(N)=NN=C1C1=CC=CC(Cl)=C1Cl PYZRQGJRPPTADH-UHFFFAOYSA-N 0.000 description 2
- 229960004194 lidocaine Drugs 0.000 description 2
- 230000028161 membrane depolarization Effects 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- XTEGVFVZDVNBPF-UHFFFAOYSA-N naphthalene-1,5-disulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1S(O)(=O)=O XTEGVFVZDVNBPF-UHFFFAOYSA-N 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000002981 neuropathic effect Effects 0.000 description 2
- 230000004112 neuroprotection Effects 0.000 description 2
- 239000002581 neurotoxin Substances 0.000 description 2
- 231100000618 neurotoxin Toxicity 0.000 description 2
- 230000003040 nociceptive effect Effects 0.000 description 2
- 229940124637 non-opioid analgesic drug Drugs 0.000 description 2
- 230000001473 noxious effect Effects 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 229940127240 opiate Drugs 0.000 description 2
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 208000033808 peripheral neuropathy Diseases 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 210000003594 spinal ganglia Anatomy 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000011593 sulfur Chemical group 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N thiocyanic acid Chemical compound SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 2
- 230000008448 thought Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 206010044652 trigeminal neuralgia Diseases 0.000 description 2
- 125000004952 trihaloalkoxy group Chemical group 0.000 description 2
- 208000003663 ventricular fibrillation Diseases 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- VLPIATFUUWWMKC-SNVBAGLBSA-N (2r)-1-(2,6-dimethylphenoxy)propan-2-amine Chemical compound C[C@@H](N)COC1=C(C)C=CC=C1C VLPIATFUUWWMKC-SNVBAGLBSA-N 0.000 description 1
- BUJAGSGYPOAWEI-SECBINFHSA-N (2r)-2-amino-n-(2,6-dimethylphenyl)propanamide Chemical compound C[C@@H](N)C(=O)NC1=C(C)C=CC=C1C BUJAGSGYPOAWEI-SECBINFHSA-N 0.000 description 1
- 125000004642 (C1-C12) alkoxy group Chemical group 0.000 description 1
- 125000006711 (C2-C12) alkynyl group Chemical group 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 125000005988 1,1-dioxo-thiomorpholinyl group Chemical group 0.000 description 1
- 125000005877 1,4-benzodioxanyl group Chemical group 0.000 description 1
- SJJCQDRGABAVBB-UHFFFAOYSA-N 1-hydroxy-2-naphthoic acid Chemical compound C1=CC=CC2=C(O)C(C(=O)O)=CC=C21 SJJCQDRGABAVBB-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- 125000005987 1-oxo-thiomorpholinyl group Chemical group 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- BNYCHCAYYYRJSH-UHFFFAOYSA-N 1h-pyrazole-5-carboxamide Chemical class NC(=O)C1=CC=NN1 BNYCHCAYYYRJSH-UHFFFAOYSA-N 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- 229940013085 2-diethylaminoethanol Drugs 0.000 description 1
- 125000004635 2-oxazepinyl group Chemical group O1N(CC=CC=C1)* 0.000 description 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 1
- 125000004638 2-oxopiperazinyl group Chemical group O=C1N(CCNC1)* 0.000 description 1
- 125000004637 2-oxopiperidinyl group Chemical group O=C1N(CCCC1)* 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
- 125000005986 4-piperidonyl group Chemical group 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- BMFMQGXDDJALKQ-BYPYZUCNSA-N Argininic acid Chemical compound NC(N)=NCCC[C@H](O)C(O)=O BMFMQGXDDJALKQ-BYPYZUCNSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
- 229940124638 COX inhibitor Drugs 0.000 description 1
- LSPHULWDVZXLIL-UHFFFAOYSA-N Camphoric acid Natural products CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
- 206010058019 Cancer Pain Diseases 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- OKTJSMMVPCPJKN-NJFSPNSNSA-N Carbon-14 Chemical compound [14C] OKTJSMMVPCPJKN-NJFSPNSNSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000013138 Drug Receptors Human genes 0.000 description 1
- 108010065556 Drug Receptors Proteins 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000001640 Fibromyalgia Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- DSLZVSRJTYRBFB-UHFFFAOYSA-N Galactaric acid Natural products OC(=O)C(O)C(O)C(O)C(O)C(O)=O DSLZVSRJTYRBFB-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
- 101000620451 Homo sapiens Leucine-rich glioma-inactivated protein 1 Proteins 0.000 description 1
- 208000035154 Hyperesthesia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020844 Hyperthermia malignant Diseases 0.000 description 1
- 206010021036 Hyponatraemia Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 102100022275 Leucine-rich glioma-inactivated protein 1 Human genes 0.000 description 1
- 208000026709 Liddle syndrome Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000018717 Malignant hyperthermia of anesthesia Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010061533 Myotonia Diseases 0.000 description 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000007072 Nerve Growth Factors Human genes 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000000450 Pelvic Pain Diseases 0.000 description 1
- CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 206010037113 Pseudoaldosteronism Diseases 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 206010038678 Respiratory depression Diseases 0.000 description 1
- 208000005793 Restless legs syndrome Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039020 Rhabdomyolysis Diseases 0.000 description 1
- FTALBRSUTCGOEG-UHFFFAOYSA-N Riluzole Chemical compound C1=C(OC(F)(F)F)C=C2SC(N)=NC2=C1 FTALBRSUTCGOEG-UHFFFAOYSA-N 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010057040 Temperature intolerance Diseases 0.000 description 1
- 229940123445 Tricyclic antidepressant Drugs 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960004909 aminosalicylic acid Drugs 0.000 description 1
- 229960000836 amitriptyline Drugs 0.000 description 1
- KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 210000004727 amygdala Anatomy 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000001746 atrial effect Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000037424 autonomic function Effects 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 125000002785 azepinyl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000005870 benzindolyl group Chemical group 0.000 description 1
- 125000005875 benzo[b][1,4]dioxepinyl group Chemical group 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 description 1
- 125000000928 benzodioxinyl group Chemical group O1C(=COC2=C1C=CC=C2)* 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 125000005878 benzonaphthofuranyl group Chemical group 0.000 description 1
- 125000004619 benzopyranyl group Chemical group O1C(C=CC2=C1C=CC=C2)* 0.000 description 1
- 125000005874 benzothiadiazolyl group Chemical group 0.000 description 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 208000028683 bipolar I disease Diseases 0.000 description 1
- 208000025307 bipolar depression Diseases 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- LSPHULWDVZXLIL-QUBYGPBYSA-N camphoric acid Chemical compound CC1(C)[C@H](C(O)=O)CC[C@]1(C)C(O)=O LSPHULWDVZXLIL-QUBYGPBYSA-N 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 230000011128 cardiac conduction Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229960000590 celecoxib Drugs 0.000 description 1
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000012069 chiral reagent Substances 0.000 description 1
- SURLGNKAQXKNSP-DBLYXWCISA-N chlorin Chemical compound C\1=C/2\N/C(=C\C3=N/C(=C\C=4NC(/C=C\5/C=CC/1=N/5)=CC=4)/C=C3)/CC\2 SURLGNKAQXKNSP-DBLYXWCISA-N 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000012084 conversion product Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 229940111134 coxibs Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 229960002887 deanol Drugs 0.000 description 1
- 125000005507 decahydroisoquinolyl group Chemical group 0.000 description 1
- 125000004855 decalinyl group Chemical group C1(CCCC2CCCCC12)* 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229960000632 dexamfetamine Drugs 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229960002069 diamorphine Drugs 0.000 description 1
- 125000005509 dibenzothiophenyl group Chemical group 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- 125000005879 dioxolanyl group Chemical group 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 201000006517 essential tremor Diseases 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 125000003844 furanonyl group Chemical group 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 description 1
- 208000030304 gastrointestinal bleeding Diseases 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 210000000020 growth cone Anatomy 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 230000008543 heat sensitivity Effects 0.000 description 1
- 125000004447 heteroarylalkenyl group Chemical group 0.000 description 1
- 125000005980 hexynyl group Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- XGIHQYAWBCFNPY-AZOCGYLKSA-N hydrabamine Chemical compound C([C@@H]12)CC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC[C@@]1(C)CNCCNC[C@@]1(C)[C@@H]2CCC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC1 XGIHQYAWBCFNPY-AZOCGYLKSA-N 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- JYGFTBXVXVMTGB-UHFFFAOYSA-N indolin-2-one Chemical group C1=CC=C2NC(=O)CC2=C1 JYGFTBXVXVMTGB-UHFFFAOYSA-N 0.000 description 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000004628 isothiazolidinyl group Chemical group S1N(CCC1)* 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- 125000003965 isoxazolidinyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940099563 lactobionic acid Drugs 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 201000007004 malignant hyperthermia Diseases 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000012241 membrane hyperpolarization Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 229960003404 mexiletine Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000004412 neuroendocrine cell Anatomy 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 210000000929 nociceptor Anatomy 0.000 description 1
- 108091008700 nociceptors Proteins 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 229940121367 non-opioid analgesics Drugs 0.000 description 1
- 125000002868 norbornyl group Chemical group C12(CCC(CC1)C2)* 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000005060 octahydroindolyl group Chemical group N1(CCC2CCCCC12)* 0.000 description 1
- 125000005061 octahydroisoindolyl group Chemical group C1(NCC2CCCCC12)* 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229960005010 orotic acid Drugs 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229940116315 oxalic acid Drugs 0.000 description 1
- 125000000160 oxazolidinyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000000466 oxiranyl group Chemical group 0.000 description 1
- 125000005476 oxopyrrolidinyl group Chemical group 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 229940124583 pain medication Drugs 0.000 description 1
- 230000008050 pain signaling Effects 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000004963 pathophysiological condition Effects 0.000 description 1
- 235000019371 penicillin G benzathine Nutrition 0.000 description 1
- 125000005981 pentynyl group Chemical group 0.000 description 1
- 230000009984 peri-natal effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 230000002974 pharmacogenomic effect Effects 0.000 description 1
- 125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 description 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- 125000001644 phenoxazinyl group Chemical group C1(=CC=CC=2OC3=CC=CC=C3NC12)* 0.000 description 1
- 229960002036 phenytoin Drugs 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 238000002600 positron emission tomography Methods 0.000 description 1
- AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 description 1
- 229960001233 pregabalin Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 125000006410 propenylene group Chemical group 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 210000000449 purkinje cell Anatomy 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229960001404 quinidine Drugs 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 125000004621 quinuclidinyl group Chemical group N12C(CC(CC1)CC2)* 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229960004181 riluzole Drugs 0.000 description 1
- 229960000371 rofecoxib Drugs 0.000 description 1
- RZJQGNCSTQAWON-UHFFFAOYSA-N rofecoxib Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=C(C=2C=CC=CC=2)C(=O)OC1 RZJQGNCSTQAWON-UHFFFAOYSA-N 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 235000015598 salt intake Nutrition 0.000 description 1
- 201000000306 sarcoidosis Diseases 0.000 description 1
- 210000004116 schwann cell Anatomy 0.000 description 1
- 229940116353 sebacic acid Drugs 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000001044 sensory neuron Anatomy 0.000 description 1
- 229940125706 skeletal muscle relaxant agent Drugs 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000003797 solvolysis reaction Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000004685 tetrahydrates Chemical class 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 125000000147 tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000001984 thiazolidinyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000005985 thienyl[1,3]dithianyl group Chemical group 0.000 description 1
- 125000000464 thioxo group Chemical group S=* 0.000 description 1
- 229960002872 tocainide Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 102000035160 transmembrane proteins Human genes 0.000 description 1
- 108091005703 transmembrane proteins Proteins 0.000 description 1
- 238000012384 transportation and delivery Methods 0.000 description 1
- 238000011277 treatment modality Methods 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- 239000003029 tricyclic antidepressant agent Substances 0.000 description 1
- 150000004684 trihydrates Chemical class 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 125000005455 trithianyl group Chemical group 0.000 description 1
- 229910052722 tritium Inorganic materials 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229960002004 valdecoxib Drugs 0.000 description 1
- LNPDTQAFDNKSHK-UHFFFAOYSA-N valdecoxib Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1C1=CC=C(S(N)(=O)=O)C=C1 LNPDTQAFDNKSHK-UHFFFAOYSA-N 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 229940072358 xylocaine Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67089605P | 2005-04-11 | 2005-04-11 | |
| US60/670,896 | 2005-04-11 | ||
| PCT/US2006/014352 WO2006110917A2 (en) | 2005-04-11 | 2006-04-11 | Spiro-oxindole compounds and their uses as therapeutic agents |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012201716A Division JP5548745B2 (ja) | 2005-04-11 | 2012-09-13 | スピロオキシインドール化合物および治療剤としてのその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008535930A JP2008535930A (ja) | 2008-09-04 |
| JP2008535930A5 JP2008535930A5 (enExample) | 2011-01-20 |
| JP5118627B2 true JP5118627B2 (ja) | 2013-01-16 |
Family
ID=36952847
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008506802A Expired - Fee Related JP5118627B2 (ja) | 2005-04-11 | 2006-04-11 | スピロオキシインドール化合物および治療剤としてのその使用 |
| JP2012201716A Expired - Fee Related JP5548745B2 (ja) | 2005-04-11 | 2012-09-13 | スピロオキシインドール化合物および治療剤としてのその使用 |
| JP2014078569A Withdrawn JP2014129422A (ja) | 2005-04-11 | 2014-04-07 | スピロオキシインドール化合物および治療剤としてのその使用 |
| JP2016011773A Pending JP2016056212A (ja) | 2005-04-11 | 2016-01-25 | スピロオキシインドール化合物および治療剤としてのその使用 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012201716A Expired - Fee Related JP5548745B2 (ja) | 2005-04-11 | 2012-09-13 | スピロオキシインドール化合物および治療剤としてのその使用 |
| JP2014078569A Withdrawn JP2014129422A (ja) | 2005-04-11 | 2014-04-07 | スピロオキシインドール化合物および治療剤としてのその使用 |
| JP2016011773A Pending JP2016056212A (ja) | 2005-04-11 | 2016-01-25 | スピロオキシインドール化合物および治療剤としてのその使用 |
Country Status (30)
| Country | Link |
|---|---|
| US (4) | US7700641B2 (enExample) |
| EP (4) | EP2752417B1 (enExample) |
| JP (4) | JP5118627B2 (enExample) |
| KR (5) | KR20140063803A (enExample) |
| CN (2) | CN102153562B (enExample) |
| AR (1) | AR056968A1 (enExample) |
| AT (1) | ATE543825T1 (enExample) |
| AU (1) | AU2006235593B2 (enExample) |
| BR (1) | BRPI0607926A2 (enExample) |
| CA (3) | CA2853635C (enExample) |
| DK (1) | DK1888595T3 (enExample) |
| EC (1) | ECSP077852A (enExample) |
| ES (2) | ES2381683T3 (enExample) |
| HK (1) | HK1199874A1 (enExample) |
| HR (1) | HRP20070505B1 (enExample) |
| IL (1) | IL186616A (enExample) |
| MA (1) | MA29684B1 (enExample) |
| MX (1) | MX2007012636A (enExample) |
| MY (2) | MY158766A (enExample) |
| NO (1) | NO20074619L (enExample) |
| NZ (1) | NZ561210A (enExample) |
| PL (1) | PL1888595T3 (enExample) |
| PT (1) | PT1888595E (enExample) |
| RS (1) | RS52295B (enExample) |
| RU (1) | RU2415143C2 (enExample) |
| SG (1) | SG161262A1 (enExample) |
| SI (1) | SI1888595T1 (enExample) |
| TN (1) | TNSN07382A1 (enExample) |
| TW (1) | TWI374141B (enExample) |
| WO (1) | WO2006110917A2 (enExample) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9278088B2 (en) | 2002-02-19 | 2016-03-08 | Xenon Pharmaceuticals Inc. | Methods for identifying analgesic agents |
| MY145694A (en) | 2005-04-11 | 2012-03-30 | Xenon Pharmaceuticals Inc | Spiroheterocyclic compounds and their uses as therapeutic agents |
| MY158766A (en) | 2005-04-11 | 2016-11-15 | Xenon Pharmaceuticals Inc | Spiro-oxindole compounds and their uses as therapeutic agents |
| TW200833698A (en) * | 2006-10-12 | 2008-08-16 | Xenon Pharmaceuticals Inc | Spiroheterocyclic compounds and their uses as therapeutic agents |
| WO2008046087A2 (en) * | 2006-10-12 | 2008-04-17 | Xenon Pharmaceuticals Inc. | Spiro compounds and their uses as therapeutic agents |
| ATE545416T1 (de) * | 2006-10-12 | 2012-03-15 | Xenon Pharmaceuticals Inc | Verwendung von spiro-oxindol-verbindungen als therapeutika |
| CL2007002953A1 (es) * | 2006-10-12 | 2008-02-01 | Xenon Pharmaceuticals Inc | Compuestos derivados de espiro-oxindol; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del dolor, cancer, prurito, hiperplasia prostatica benigna, hipercolesterolemia. |
| JP2010522690A (ja) * | 2006-10-12 | 2010-07-08 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | 三環式スピロオキシインドール誘導体および治療薬としてのその使用 |
| US7553833B2 (en) * | 2007-05-17 | 2009-06-30 | Hoffmann-La Roche Inc. | 3,3-spiroindolinone derivatives |
| MX2010002938A (es) | 2007-09-24 | 2010-04-01 | Comentis Inc | Derivados de (3-hidroxi-4-amino-butan-2-il)-3-(2-tiazol-2-il-pirro lidin-1-carbonil)benzamida y compuestos relacionados como inhibidores de beta-secretasa para tratar enfermedad de alzheimer. |
| JP2010540628A (ja) * | 2007-10-04 | 2010-12-24 | メルク・シャープ・エンド・ドーム・コーポレイション | カルシウムチャネル遮断薬としてのn−置換されたオキシインドリン誘導体 |
| US8273749B2 (en) * | 2007-10-04 | 2012-09-25 | Merck Sharp & Dohme Corp. | N-substituted oxindoline derivatives as calcium channel blockers |
| HRP20150882T1 (hr) | 2008-10-17 | 2015-09-25 | Xenon Pharmaceuticals Inc. | Spirooksindolski spojevi i njihova upotreba kao terapijska sredstva |
| AU2014265116B2 (en) * | 2008-10-17 | 2017-02-02 | Xenon Pharmaceuticals Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
| WO2010045197A1 (en) * | 2008-10-17 | 2010-04-22 | Xenon Pharmaceuticals, Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
| US20110269788A1 (en) | 2008-12-29 | 2011-11-03 | Xenon Pharmaceuticals Inc. | Spiro-oxindole-derivatives as sodium channel blockers |
| AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
| AU2015224493B2 (en) * | 2009-06-29 | 2017-06-15 | Xenon Pharmaceuticals Inc. | Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents |
| MY165579A (en) * | 2009-10-14 | 2018-04-05 | Xenon Pharmaceuticals Inc | Synthetic methods for spiro-oxindole compounds |
| US20110086899A1 (en) * | 2009-10-14 | 2011-04-14 | Xenon Pharmaceuticals Inc. | Pharmaceutical compositions for oral administration |
| JP2013521232A (ja) * | 2010-02-26 | 2013-06-10 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | 局所投与のためのスピロオキシインドール化合物の医薬組成物および治療剤としてのその使用 |
| EP2593434A1 (en) | 2010-07-16 | 2013-05-22 | Purdue Pharma LP | Pyridine compounds as sodium channel blockers |
| WO2012049555A1 (en) | 2010-10-13 | 2012-04-19 | Lupin Limited | Spirocyclic compounds as voltage-gated sodium channel modulators |
| ES2583061T3 (es) | 2010-12-21 | 2016-09-16 | Bayer Intellectual Property Gmbh | Método para la producción de oxindoles sustituidos en el N con sulfonilo |
| HRP20161412T1 (hr) | 2011-06-27 | 2016-12-02 | Newron Pharmaceuticals S.P.A. | Fluorirani derivati arilalkilaminokarboksamida |
| EP2753317B1 (en) * | 2011-09-06 | 2020-02-26 | CuRNA, Inc. | TREATMENT OF DISEASES RELATED TO ALPHA SUBUNITS OF SODIUM CHANNELS, VOLTAGE-GATED (SCNxA) WITH SMALL MOLECULES |
| AU2013203824A1 (en) | 2012-03-16 | 2013-10-03 | Purdue Pharma L.P. | Substituted pyridines and pryimidines as sodium channel blockers |
| HK1205113A1 (en) | 2012-04-12 | 2015-12-11 | Xenon Pharmaceuticals Inc. | Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents |
| KR101719893B1 (ko) * | 2012-05-22 | 2017-03-24 | 제넨테크, 인크. | N-치환된 벤즈아미드 및 통증의 치료에서 이들의 용도 |
| US9714252B2 (en) | 2012-12-20 | 2017-07-25 | Purdue Pharma L.P. | Cyclic sulfonamides as sodium channel blockers |
| CN103554119B (zh) * | 2013-10-15 | 2015-09-16 | 华东师范大学 | 四氢呋喃并苯并二氢吡喃多环化合物的制备方法 |
| CN103554118B (zh) * | 2013-10-15 | 2015-08-19 | 华东师范大学 | 四氢呋喃并苯并二氢吡喃多环化合物及其应用 |
| CN103554120B (zh) * | 2013-10-16 | 2015-06-24 | 华东师范大学 | 3,3-螺(2-四氢呋喃)氧化吲哚多环状化合物的制备方法 |
| CN103554121B (zh) * | 2013-10-16 | 2015-06-24 | 华东师范大学 | 3,3-螺(2-四氢呋喃)氧化吲哚多环状化合物及其应用 |
| TW201623264A (zh) | 2014-03-29 | 2016-07-01 | 魯賓有限公司 | 作為電位閘控鈉通道調節劑之磺胺化合物 |
| US10730866B2 (en) | 2014-04-07 | 2020-08-04 | Purdue Pharma L.P. | Indole derivatives and use thereof |
| MX2016016363A (es) | 2014-06-12 | 2017-04-06 | Adamed Sp Zoo | Compuestos que comprenden un sistema de 1,1',2,5'-tetrahidroespiro [indol-3,2'-pirrol]-2,5'-diona como inhibidores de la interaccion de proteina-proteina p53-mdm2. |
| WO2016109795A1 (en) | 2014-12-31 | 2016-07-07 | Concert Pharmaceuticals, Inc. | Deuterated funapide and difluorofunapide |
| TW201636017A (zh) | 2015-02-05 | 2016-10-16 | 梯瓦製藥國際有限責任公司 | 以螺吲哚酮化合物之局部調配物治療帶狀疱疹後遺神經痛之方法 |
| US9840513B2 (en) * | 2015-07-16 | 2017-12-12 | Abbvie S.Á.R.L. | Substituted tricyclics and method of use |
| TW201722938A (zh) | 2015-09-04 | 2017-07-01 | 魯賓有限公司 | 作為電位閘控鈉通道調節子之磺醯胺化合物 |
| CN108699015A (zh) | 2015-12-18 | 2018-10-23 | 默沙东公司 | 对电压门控性钠通道具有选择性活性的羟基烷基胺-和羟基环烷基胺-取代的二胺-芳基磺胺化合物 |
| WO2017127409A1 (en) | 2016-01-20 | 2017-07-27 | Chemocentryx, Inc. | 2-oxindole compounds |
| US10118932B2 (en) | 2016-06-16 | 2018-11-06 | Xenon Pharmaceuticals Inc. | Solid state forms of spiro-oxindole compounds |
| WO2017218920A1 (en) | 2016-06-16 | 2017-12-21 | Teva Pharmaceuticals International Gmbh | Asymmetric synthesis of funapide |
| WO2018163077A1 (en) | 2017-03-08 | 2018-09-13 | Lupin Limited | Indanyl compounds as voltage gated sodium channel modulators |
| EP3592747A1 (en) | 2017-03-10 | 2020-01-15 | Council of Scientific and Industrial Research | Spirooxindole compounds as gsk3 inhibitors and process for preparation thereof |
| US10513515B2 (en) | 2017-08-25 | 2019-12-24 | Biotheryx, Inc. | Ether compounds and uses thereof |
| KR101857408B1 (ko) * | 2018-02-28 | 2018-05-14 | 경북대학교 산학협력단 | 탈모 예방 또는 치료용 조성물 |
| EP3830093A1 (en) | 2018-07-27 | 2021-06-09 | Biotheryx, Inc. | Bifunctional compounds as cdk modulators |
| CN108976243B (zh) * | 2018-08-23 | 2020-03-03 | 青岛农业大学 | 通过二甲基呋喃与含氧化吲哚邻羟基苄醇合成螺-色满-4,3′-氧化吲哚的合成方法 |
| US11897930B2 (en) | 2020-04-28 | 2024-02-13 | Anwita Biosciences, Inc. | Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications |
| KR102662391B1 (ko) | 2021-12-10 | 2024-05-03 | 원광대학교산학협력단 | 벤자제피노인돌 유도체 및 이의 제조 방법 |
| CN116173015B (zh) * | 2022-05-19 | 2024-09-20 | 四川大学 | 一种环己烯基异硫氰酸酯类化合物在制备Caspase-1抑制剂中的用途 |
| CN115160331B (zh) * | 2022-08-04 | 2023-06-02 | 青岛农业大学 | 一种氧化吲哚螺烯丙基取代色满骨架及其制备方法 |
| CN116554185B (zh) * | 2023-01-03 | 2025-07-08 | 中国科学技术大学 | 一种手性螺环氧化吲哚类化合物及其制备方法 |
| CN119823139A (zh) * | 2024-12-12 | 2025-04-15 | 武汉光化学技术研究院 | 一种手性螺环氧化吲哚类化合物及其合成方法 |
Family Cites Families (138)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3189617A (en) * | 1961-02-03 | 1965-06-15 | Sterling Drug Inc | 1-aryloxindoles and their preparation |
| DE1956237A1 (de) | 1969-11-08 | 1971-05-13 | Basf Ag | Spiro-pyrrolizidon-oxindole |
| DE2113343A1 (de) | 1971-03-19 | 1972-09-21 | Thiemann Chem Pharm Fab | Indolo[2,3-b] chinolone und Verfahren zu ihrer Herstellung |
| US3723459A (en) * | 1971-04-23 | 1973-03-27 | Mc Neil Labor Inc | 2-oxospiro (indoline -3,4{40 -thiochroman) derivatives |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| SE400966B (sv) * | 1975-08-13 | 1978-04-17 | Robins Co Inc A H | Forfarande for framstellning av 2-amino-3-(eller 5-)bensoyl-fenylettiksyror |
| US4670566A (en) * | 1979-07-12 | 1987-06-02 | A. H. Robins Company, Incorporated | 3-methyl-hio-4-(5-, 6-, or 7-)phenylindolindolin-2-ones |
| DE3019562A1 (de) * | 1980-05-22 | 1981-11-26 | Daimler-Benz Ag, 7000 Stuttgart | Vorrichtung zum steuern einer brennkraftmaschine |
| US4326525A (en) | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
| US4440785A (en) * | 1980-10-30 | 1984-04-03 | A. H. Robins Company, Inc. | Methods of using 2-aminobiphenylacetic acids, esters, and metal salts thereof to treat inflammation |
| US4438130A (en) * | 1981-11-12 | 1984-03-20 | The Upjohn Company | Analgesic 1-oxa-, aza- and thia-spirocyclic compounds |
| JPS60142984A (ja) | 1983-12-28 | 1985-07-29 | Kyorin Pharmaceut Co Ltd | 新規なスピロピロリジン−2,5−ジオン誘導体およびその製造法 |
| US4569942A (en) | 1984-05-04 | 1986-02-11 | Pfizer Inc. | N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents |
| JPS6130554A (ja) | 1984-07-23 | 1986-02-12 | Ono Pharmaceut Co Ltd | プロスタグランジン類似化合物のある特定の立体配置を有する異性体及びそれらを有効成分として含有する治療剤 |
| US4690943A (en) | 1984-09-19 | 1987-09-01 | Pfizer Inc. | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds |
| US4721721A (en) | 1984-12-18 | 1988-01-26 | Rorer Pharmaceutical Corporation | 6-(4-thiazole) compounds, cardiotonic compositions including the same, and their uses |
| JPS62194907A (ja) * | 1986-02-21 | 1987-08-27 | Bridgestone Corp | 外観の改良された低転り抵抗ラジアルタイヤ |
| DE3608088C2 (de) * | 1986-03-07 | 1995-11-16 | Schering Ag | Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten |
| WO1993012786A1 (en) | 1986-07-10 | 1993-07-08 | Howard Harry R Jr | Indolinone derivatives |
| GB2205103A (en) * | 1987-05-21 | 1988-11-30 | Shell Int Research | Modified block copolymers and process for the preparation thereof |
| IL87116A (en) * | 1987-07-17 | 1993-03-15 | Schering Ag | 9-halogen-(z)-prostaglandin derivatives and pharmaceutical compositions containing the same |
| US5182289A (en) * | 1988-06-14 | 1993-01-26 | Schering Corporation | Heterobicyclic compounds having antiinflammatory activity |
| KR930011300B1 (ko) | 1989-07-25 | 1993-11-29 | 다이호오 야꾸힌 고오교오 가부시끼가이샤 | 옥시인돌유도체 |
| DE3932953A1 (de) | 1989-10-03 | 1991-04-11 | Boehringer Mannheim Gmbh | Neue 2-bicyclo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE3935514A1 (de) | 1989-10-25 | 1991-05-02 | Boehringer Mannheim Gmbh | Neue bicyclo-imidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| US5023265A (en) * | 1990-06-01 | 1991-06-11 | Schering Corporation | Substituted 1-H-pyrrolopyridine-3-carboxamides |
| US5484778C1 (en) | 1990-07-17 | 2001-05-08 | Univ Cleveland Hospitals | Phthalocynine photosensitizers for photodynamic therapy and methods for their use |
| AU648359B2 (en) | 1990-11-22 | 1994-04-21 | Janssen Pharmaceutica N.V. | Isonicotinic acid derivatives |
| US5116854A (en) * | 1991-06-28 | 1992-05-26 | Pfizer Inc. | Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles |
| FR2686878B1 (fr) | 1992-01-30 | 1995-06-30 | Sanofi Elf | Derives du n-sulfonyl oxo-2 indole, leur preparation, les compositions pharmaceutiques en contenant. |
| US5663431A (en) * | 1992-01-30 | 1997-09-02 | Sanofi | 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
| FR2708605A1 (fr) | 1993-07-30 | 1995-02-10 | Sanofi Sa | Dérivés du N-sulfonylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant. |
| US5686624A (en) * | 1992-01-30 | 1997-11-11 | Sanofi | 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
| US5849780A (en) * | 1992-01-30 | 1998-12-15 | Sanofi | 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
| EP0654024A1 (en) | 1992-08-06 | 1995-05-24 | Warner-Lambert Company | 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties |
| US5278162A (en) * | 1992-09-18 | 1994-01-11 | The Du Pont Merck Pharmaceutical Company | 3,3'-disubstituted-1,3-dihydro-2H-pyrrolo[2,3-b]heterocyclic-2-one useful in the treatment of cognitive disorders of man |
| US5296478A (en) * | 1992-10-07 | 1994-03-22 | The Dupont Merck Pharmaceutical Co. | 1-substituted oxindoles as cognition enhancers |
| US5776936A (en) * | 1992-11-13 | 1998-07-07 | Pharmacia & Upjohn Company | Marcfortine/paraherquamide derivatives useful as antiparasitic agents |
| DE4242451A1 (de) | 1992-12-16 | 1994-06-23 | Basf Ag | Verfahren zur Herstellung von 5-Ringheterocyclen |
| US5298522A (en) | 1993-01-22 | 1994-03-29 | Pfizer Inc. | 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio |
| FR2708606B1 (fr) * | 1993-07-30 | 1995-10-27 | Sanofi Sa | Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant. |
| US5502072A (en) | 1993-11-26 | 1996-03-26 | Pfizer Inc. | Substituted oxindoles |
| AT400950B (de) * | 1994-02-04 | 1996-04-25 | Immodal Pharmaka Gmbh | Verfahren zur technischen herstellung definierter isomerengemische aus verbindungen mit spirozyklischen - aminocarboxyl- und/oder spirozyklischen - aminocarbonyl-systemen |
| CN1047386C (zh) * | 1994-04-07 | 1999-12-15 | 西玛夫公司 | 新型褪黑激素拮抗物螺旋[吲哚吡咯烷丁]衍生物,其制备方法及其作为药物产品的用途 |
| FR2722195B1 (fr) | 1994-07-07 | 1996-08-23 | Adir | Nouveaux derives de 1,3-dihydro-2h-pyrrolo(2,3-b) pyridin-2-ones et oxazolo(4,5-b) pyridin-2(3h)-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US5618819A (en) * | 1994-07-07 | 1997-04-08 | Adir Et Compagnie | 1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-(3H)-one compounds |
| CA2235686C (en) | 1995-10-24 | 2007-06-26 | Sanofi | Indolin-2-one derivatives, process for their production and the pharmaceutical compositions containing them |
| FR2740136B1 (fr) * | 1995-10-24 | 1998-01-09 | Sanofi Sa | Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant |
| HUP9600855A3 (en) | 1996-04-03 | 1998-04-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing tenidap |
| JPH1095766A (ja) | 1996-09-19 | 1998-04-14 | Sanwa Kagaku Kenkyusho Co Ltd | アセトアミド誘導体、及びその用途 |
| FR2757157B1 (fr) | 1996-12-13 | 1999-12-31 | Sanofi Sa | Derives d'indolin-2-one, procede pour leur preparation et compositions pharmaceutiques les contenant |
| EP0989856B1 (de) * | 1997-01-20 | 2010-05-12 | IMMODAL PHARMAKA GESELLSCHAFT m.b.H. | Verfahren und stoffe zur freisetzung eines wachstumsfaktors aus endothelzellen, und nach dem verfahren freigesetzter wachstumsfaktor sowie seine verwendung |
| NO317155B1 (no) * | 1997-02-04 | 2004-08-30 | Ono Pharmaceutical Co | <omega>-cykloalkyl-prostagladin-E<N>2</N>-derivater |
| PT1008588E (pt) * | 1997-02-10 | 2003-09-30 | Ono Pharmaceutical Co | Derivados da 11,15-o-diaklquil-prostaglandina e processo de producao dos mesmos e farmaco que os contem como ingrediente activo |
| NZ501236A (en) | 1997-05-07 | 2002-02-01 | Galen Chemicals Ltd | Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors in a polymer matrix and surrounded by a sheath |
| WO1999033794A1 (en) * | 1997-12-25 | 1999-07-08 | Ono Pharmaceutical Co., Ltd. | φ-CYCLOALKYL-PROSTAGLANDIN E2 DERIVATIVES |
| JP4087938B2 (ja) * | 1998-02-04 | 2008-05-21 | 高砂香料工業株式会社 | ヒノキチオ−ル類の分岐サイクロデキストリン包接化合物からなる抗菌剤およびそれを含有する組成物 |
| CZ302147B6 (cs) | 1998-04-01 | 2010-11-18 | Nortran Pharmaceuticals Inc. | Aminocyklohexyletherová sloucenina, použití této slouceniny pri výrobe léciva, farmaceutická kompozice tuto slouceninu obsahující a tato sloucenina a kompozice pro použití pri lécení |
| US20040038970A1 (en) * | 1998-06-12 | 2004-02-26 | Societe De Conseils De Recherches Etd' Application Scientifiques, S.A.S. A Paris, France Corp. | Beta-carboline compounds |
| CN1169808C (zh) * | 1998-06-12 | 2004-10-06 | 研究及应用科学协会股份有限公司 | β-咔啉化合物 |
| US6235780B1 (en) * | 1998-07-21 | 2001-05-22 | Ono Pharmaceutical Co., Ltd. | ω-cycloalkyl-prostaglandin E1 derivatives |
| AU5227999A (en) | 1998-07-27 | 2000-02-21 | Abbott Laboratories | Substituted oxazolines as antiproliferative agents |
| US6407101B1 (en) * | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
| US6355648B1 (en) * | 1999-05-04 | 2002-03-12 | American Home Products Corporation | Thio-oxindole derivatives |
| WO2000071129A1 (en) | 1999-05-21 | 2000-11-30 | Bristol-Myers Squibb Company | Pyrrolotriazine inhibitors of kinases |
| ES2306665T3 (es) * | 1999-07-21 | 2008-11-16 | Boehringer Ingelheim Pharmaceuticals Inc. | Pequeñas moleculas utiles en el tratamiento de la enfermedad inflamatoria. |
| US6566372B1 (en) * | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
| WO2001038564A2 (en) | 1999-11-26 | 2001-05-31 | Mcgill University | Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy |
| FR2807038B1 (fr) | 2000-04-03 | 2002-08-16 | Sanofi Synthelabo | Nouveaux derives d'indolin-2-one, leur preparation et les compositions pharmaceutiques les contenant |
| US20020045566A1 (en) | 2000-10-13 | 2002-04-18 | Gribkoff Valentin K. | Selective maxi-K potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof |
| CA2421594A1 (en) | 2000-11-10 | 2002-05-16 | John Arnold Werner | 3-substituted oxindole beta 3 agonists |
| US6670357B2 (en) * | 2000-11-17 | 2003-12-30 | Bristol-Myers Squibb Company | Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| RU2233082C2 (ru) * | 2001-06-26 | 2004-07-27 | Институт животноводства УААН | Регулятор вакуума доильного агрегата |
| US20030078278A1 (en) | 2001-06-26 | 2003-04-24 | Pfizer Inc. | Spiropiperidine compounds as ligands for ORL-1 receptor |
| ES2262817T3 (es) * | 2001-08-14 | 2006-12-01 | Eli Lilly And Company | Agonistas beta-3 oxindol 3-sustituidos. |
| US7244744B2 (en) | 2001-11-01 | 2007-07-17 | Icagen, Inc. | Piperidines |
| ATE455104T1 (de) | 2001-11-01 | 2010-01-15 | Icagen Inc | Pyrazolamide zur anwendung in der behandlung von schmerz |
| US7205407B2 (en) * | 2001-11-20 | 2007-04-17 | Eli Lilly And Company | 3-Substituted oxindole β3 agonists |
| SE0104341D0 (sv) * | 2001-12-20 | 2001-12-20 | Astrazeneca Ab | New use |
| WO2003064425A1 (en) | 2002-01-28 | 2003-08-07 | Pfizer Japan Inc. | N-substituted spiropiperidine compounds as ligands for orl-1 receptor |
| US6995144B2 (en) * | 2002-03-14 | 2006-02-07 | Eisai Co., Ltd. | Nitrogen containing heterocyclic compounds and medicines containing the same |
| US7250442B2 (en) | 2002-03-15 | 2007-07-31 | Eli Lilly And Company | Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators |
| GB0213715D0 (en) | 2002-06-14 | 2002-07-24 | Syngenta Ltd | Chemical compounds |
| CN1662206A (zh) | 2002-06-25 | 2005-08-31 | 惠氏公司 | 硫代-2-羟基吲哚衍生物在治疗皮肤病中的用途 |
| AU2003245637A1 (en) | 2002-06-25 | 2004-01-06 | Wyeth | Use of thio-oxindole derivatives in treatment of hormone-related conditions |
| US7256218B2 (en) | 2002-11-22 | 2007-08-14 | Jacobus Pharmaceutical Company, Inc. | Biguanide and dihydrotriazine derivatives |
| EP1626722A1 (en) * | 2003-05-16 | 2006-02-22 | Pfizer Products Inc. | Method for enhancing cognition using ziprasidone |
| CA2525868A1 (en) * | 2003-05-16 | 2004-11-25 | Pfizer Products Inc. | Anxiety treatments with ziprasidone |
| WO2004100954A1 (en) * | 2003-05-16 | 2004-11-25 | Pfizer Products Inc. | Treatment of psychotic and depressive disorders |
| CA2525326A1 (en) * | 2003-05-16 | 2004-11-25 | Pfizer Products Inc. | Treatment of bipolar disorders and associated symptoms |
| CN101693697A (zh) | 2003-07-30 | 2010-04-14 | 泽农医药公司 | 哌嗪衍生物和它们作为治疗剂的用途 |
| DE10337184A1 (de) | 2003-08-13 | 2005-03-10 | Gruenenthal Gmbh | Substituierte 3-Pyrrolidin-Indol-Derivate |
| WO2005016913A1 (en) * | 2003-08-19 | 2005-02-24 | Pfizer Japan, Inc. | Tetrahydroisoquinoline or isochroman compounds as orl-1 receptor ligands for the treatment of pain and cns disorders |
| JPWO2005035498A1 (ja) * | 2003-10-08 | 2006-12-21 | 住友製薬株式会社 | 含窒素二環性化合物の摂食調節剤としての用途 |
| EP1557166A1 (en) | 2004-01-21 | 2005-07-27 | Newron Pharmaceuticals S.p.A. | Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders |
| US7507760B2 (en) * | 2004-01-22 | 2009-03-24 | Neuromed Pharmaceuticals Ltd. | N-type calcium channel blockers |
| GB0406867D0 (en) | 2004-03-26 | 2004-04-28 | F2G Ltd | Antifungal agents |
| BRPI0509377A (pt) | 2004-03-29 | 2007-09-11 | Pfizer | compostos de ácido alfa arila ou heteroaril metil beta piperidino propanóico como antagonistas do receptor orl1 |
| WO2005099689A1 (en) | 2004-04-01 | 2005-10-27 | Case Western Reserve University | Topical delivery of phthalocyanines |
| GT200500063A (es) | 2004-04-01 | 2005-10-14 | Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias | |
| US20070299102A1 (en) * | 2004-04-08 | 2007-12-27 | Topo Target A/S | Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer |
| AU2005237520B2 (en) | 2004-04-27 | 2012-01-19 | Wyeth | Purification of progesterone receptor modulators |
| EP1742920A2 (en) | 2004-05-05 | 2007-01-17 | Unibioscreen S.A. | Naphthalimide derivatives for the treatment of cancer |
| TWI350168B (en) | 2004-05-07 | 2011-10-11 | Incyte Corp | Amido compounds and their use as pharmaceuticals |
| JP2007537235A (ja) | 2004-05-14 | 2007-12-20 | ファイザー・プロダクツ・インク | 異常細胞増殖の治療用ピリミジン誘導体 |
| MXPA06014573A (es) | 2004-06-24 | 2007-03-12 | Incyte Corp | Compuestos amido y su uso como farmaceuticos. |
| GT200500186A (es) | 2004-07-07 | 2006-03-02 | Regimenes anticonceptivos con antagonistas del receptor de progesterona y kits | |
| GT200500185A (es) | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
| GT200500183A (es) | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
| JP4677323B2 (ja) | 2004-11-01 | 2011-04-27 | キヤノン株式会社 | 画像処理装置及び画像処理方法 |
| CA2587153A1 (en) | 2004-11-18 | 2006-05-26 | Incyte Corporation | Inhibitors of 11-.beta. hydroxyl steroid dehydrogenase type 1 and methods of using the same |
| DE102005007694A1 (de) | 2005-02-18 | 2006-09-21 | Henkel Kgaa | Mittel zum Färben von keratinhaltigen Fasern |
| KR100944301B1 (ko) | 2005-02-22 | 2010-02-24 | 더 리젠츠 오브 더 유니버시티 오브 미시간 | Mdm2의 소분자 억제제 및 이의 용도 |
| MY158766A (en) | 2005-04-11 | 2016-11-15 | Xenon Pharmaceuticals Inc | Spiro-oxindole compounds and their uses as therapeutic agents |
| MY145694A (en) * | 2005-04-11 | 2012-03-30 | Xenon Pharmaceuticals Inc | Spiroheterocyclic compounds and their uses as therapeutic agents |
| AR053713A1 (es) | 2005-04-20 | 2007-05-16 | Xenon Pharmaceuticals Inc | Compuestos heterociclicos y sus usos como agentes terapeuticos |
| AR056317A1 (es) * | 2005-04-20 | 2007-10-03 | Xenon Pharmaceuticals Inc | Compuestos de oxindol y composicion farmaceutica |
| CN101166722A (zh) * | 2005-04-29 | 2008-04-23 | 惠氏公司 | 制备3,3-二取代的羟吲哚和硫代羟吲哚的方法 |
| WO2006125048A2 (en) * | 2005-05-16 | 2006-11-23 | Gilead Sciences, Inc. | Hiv-integrase inhibitor compounds |
| PL1924264T3 (pl) * | 2005-09-01 | 2014-03-31 | Hoffmann La Roche | Diaminopirymidyny jako modulatory P2X<sub>3</sub> I P2X<sub>2/3</sub> |
| TW200833698A (en) | 2006-10-12 | 2008-08-16 | Xenon Pharmaceuticals Inc | Spiroheterocyclic compounds and their uses as therapeutic agents |
| WO2008046082A2 (en) | 2006-10-12 | 2008-04-17 | Xenon Pharmaceuticals Inc. | Use of heterocyclic compounds as therapeutic agents |
| JP2010522690A (ja) | 2006-10-12 | 2010-07-08 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | 三環式スピロオキシインドール誘導体および治療薬としてのその使用 |
| WO2008046087A2 (en) | 2006-10-12 | 2008-04-17 | Xenon Pharmaceuticals Inc. | Spiro compounds and their uses as therapeutic agents |
| CL2007002953A1 (es) | 2006-10-12 | 2008-02-01 | Xenon Pharmaceuticals Inc | Compuestos derivados de espiro-oxindol; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del dolor, cancer, prurito, hiperplasia prostatica benigna, hipercolesterolemia. |
| WO2008046084A2 (en) | 2006-10-12 | 2008-04-17 | Xenon Pharmaceuticals Inc. | Spiroheterocyclic compounds and their uses as therapeutic agents |
| ATE545416T1 (de) * | 2006-10-12 | 2012-03-15 | Xenon Pharmaceuticals Inc | Verwendung von spiro-oxindol-verbindungen als therapeutika |
| WO2008046083A2 (en) | 2006-10-12 | 2008-04-17 | Xenon Pharmaceuticals Inc. | Use of oxindole compounds as therapeutic agents |
| WO2008117050A1 (en) | 2007-03-27 | 2008-10-02 | Astrazeneca Ab | Pyrazolyl-amino-substituted pyrazines and their use for the treatment of cancer |
| WO2010045197A1 (en) | 2008-10-17 | 2010-04-22 | Xenon Pharmaceuticals, Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
| HRP20150882T1 (hr) | 2008-10-17 | 2015-09-25 | Xenon Pharmaceuticals Inc. | Spirooksindolski spojevi i njihova upotreba kao terapijska sredstva |
| WO2010053998A1 (en) | 2008-11-05 | 2010-05-14 | Xenon Pharmaceuticals, Inc. | Spiro-condensed indole derivatives as sodium channel inhibitors |
| US20110269788A1 (en) | 2008-12-29 | 2011-11-03 | Xenon Pharmaceuticals Inc. | Spiro-oxindole-derivatives as sodium channel blockers |
| WO2010132352A2 (en) | 2009-05-11 | 2010-11-18 | Xenon Pharmaceuticals Inc. | Spiro compounds and their use as therapeutic agents |
| AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
| US20110086899A1 (en) * | 2009-10-14 | 2011-04-14 | Xenon Pharmaceuticals Inc. | Pharmaceutical compositions for oral administration |
| MY165579A (en) * | 2009-10-14 | 2018-04-05 | Xenon Pharmaceuticals Inc | Synthetic methods for spiro-oxindole compounds |
| JP2013521232A (ja) | 2010-02-26 | 2013-06-10 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | 局所投与のためのスピロオキシインドール化合物の医薬組成物および治療剤としてのその使用 |
-
2006
- 2006-04-10 MY MYPI2010003197A patent/MY158766A/en unknown
- 2006-04-10 AR ARP060101418A patent/AR056968A1/es unknown
- 2006-04-10 MY MYPI20061652A patent/MY144968A/en unknown
- 2006-04-11 EP EP14001216.2A patent/EP2752417B1/en not_active Not-in-force
- 2006-04-11 CA CA2853635A patent/CA2853635C/en not_active Expired - Fee Related
- 2006-04-11 AT AT06750402T patent/ATE543825T1/de active
- 2006-04-11 PT PT06750402T patent/PT1888595E/pt unknown
- 2006-04-11 KR KR1020147009732A patent/KR20140063803A/ko not_active Ceased
- 2006-04-11 RS RS20120184A patent/RS52295B/sr unknown
- 2006-04-11 CA CA2956647A patent/CA2956647A1/en not_active Abandoned
- 2006-04-11 ES ES06750402T patent/ES2381683T3/es active Active
- 2006-04-11 WO PCT/US2006/014352 patent/WO2006110917A2/en not_active Ceased
- 2006-04-11 AU AU2006235593A patent/AU2006235593B2/en not_active Ceased
- 2006-04-11 EP EP11009687.2A patent/EP2428515B9/en not_active Not-in-force
- 2006-04-11 CN CN201110027693.XA patent/CN102153562B/zh not_active Expired - Fee Related
- 2006-04-11 NZ NZ561210A patent/NZ561210A/en unknown
- 2006-04-11 EP EP17000910.4A patent/EP3241834A1/en not_active Withdrawn
- 2006-04-11 TW TW095112903A patent/TWI374141B/zh not_active IP Right Cessation
- 2006-04-11 JP JP2008506802A patent/JP5118627B2/ja not_active Expired - Fee Related
- 2006-04-11 KR KR1020077026134A patent/KR101402557B1/ko not_active Expired - Fee Related
- 2006-04-11 PL PL06750402T patent/PL1888595T3/pl unknown
- 2006-04-11 DK DK06750402.7T patent/DK1888595T3/da active
- 2006-04-11 US US11/402,310 patent/US7700641B2/en active Active
- 2006-04-11 HR HRP20070505AA patent/HRP20070505B1/hr not_active IP Right Cessation
- 2006-04-11 MX MX2007012636A patent/MX2007012636A/es active IP Right Grant
- 2006-04-11 RU RU2007141632/04A patent/RU2415143C2/ru not_active IP Right Cessation
- 2006-04-11 KR KR1020167030733A patent/KR20160130864A/ko not_active Withdrawn
- 2006-04-11 BR BRPI0607926-1A patent/BRPI0607926A2/pt not_active IP Right Cessation
- 2006-04-11 CN CNA2006800117339A patent/CN101184761A/zh active Pending
- 2006-04-11 KR KR1020157020622A patent/KR20150091542A/ko not_active Withdrawn
- 2006-04-11 SI SI200631311T patent/SI1888595T1/sl unknown
- 2006-04-11 ES ES11009687.2T patent/ES2488618T3/es active Active
- 2006-04-11 SG SG201002513-8A patent/SG161262A1/en unknown
- 2006-04-11 EP EP06750402A patent/EP1888595B1/en not_active Not-in-force
- 2006-04-11 KR KR1020137016857A patent/KR101432460B1/ko not_active Expired - Fee Related
- 2006-04-11 CA CA2604115A patent/CA2604115C/en not_active Expired - Fee Related
-
2007
- 2007-09-12 NO NO20074619A patent/NO20074619L/no not_active Application Discontinuation
- 2007-10-10 TN TNP2007000382A patent/TNSN07382A1/en unknown
- 2007-10-11 IL IL186616A patent/IL186616A/en not_active IP Right Cessation
- 2007-10-30 MA MA30344A patent/MA29684B1/fr unknown
- 2007-10-30 EC EC2007007852A patent/ECSP077852A/es unknown
-
2009
- 2009-12-30 US US12/650,196 patent/US8106087B2/en active Active
- 2009-12-30 US US12/650,218 patent/US7935721B2/en not_active Expired - Fee Related
-
2011
- 2011-04-01 US US13/078,678 patent/US20120122909A9/en not_active Abandoned
-
2012
- 2012-09-13 JP JP2012201716A patent/JP5548745B2/ja not_active Expired - Fee Related
-
2014
- 2014-04-07 JP JP2014078569A patent/JP2014129422A/ja not_active Withdrawn
-
2015
- 2015-01-08 HK HK15100208.1A patent/HK1199874A1/en unknown
-
2016
- 2016-01-25 JP JP2016011773A patent/JP2016056212A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5118627B2 (ja) | スピロオキシインドール化合物および治療剤としてのその使用 | |
| JP5460324B2 (ja) | 治療剤としてのスピロ−オキシインドール化合物の使用 | |
| JP2008536941A (ja) | オキシインドール化合物および治療剤としてのその使用 | |
| JP2008535916A (ja) | スピロ複素環化合物および治療剤としてのその使用 | |
| JP2008536942A (ja) | 2−ピロリドン誘導体および炎症状態および疼痛の治療のためのその使用 | |
| HK1113682A (en) | Spiro-oxindole compounds and their uses as therapeutic agents | |
| HK1161873B (en) | Spiro-oxindole compounds and their uses as therapeutic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090209 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090209 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101125 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20111012 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111122 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120220 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120227 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120321 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120328 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120413 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120423 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20120413 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120516 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120913 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20120925 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20121015 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20121019 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20151026 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |